فریدون عزیزی

Fereidoun Azizi, M.D.

Director, Endocrine Research Center, SBUMS

Professor of Internal Medicine, Endocrinology and Metabolism

Short CV

Born in 1942, in Tehran, the capital city of Iran, Fereidoun Azizi obtained his MD from Tehran University, School of Medicine in 1966, Dr. Azizi then completed his internal medicine speciality, endocrinology and methabolism subspeciality and nuclear medicine speciality from Tufts University, School of Medicine, Boston, USA and obtained three American Boards of Internal Medicine, Endocrinology and Metabolism, and Nuclear Medicine in 1972, 1973 and 1974, respectively. He was appointed assistant professor of medicine at Tufts University, and Chief of Endocrinology and acting-chief of Nuclear Medicine at St. Elizabeth’s Hospital of Boston, Tufts Medical School from 1974 until 1979, when he returned to Iran. He began his affilation with Beheshti University, and has since served as associate professor in 1979 and as professor of medicine and endocrinology since 1985. His appointements have been Dean of the medical school, Chancellor of Shahid Beheshti University of Medical Sciences, Head of the medical group of Supreme Council for Educational Programming and Director of Medical Commission of Council for Scientific Research in the Islamic Republic of Iran. He has served as President of Iranian College of Internal Medicine and is currently the president of the Iran Endocrine Society and Scientific Vice-President of Iranian Academy of Medical Sciences.

            Professor Azizi’s many research contributions have been in various fields of endocrinology and metabolism, in particular the hypothalamic-pituitary-thyroid axis. He began his work with Professor L.E. Braverman in Boston and continued his interest in thyroid pathophysiology in Iran. He focused many of his research projects in 80’s in iodine deficiency in Iran, presented the results to the Minister of Health of Iran in 1988 and initiated the first national IDD survey, which led to the formation of National Council for Control of Iodine Deficiency Disorders in Iran in 1989; as the head of this council, he has been working with all related officials of the government for monitoring of IDD programs, in order to ensure sustained elimination of iodine deficiency in the last 20 years in Iran.

Professot Azizi was the Regional Coordinator for the Middle East and North Africa of Internaltional Council for Control of Iodine Deficiency Disorders (ICCIDD) and served as consultant and advisor to WHO and UNICEF on multiple occasions. He is the Editor-in-Chief of the International Journal of Endocrinology and Metabolism. Professor Azizi has published 685 peer reviewed international paper and 600 scientific papers in Iranian medical Journals and has contributed chapters to many scientific books. He is an invited reviewer for more than 20 scientific medical journals and 30 full text or chapters in scientific books. He is an invited reviewer for more than 26 scientific medical journals. He has received many awards including five awards from presidents of I.R. Iran for “Distinguished Professor”, “Research Excellence”, “Kharazmi Festival”, “Distinguished Research Center”and “Health Promition” in 1992, 1994, 1997, 2002 and 2008; State of Kwait Prize for excellence in diabetes in Eastern Mediterranean Region in 2007 and Nagataki Prize from Asia-Oceania Congress of Endocrinology in 2009. He was selected, as Distinguished Scienctist of the Year by Iranian Academy of Medical Sciences in 2011. Professor Azizi has been announced as “the most prominent scientist of the Islamic World by ISC in 2009, 2011 and 2013. He received Allameh Tabatabai Prize from the president of the Islamic Republic of Iran in 2012.

Professor Azizi has been the Leading Professor and Director of Endocrine Division at Taleghani Medical center, Shahid Beheshti University of Medical Sciences since 1989 and Director of Endocrine Research Center since 1994. He has had a large endocrine practice since 1979.

1. Azizi F, Post-transfusion hepatitis rate unknown. New Eng J Med 1971; 285:1321-2.
2. Azizi F, Vagenakis A, Reichlin S, Braverman L, Ingbar S: Persistent thyroregulatory dysfunction in rats made hyperthyroid at birth. Program of American Thyroid Association, 48th meeting, September 1972.
3. Azizi F, Vagenakis A, Corman A, Patch V, Samaraweera A, Braverman L, Ingbar: Depression of peripheral thyroxine turnover in heroin addicts. J Clin Invest 1972; 51:7a.
4. Azizi F: Liver disease in addicts. Ann Int Med 1972; 76: 829-30.
5. Abreau C, Azizi F, Vagenakis A, Ingbar S, Braverman LE: Clinical evaluation of a new method for indirectly measuring serum free T4 concentration. J Nucl Med 1973; 14: 159-63.
6. Azizi F, Castelli W, Pabon M, Mitchell M. Effect of growth hormone on plasma triglycerides in man. Proc Soc Exp Biol 1973; 143: 1187-90.
7. Portnay GI, Abreau C, Azizi F, Vagenakis A, Braverman LE: A single test for measuring serum concentration of thyroxine (T₄ (D)) and free thyroxine (FT₄). Clinical Research 1973; 21: 500.
8. Abreau C, Vagenakis A, Azizi, F, Portnay GI, Braverman LE: A single method for measuring thyroxine and free thyroxine in serum. J Nucl Med 1973; 14: 740-6.
9. Azizi F, Braverman LE: Free thyroxine equivalent. Bul. IMA 1973; 4: 10-4.
10. Azizi F, Portnay GI, Vagenakis A, Rapoport B, Ingbar S, Braverman LE: Pituitary-thyroid response to intramuscular TRH. Clinical Research 1973; 21: 484.
11. Azizi F, Vagenakis A, Langcope C, Ingbar S, Braverman LE: Decreased serum testosterone concentration in male heroin and methadone addicts. Steroids 1973; 22: 467-72.
12. Vagenakis A, Azizi F, Portnay GI, Derideer J, Braverman LE, Ingbar S. Diminished TSH reserve following long term thyroid suppression.  J Clin Invest 1973; 52: 85a.
13. Azizi F, Vagenakis A, Bollinger J, Ingbar S, Braverman LE: Functional response of pituitary and thyroid to a large dose of TRH in the rat. Program of the 55th Annual Meeting of Endocrine Society 1973; p 291.
14. Portnay GO, Brien J, Bush JE, Vagenakis A, Azizi F, Arky RA, Ingbar S, Braverman LE: Effects of prolonged starvation on serum TSH, T₄ and T₃ concentration in man. Clinical Research 1973; 21: 958.
15. Azizi F, Vagenakis AG, Bollinger J. The effect of single large dose of thyrotropin releasing hormone on various aspects of thyroid function in the rat. Endocrinology 1974; 95: 1767-70.
16. Azizi F. Agranulocytosis from methaqualone? Annals of Internal Medicine 1974; 81: 268-9.
17. Azizi F, Vagenakis AG, Ingbar SH, Braverman LE. Permanent alterations in feedback control of TSH secretion in rats treated with TRH during the neonatal period. Clinical Research 1974; 22: 690A.
18. Azizi F, Vagenkis A, Bollinger J, Reichlin S, Braverman LE, Ingbar S: Persistent abnormalities in pituitary function following neonatal thyrotoxicosis in the rat. Endocrinology 1974; 94: 1681-88.
19. Azizi F, Vagenakis A, Portnay GI, Braverman LE, Ingbar S: Thyroxine transport and metabolism in methadone and heroin addicts. Ann Int Med 1974; 80: 194-9.
20. Azizi F, Vagenakis A, Bush J, Braverman LE: The effect of propranolol on various aspects of thyroid function in the rat. Metabolism 1974; 23: 525-9.
21. Azizi F, Chandler C, Bozorgzadeh H, Braverman LE: The occurrence of hyperthyroidism in patients with Downs' syndrome. Johns Hopkins Med J 1974; 134: 303-6.
22. Vagenakis A, Azizi F, Portnay GI, Braverman LE, Rapoport B, Ingbar S: Hyper-response to TRH accompanying small decreases in serum thyroid hormone concentrations. Clinical Research 1974; 22: 352a.
23. Azizi F, Bentley D, Vagenakis A, Portnay GI, Schwachman H, Ingbar S, Braverman LE: Abnormal thyroid function and the response to iodides in cystic fibrosis. Trans Assoc Am Physicians 1974; 87:111-9.
24. Azizi F: Agranulocytosis possibly induced by methaqualone. Ann Int Med 1974; 81: 268-9.
25. Vagenakis A, Rapoport B, Azizi F, Portnay GI, Braverman LE, Ingbar S: Hyper-response to thyrotropin releasing hormone (TRH) accompanying small decreases in serum thyroid hormone concentrations. J Clin Invest 1974; 53: 913-8.
26. Portnay GO, Brien J, Bush J, Vagenakis A, Azizi F, Arky RA, Ingbar S, Braverman LE: The effect of starvation on the concentration and binding of thyroxine and triiodothyronine in serum and the response to TRH. J Clin Endo Metab 1974; 39: 191-4.
27. Azizi F, Vagenakis A, Portnay GI, Bust J, Braverman LE, Ingbar S: A reinvestigation of the effects of phenobarbital on thyroid hormone economy in the rat. Program of the 56^th Annual Meeting of Endocrine Society, June, 1974.
28. Azizi F, et al: Permanent alteration in rats treated with TRH during the neonatal period. Clin Research 1974; 22: 690A.
29. Azizi F: The treatment of Gaves' disease. JAMA 1974; 228: 976 (L).
30. Azizi F, Vagenakis AG, Ingbar SH, Braverman LE. The time course of changes in TRH responsiveness in man following a single dose of liothyronine. Metabolism 1975; 24: 691-4.
31. Vagenakis AG, Rapoport B, Azizi F: Hyperresponse to thyrotropin releasing hormone accompanying small decreases in serum thyroid hormone concentrations. J Clin Invest 1974; 54: 913-8.
32. Azizi F, Vagenakis AG, Braverman LE: The effect of intramuscular thyrotropin releasing hormone on the thyroid 131^I uptake in man. Johns Hopkins Medical Journal 1975; 136: 11-4.
33. Azizi F, Vagenakis AG, Ingbar SH, Braverman LE. Permanent increase in pituitary TSH reserve following chronic TRH administration in the immature rat. Clin Res 1975; 23: 233A.
34. Vagenakis AG, Azizi F, Portnay GI: Diversion of peripheral thyroxine (T4) metabolism from activating to inactivating pathways during complete fasting (CF). Clin Res 1975; 23: 390A.
35. Azizi F, Vagenakis A, Portnay GI, Ingbar S, Braverman LE: Effect of a single oral dose of triiodothyronine on the subsequent response TRH on normal individuals. J Clin Endocrinol Metab 1975; 40: 157-9.
36. Azizi F, et al: Effects of diphenyl-hydantion on thyro-regulatory mechanism in the rat. Program of the 57th Annual Meeting of Endocrine Society, June 1975.
37. Azizi F, Vagenakis A, Portnay GI, Rapoport B, Ingbar S, Braverman LE: Pituitary-thyroid responsiveness to intramuscular thyrotropin-releasing hormone (TRH) based on analyses of serum thyroxine, triiodothyronine and thyrotropin concentration. New Engl J Med 1975; 292: 273-7.
38. Azizi F, Vagenakis A, Braverman LE: The effect of intramuscular TRH on the thyroid ¹³¹I uptake in man. Johns Hopkins Med J 1975; 136: 11-4.
39. Azizi F, et al: Evaluation of radioimmunonassay method for measuring serum concentration of thyroxine. Clin. Research 1975; 23: 572a.
40. Vagenakis A, Burger A, Portnay GI, Rudolph M, O Brien J, Azizi F, Arky RA, Nicol P, Ingbar S, Braverman LE: Diversion of peripheral thyroxine metabolism from activating to inactivating pathways during complete fasting. J Clin Endo Metab 1975; 141: 194.
41. Vagenakis A, Braverman LE, Azizi F, Potnay G, Ingbar S: Recovery of pituitary thyrotropic function after withdrawal of prolonged thyroid suppression therapy. N Engl J Med 1975; 293: 681-4.
42. Rogado A, Azizi F, Graham J: The heel of achilles. Headaches 1976; 15: 237-2.
43. Rosenthal D, Chandler H, Azizi F, Schneider P: Uptake of bone image agents by diffuse pulmonary metastatic calcification. A J Roentgenol 1977; 129: 871-4.
44. Sawin C, Chopra D, Albano J, Azizi F: The free T₃ index. Ann Int Med 1978; 88: 474-7.
45. Azizi F: Effect of dietary composition on fasting induced changes in serum thyroid hormone and thyrotropin. Metabolism 1978; 27: 935-42.
46. Harris A, Fang S, Azizi F, Vagenakis A, Braverman LE: Effect of starvation on hypothalamic-pituitary-thyroid function in the rat. Metabolism 1978; 27: 1074-83.
47. Azizi F, Belur R, Albano J: Malabsorption of thyroid hormones after jejunoileal bypass for obesity. Ann Int Med 1979; 90: 941-2.
48. Sawin CT, Chpora D, Azizi F, et al: The aging thyroid: Increased prevalence of elevated serum thyrotropin (TRH) in the elderly. JAMA 1979; 242: 247-50.
49. Azizi F, Mannix J, Nelson R: Effect of winter sleep on the pituitary thyroid axis in the American black bear. Am J Physiol 1979; 237: E227-30.
50. Azizi F: Change in pituitary and thyroid function with increasing age in young male rats. AM J Physiol 1979; 237: E224-6.
51. Theodoropoulos T, Fang SL, Azizi F, Ingbar SH, Vagenakis AG, Braverman LE: Effect of diphyenylhydantoin on hypothalamic-pituitary-thyroid function in the rat. Am J Physiol 1980; 239: E468-73.
52. Navai L, Kimiagar M, Azizi F: Permissive setting in causation of endemic goiter. Recent Advances in Nutriology 1: 85A-89A.
53. Rhie FH, Ganda OP, Bern MM, Soeldner JS, Gerson B, Azizi F: Insulin resistance and monoclonal gammopathy. Metabolisn 1981; 30: 41-5.
54. Azizi F: γ-glutamyl transpeptidase levels in thyroid disease. Arch Int Med 1982; 142: 79-81.
55. Azizi F, Lipinska I: High-density lipoprotein in thyroid disease. Proceedings of the second  Asia and Oceania thyroid association meeting. Current Problems in Thyroid Research. Excerpta  medica 1983; 605: 186.
56. Azizi F: Environmental iodine intake affects the response to methimazole in patients with diffuse toxic goitre. J Clin Endocrinol Metab 1985; 61: 374-7.
57. Azizi F, Kimiagar M, Nafarabadi M, Mostafavi H: Goitre in Tehran and suburbs. Recent progress in thyroidology. Vichayanart A. et al. (ed.) Proceeding of the third Asia & Oceania Thyroid Association. Dec. 4-6, 1986, P. 388-91.
58. Azizi F: Unusual response to thionamide compounds in Tehran. Recent progress in thyroidology. Vichayanart A. et al. (ed). Proceedings of the third Asia and oceania thyroid Association. Dec. 4-6, 1986, 475-8.
59. Azizi F: Rasouli H: Serum glucose, bilirubin, calcium, phosphorus, protein and albumin concentrations during Ramadan. Med J IRI 1987; 1: 38-41.
60. Azizi F, Jalali N, Nafarabadi M: The effect of chemical weapons on serum concentrations of various hormones. Iran. J Med Sciences 1989; 4: 46-50.
61. Azizi F: Medical treatment of toxic goitre in an area of iodine deficiency. Med J IRI 1988; 2: 119-22.
62. Kimiagar M, Yassai MB, Nafarabadi M, Samami B, Azizi F: Endemic goitre in Boyer-Ahmad. Med J IRI 1989; 3: 27-9.
63. Azizi F: Response to antithyroids and ablation in 206 Patients with diffuse toxic goitre in an area of iodine deficiency. Lee M, et al (ed). Progress in thyroidology 1989. Proceedings of the 4th Asia and Oceania Thyroid Association meeting. Korea, 19-21. April 1989, P. 451-4.
64. Azizi F, Elyasi H, Sohrabpour H et al: Serum concentrations of various hormones following exposure to chemical weapons containing sulfur mustard. Med J IRI 1989; 3: 105-7.
65. Kimiagar M, Azizi F, Navai L, et al: Survey of iodine deficiency in a rural area near Tehran: Association of food intake and endemic goitre. Europ J Clin Nutr 1990; 44: 17-22.
66. Azizi F, Kimiagar M, Nafarabadi M, Yassai M: Current status of iodine deficiency disorders in the Islamic Republic of Iran. EMR Health Sery J 1990; 8: 23-7.
67. Azizi F، Amid MH: Clinical presentation of chemical warfare injuries in children and teenagers. Med J IRI 1990; 4: 103-8.
68. Azizi F، Elyasi H، Jalali N، Nafarabadi M: Transient decreased serum testosterone after exposure to mustard gas. Med J IRI 1990; 4: 191-5.
69. Azizi F: Serum levels of prolactin، thyrotropin، thyroid hormones، male reproductive function and TRH responsiveness in intermittent Islamic fasting. Med J IRI 1991; 5: 145-8.
70. Azizi F: Outcome of three forms of therapy for diffuse toxic goitre in an area of iodine deficiency. Iran J Med Sci 1991; 16: 104-11.
71. Azizi F, et al: The effect of thyroxine therapy on the size of cold thyroid nodules in patients from  an iodine-deficient area. Med J IRI 1992; 6: 161-5.
72. Azizi F: Environmental iodine affects clinical presentation and thyroid function in subacute  thyroiditis. Iran J Med Sci 1992; 7: 93-9.
73. Azizi F: Environmental iodine intake affects clinical presentation and thyroid function in subacute thyroiditis. Iran J Med Sci 1992; 17: 93-9.
74. Azizi F, Amini M, Arbab P: Time course of changes in free thyroid indices, rT₃, TSH, cortisol and ACTH following exposure to sulfur mustard. Experim & Clin Endocrinal 1993; 101: 303-6.
75. Azizi F, Sarshar A, Nafarabadi M, Ghazi A, Kimiagar M, Noohi S, Rahbar N, Bahrami A, Kalantari S: Impairment of neuromotor and cognitive development in iodine deficient school children with normal physical growth. Acta Endocr 1993; 129: 501-4.
76. Azizi F, Ghazi A, Nafarabadi M, Kimiagar M: Long-lasting normal serum TSH after withdrawal of thyroxine in hypothyroid subjects with iodine deficiency. IR J Med Sci 1993; 18: 123-7.
77. Azizi F, Nafarabadi M: Serum thyroid hormone concentration in healthy women during month of Ramadan. Emirates Med J 1994; 12: 140-3.
78. Azizi F, Keshavarz A, Roshanzamir F, Nafarabadi M: Reproductive function in men following exposure to chemical warfare containing sulfur mustard. Medicine & War 1995; 11: 34-44.
79. Azizi F, Kalani H, Kimiagar M, et al: Physical, neuromotor and intellectual impairment in non-cretinous school children with iodine deficiency. Int J Vit Nut Res 1995; 65: 199-205.
80. Azizi F: Effect of methimazole treatment of maternal thyrotoxicosis on thyroid function in breast-feeding infants. J pediatr 1996; 128: 855-9.
81. Azizi F, Katchoui A: Brucella infection of the thyroid gland. Thyroid 1996; 6: 461-3.
82. Azizi F, Kimiagar M, Ghazi A, et al: Treatment of goitrous hypothyroidism with iodized oil supplementation in an area of iodine deficiency. Exp Clin Endocrinol & Diab 1996; 104: 387-91.
83. Azizi F: Medical aspects of Islamic fasting. Med J IRI 1996; 10: 241-6.
84. Azizi F: Diabetes mellitus in the Islamic Republic of Iran. IDF Bulletin 1996; 41: 38-9.
85. Azizi F, Kimiagar M, Ghazi A, et al: The effects of iodized oil injection in eu- and hypothyroid iodine deficient girls. J Endocrinol Invest 1997; 20: 18-23.
86. Azizi F: The reform of medical education in I.R.Iran. Med Edu 1997; 31: 159-62.
87. Navai L, Kimiagar M, Azizi F: Diabetes and IGT prevalence in Islamshar: Comparison of screening criteria. J Diab Assoc India 1999; 39: 9-14.
88. Azizi F, Khoshniat M, Bahrainian M, Hedayati M: Thyroid function and intellectual development of infants nursed by mothers taking methimazole. J Clin Endocrinol Metab 2000; 85: 3233-8.
89. Salarkia N, Azizi F, Kimiagar M, et al: L Monitoring iodine following consumption of iodized salt in Tehran inhabitants. Int J Vit Nutr Res 2000; 70: 65-9.
90. Azizi F: Research in medical education. J Iranian Medical Edu 2000; 2: 3-7.
91. Azizi F, Rahmani M, Majid M, et al: Tehran Lipid and Glucose Study (TLGS): Rationale and Design. CVD Prevention 2000; 3: 50-3.
92. Azizi F: IDD in the Middle East. IDD Newsletter 2001; 17: 33-9.
93. Azizi F, Daftarian N: Side-effects of iodized oil administration in patients with simple goiter. J Endocrinol Invest 2001; 24: 72-7.
94. Azizi F, Afkhami M, Sarshar A, Nafarabadi M: Effects of transient neonatal hyperthyrotropinemia on intellectual quotient and psychomotor performance. Int J Vit Nut Res 2001; 71: 70-3.
95. Azizi F, Allahverdian S, Mirmiran P, Rahmani M, Mohammadi F: Dietary factors and body mass index in a group of Iranian adolescents. Tehran lipid and glucose study. Int J Vit Nut Res 2001; 71: 123-7.
96. Azizi F, Rahmani M, Majid M, et al: Serum lipid levels in an Iranian population of children and adolescents: Tehran Lipid and Glucose Study. Europ J Epidemiol 2001; 17: 281-8.
97. Shahbazian HB, Sarvghadi F, Azizi F: Prevalence and characteristics of postpartum thyroiditis in Tehran. Europ J Endocrinol 2001; 145: 397-401.
98. Azizi F, Rahmani M, Allahverdian S, Hedayati M. Effect of salted food consumption on urinary iodine and thyroid function tests in two provinces in the Islamic Republic of Iran. Eastern Mederranean Health J, 2001; 7: 115-120.
99. Azizi F, Delshad H, Mehrabi Y: Thyroid volume in schoolchildren of Tehran: Comparison with European schoolchildren. J Endocrinol Invest 2001; 24: 756-62.
100. Hedayati M, Yazdanparast R, Azizi F: Determination of human tumor necrosis factor by a highly sensitive enzyme immunoassay. Biochem Biophys Res Commun 2001; 289: 295-8.
101. Azizi F: Published researches in medical education in Iran. Iranian J Med Edu 2001; 1: 3-7.
102. Azizi F: Continuing professional development in health sector. Iranian J Med Edu 2001; 1: 53-63.
103. Houssaini SJ, Aslani A, Azizi F, et al: Evaluating the effectiveness of a continuing medical education program on urinary stone. Iranian J Med Edu 2001; 1: 64-9.
104. Azizi F, Navai L, Fattahi F. Goiter prevalence, urinary iodine excretion, thyroid function and anti-thyroid antibodies after 12 years of salt iodization in Shhriar, Iran. Int J Vit Nutr Res 2002; 72: 291-5.
105. Mirmiran P, Mohammadi F, Allahverdian S, Azizi F: Association of educational level and marital status with dietary intake and cardiovascular risk factors in Tehranian adults: Tehran Lipid and Glucose Study (TLGS). Nutr Res 2002; 22: 1365-75
106. Rahmani M, Raiszadeh F, Allahverdian S, Kiaii S, Navab M, Azizi F: Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects. Altherosclerosis 2002; 162: 381-9.
107. Ordookhani A, Mirmiran P, Hajipour R, Hedayati M, Azizi F: Screening for congenital hypothyroidism in the Islamic Republic of Iran: Strategies, obstracles and future perspectives. East Med Health J 2002; 8: 481-9.
108. Azizi F, Rahmani M, Raiszadeh F, et al: Association of lipid, lipoproteins, apolipoproteins, and paroxonase enzyme activity with premature coronary artery disease. Coronary Artery Disease 2002; 13: 9-16.
109. Azizi F, Sheikholeslam R, Hedayati M, et al: Sustainable control of iodine deficiency in Iran. J Endocrinol Invest 2002; 25: 409-13.
110. Azizi F, Hedayati M: Thyroid function in breast-fed infants whose mothers take high doses of methimazole. J Endocrinol Invest 2002; 25: 493-6.
111. Azizi F, Khamseh ME, Bahreynian M, Hedayati M: Thyroid function and intellectual development of children of mothers taking methimazole during pregnancy. J Endocrinol Invest 2002; 25: 586-9.
112. Azizi F, Ainy E, Mirmiran P, Habibian S: Contrceptive methods and risk factors of cardivascular diseases in Terhanian women: Tehran Lipid and Glucose Study. Europ J Contracep Reprodu Health Care 2002; 7: 1-6.
113. Khamseh ME, Mollanai S, Hashemi R, Rezaizadeh A, Azizi F: Erdheim-Chester syndrom; presenting as hypogonadotropic hypogonadism and diabetes insipidus. J Endocrinol Invest 2002; 25: 727-9.
114. Azizi F, Ghanbarian A, Majid M, Rahmani M: Distribution of blood pressure and prevalence of hypertension in Tehran adult population: Tehran Lipid and Glucose Study, 1999-2000. J Hum Hypertension 2002; 16: 305-12.
115. Azizi F, Raiszadeh F, Salehi P, Rahmani M, Emami H, Ghanbarian A, Hajipour R. Determinants of serum HDL-C level in Tehran urban population: Tehran Lipid and Glucose Study. Nutr Metabol Cardiovas Dis 2002; 12: 80-9.
116. Azizi F. Developing a training course on monitoring and evaluation. IDD Newsletter 2002; 18: 26-7.
117. Azizi F, Mirmiran P, Sheikholeslam R, Hedayati M, Rastmanesh R. The relation between ferritin and goiter, urinary iodine and thyroid hormone concentration. Int J Vit Nutr Res 2002; 72: 296-9.
118. Delange F, de Benoist B, Burgi H, Azizi F, Hajipour R, Bnemiloud M, et al: Determining median uprinary iodine concentration that indicates adequate iodine intake at population level. Bull WHO 2002; 80: 633-6.
119. Mirmiran P, Mirblooki M, Azizi F: Familial clustering of obesity and the role of nutrition: Tehran Lipid and Glucose Study. Int J Obes Relat Metab Disord 2002; 26: 1617-22.
120. Mirmiran P, Kimiagar M, Azizi F: Three-year survey of effects of iodized oil injection in schoolchildren with iodine deficiency disorders. Exp Clin Endocrinol Diab 2002; 110: 393-7.
121. Azizi F, Rahmani M, Emami H, Mirmiran P, Hajipour R, Madjid M, Ghanbili J, Ghanbarian A, Mehrabi Y, Saadat N, Salehi P, Mortazavi N, Heydarian P, Sarbazi N, Allahverdian S, Saadati N, Ainy E, Moeini S. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz Praventivmed 2002; 47: 408-26.
122. Azizi F: Research in Islamic fasting and health. Ann Saudi Med 2002; 22: 186-91.
123. Azizi F: Evaluation of the community-oriented medical education in two medical schools in Sudan. Eastern Mediterranean Health Journal 2003; 9: 191-200.
124. Azizi F, Gouya MM, Vazirian P, Dolatshahi P, Habibian S: Screening for type 2 diabetes in the Iranian national programme: a preliminary report. Eastern Mediterranean Health Journal 2003; 9: 1122-7.
125. Azizi F, ِAiny E: Coronary health disease risk factors and menopause: a study in 1980 Tehranian women, the Tehran Lipid and Glucose Study. Climacteric 2003; 6: 330-6.
126. Mirmiran P, Mohammadi F, Sarbazi N, Allahverdian S, Azizi F. Gender defferences in dietary intakes, anthripometrical measurements and biochemical indioes in an urban adult population: Tehran Lipid and Glucose Study. Nut Metab Cardiovas Dis 2003; 13: 64-71.
127. Azizi F, Malik M, Bebars E, Delshad H, Bakir A: Thyroid volume in schoolchildren of Emirates. J Endocrinol Invest 2003; 26:56-60.
128. Azizi F, Aminorroya A, Hedayati M, Rezvanian H, Amini M, Mirmiran P. Urinary iodine excretion in pregnant women residing in areas with adequate iodine intake. Publ Health Nutr 2003; 6: 95-8.
129. Azizi F, Emami H, Salehi P, Ghanbarian A, Mirmiran P, Heydarian P. Cardiovascular risk factors in elderly: Tehran Lipid and Glucose Study. J Cardiovasc Risk 2003; 10: 65-73.
130. Azizi F, Rashidi A, Ghanbarian A, Majid M: Is systolic blood pressure sufficient for classification of blood pressure and determination of hypertension based on JNC-VI in an Iranian adults population? Tehran Lipid and Glucose Study (TLGS). Hum Hyperten 2003; 17: 287-91.
131. Mirmiran P, Hajipour R, Azizi F: Iodized salt consumption maintains euthyroidism in iodine deficient hypothyroid subject. J Vit Nutr Res 2003; 73: 187-91.
132. Mirmiran P, Mohammadi F, Allahverdian S, Azizi F: Estimation of energy requirements for adults: Tehran Lipid and Glucose Study. J Vit Nutr Res 2003; 73: 193-200.
133. Azizi F, Rahmani M, Ghanbarian A, Emami H, Salehi P, Mirmiran P, Sarbazi N. Serum lipid levels in an Iranian adult population.Tehran Lipid and  Glucose Study. Europ J Epidemiol 2003; 18: 311-19.
134. Ordookhani A, Mirmiran P, Hedayati M, Hajipour R, Azizi F: An interim report of the pilot study of screening for congenital hypothyroidism in Tehran and Damavand using cord blood spot samples. Eur J Pediatr 2003; 162: 202-3.
135. Azizi F, Salehi P, Etemadi A, Zahedi-Asl S: Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diab Res Clin Pract 2003; 61: 29-37.
136. Hedayati M, Yazdanparast R, Fasihi H, Azizi F: Anti-tumor activity of daphne mucronata extract and its effects on TNF-a receptors and TNF-a release in cultured human monocytes. Pharmaceutical Biology 2003; 41: 194-8.
137. Azizi F. Thyroid function in breast-fed infants is not affected by methimazole-induced materal hypothyroidism: results of a retrospective study. J Endocrinol Invest 2003; 26: 301-4.
138. Ghazi AA, Hadayegh F, Khakpour G, Azizi F, Melby JC. Bilateral testicular enlargement due to adrenal remnant in a patient with C11 hydroxylase deficiency congenital adrenal hyperplasia. J Endocrinol Invest 2003; 26: 84-7.
139. Orookhani A, Mirmiran P, Najafi R, Hedayati M, Azizi F: Congenital hypothyroidism in Iran. Indian J Pediatr 2003; 70: 625-8.
140. Azizi F: Salt Iodization, Moniyoting, and Evaluation (SIME): an effective replacement for Universal Salt Iodization (USI). Int J Endocrinol Metab 2003; 2: 46-7.
141. Azizi F, Siahkolah B: Ramadan fasting and diabetes mellitus. Arch Iranian Med 2003; 6: 237-42.
142. Azizi F, Raiszadeh F, Solati M, Etemadi A, Rahmani M, Arabi M: Serum paraoxonase 1 activity is decreased in thyroid dysfunction. J Endocrinol Invest 2003; 26: 703-9.
143. Azizi F: Continuing professional development in the health sector. In: Towards a global health workforce strategy, Ferrinho p & Dal Poz M (eds). ITGP Press, Antwerp, Belgium 2003, 309-409.
144. Azizi F, Bahrainian M, Khamseh M, Khoshniat M: Intellectual development and thyroid function in children who were breast-fed by thyrotoxic mothers taking methimazole. J Ped Endocrinol Metab 2003; 16: 1239-43.
145. Salarkia N, Hedayati M, Mirmiran P, Kimiagar M, Azizi F: Evaluation of the impact of an iodine supplementation programme on severely iodine-deficient schoolchildren with hypothyroidism. Public Health Nutrition 2003; 6: 529-33.
146. Azizi F, Malik M, Bebars E, Delshad H, Bakir A. Thyroid volumes in schoolchildren of the Emirates. J Endocrinol Invest 2003; 26: 56-60.
147. Mirmiran P, Hedayati M, Noohi S, Azizi F: The effect of iodized oil administration on the impaired hearing of iodine deficient schoolchildren. Int J Endocrinol Metab 2003; 2: 61-6.
148. Azizi F, Gouya MM, Vazirian P, Dolatshahi P, Habibian S: The diabetes prevention and control programme of the Islamic Republic of Iran. Eastern Mediterranean Health Journal 2003; 9: 1114-121.
149. Azizi F, Esmaillzadeh A, Mirmiran P. Obesity and cardiovascular risk factors in Tehranian adults: a population-based cross-sectional study. East Med Health J 2004; 10: 887-97.
150. Azizi F, Mehran L: Experiences in the prevention, Control, and elimination of iodine deficiency disorders: a regional perspective. East Med Health J 2004; 10: 761-70.
151. Raiszadeh F, Solati M, Etemadi A, Azizi F: Serum paraoxonase activity before and after treatment of thyrotoxicosis. Clin Endocrinology 2004; 60: 75-80.
152. Azizi F, Etemadi A, Hajipoor R, Mortazavi N. Trends of publication in Medical Journals in Iran in the 1990’s. Saudi Med J 2004; 25: S34.
153. Etemadi A, Raiszadeh R, Alaeddini F, Azizi F. Views of Iranian medical journal editors on medical research publication. Saudi Med J 2004; 25: S29-S33.
154. Ghanbarian A, Rashidi A, Madjid M, Azizi F. Blood pressure measures and electocardiogram-defined myocardial infarction in an Iranian population: Tehran Lipid and Glucose Study. J Clinical Hypertension 2004; 6: 71-5.
155. Mirmiran P, Azadbakht L, Esmaill Zadeh A, Azizi F: Dietary diversity score in adolescents – a good indicator of nutritional adequacy of the diet: Tehran Lipid and Glucose. Asia Pacific J Clin Nutr 2004; 13: 56-60.
156. Solati M, Ghanbarian A, Rahmani M, Sarbazi N, Allahverdian S, Azizi F: Cardiovascular risk factors in males with hypertriglycemic waist (Tehran Lipid and Glucose). Inter J Obes 2004; 28: 706-9.
157. Saadat N, Sheikholeslam R, Azizi F: Impact of iodized oil injection during pregnancy on thyroid function tests of offsprings. Med J Islamic Repub Iran 2004; 17: 277-83.
158. Azizi F: Endocrinology and metabolism in the Islamic Republic of Iran. Archives of Iranian Medicine. Endocrinology & Metabolism 2004; 7: 69-74.
159. Mirmiran P, Esmaillzadeh A, Azizi F: Detection of cardiovascular risk factors by anthropometric measures in Tehranian adults: receiver operating characteristic (ROC) curve analysis. Europ J Clinl Mutr 2004; 58: 1110-8.
160. Habibi Moeini S, Mirmiran P, Mehrabi Y, Azizi F: Evaluation of different risk factors for early diagnosis of diabetes mellitus. Iran J Med Sci 2004; 29: 21-5.
161. Rezaei-Ghaleh N, Mirbolooki M, Shiva N, Azizi F: Biomedical publications on diabetes mellitus, research gap in developing countries. Int J Endocrinol Metab 2004; 3: 51-6.
162. Mirsaeid Ghazi AA, Rais Zadeh F, Pezeshk P, Azizi F: Seasonal variation of serum 25 hydroxy D3 in residents of Tehran. J Endocrinol Invest 2004; 27: 676-9.
163. Esmaillzadeh A, Mirmiran P, Azizi F: Waist-to-hip ratio is a better screening measure for cardiovascular risk factors than other anthripometric indicator in Tehranian adult men. Inter J Obes 2004; 28: 1325-32.
164. Ordookhani A, Mirmiran P, Moharamzadeh M, Hedayati M, Azizi F: A high prevalence of consanguineous and severe congenital hypothyroidism in an Iranian population. J Pediatric Endocrinol & Metab 2004; 17: 1201-9.
165. Ghaleh NR, Siadat F, Azizi F: Quantitative and qualitative assessment of biomedical publication from Iran, Pakistan and Egypt through their impact factor. J Pak Med Assoc 2004; 54: 528-9.
166. Rezaei-Ghaleh N, Ghanbarian A, Etemadi A, Momenan A, Azizi F: Prevalence of rose angina and ECG-defined coronary heart disease and the concordance between Tehran in diabetic patients: (Tehan Lipid and Glucose Study). Proceedings of the 12th International Congress of Endocrinology Lisbon, Aug. 31-Sept. 4, 2004; 467-71.
167. Kharabsheh S, Belbesi A, Qarqash W, Azizi F: Goiter prevalence and urinary iodine excretion in schoolchildren of Jordan. Int J Vitam Nutr Res 2004; 74: 301-4.
168. Azizi F, Mirmiran P, Azadbakht L: Predictors of cardiovascular risk factors in Tehranian adolescents: Tehran Lipid and Glucose Study. Int J Vitam Nutr Res 2004; 74: 307-12.
169. Azizi F, Sadeghipour H, Siahkolah B, Rezaei-Ghaleh N: Intellectual development of children born of mothers who fasted in Ramadan during pregnancy. Int J Vitam Nutr Res 2004; 74: 374-80.
170. Azizi F, Salarkia N, Mirmiran P: Timing of the effect of iodine supplementation on intelligence Quotients of schoolchildren. Int J Endocinol Metab 2004; 2: 95-102.
171. Azizi F: Age as a predictor of recurrent hypothyroidism in patients with postpartum thyroid dysfunction. J Endocrinol Invest 2004; 27: 996-1002.
172. Nabipour I, Ghasemi F, Kiai S, Baradar-Jalili R, Azizi F. The mutations of RET proto-oncogene in medullary thyroid carcinoma in Iran. Med J IRI 2004; 18: 95-9.
173. Behjati Ardakani J, Hajipoor R, Valaie F, Azizi F: Thyroid functions in patients with glaucoma. Int J Endocrinol Metab 2005; 3: 99-103.
174. Saadat N, Emami H, Salehi P, Azizi F: Comparison of ADA and wHO criteria in detecting pattern of glucose disorders in a population-vased study: Tehran Lipid and Glucose Study. Endocrinology Metabolism 2005; 4: 158-64.
175. Mirmiran P, Esmaillzadeh A, Azizi F. Dairy consumption and body mass index: An inverse relationship. Int J Obes 2005; 29: 115-21.
176. Azizi F, Azadbakht L, Mirmiran P. Trends in overweight, obesity and central obesity among Tehranian adults between 1998-1999 and 2001-2002: Tehran Lipid and Glucose Study. Ann Nutr Metab 2005; 49: 3-8.
177. Azizi F: The occurrence of permanent thyroid failure in patients with subclinical postpartum thyroiditis. European J Endocrinol 2005; 153: 367-71.
178. Esmaillzadeh A, Mirmiran P, Azizi F: Whole-grain intake and the prevalence of hypertriglyceridemic waist phenotype in Tehranian adults. Am J Clin Nutr 2005; 81: 55-63.
179. Esmaillzadeh A, Mirmiran P, Azizi F: Whole-grain intake and the metabolic sjndrome: a faworale association in Tehranian adults. Eur J Clin Nutr 2005; 59: 353-62.
180. Azizi F, Esmaillozadeh A, Mirmiran P, Einy E. Is there an independent association between waist-to-hip ratio and cardiovascular risk factor in overweight adnd obese women? Inter J Cardiol 2005; 101: 39-46.
181. Yazdanpanah R, Hedayati M, Azizi F:  The effects of the crude and the actuve component of dendrostellera lessertii on the Co-cultures of Human Monocytes with CCRF-CEM or K562 Cell Lines. Iranian Int J Sci 2005; 6: 1-13.
182. Azizi F, Hedayati M, Rahmani M, Sheikholeslam R, Allahverdian S, Salarkia N. Reappraisal of the risk of iodine-induced hyperthyroidism: an epidemiological population survey. J Endocrinol Invest 2005; 28: 23-9.
183. Azizi F, Esmaillzadeh A, Mirmiran P. Correlates of under-and over-reporting of energy intakie in Tehranians: body mass index and lifestyle- related factors. Asia Pac J Clin Nutr 2005; 14: 54-9.
184. Azadbakht L, Mirmiran P, Shiva N, Azizi F: General obesity and central adiposity in a representative sample of Tehranian adults: Prevalence and determinants. Int J Vitam Nutr Res 2005; 75: 297-304.
185. Shahbazian HB, Sarvghadi F, Azizi F: Ultrasonographic characteristics and follow-up in post-partum thyroiditis. J Endocrinol Invest, 2005; 28: 410-12.
186. Azadbakht L, Mirmiran P, Esmailzadeh A, Azizi T, Azizi F: Beneficial Effects of a Dietary Approaches to Stop Hypertension Eating Plan on Features of the Metabolic Syndrome. Diabetes Care 2005; 28: 2823-31.
187. Sarvghadi F, Hedayati M, Mehrabi Y, Azizi F: Follow up of patients with postpartum thyroiditis: a population-based study.  Endocrine 2005; 27: 279-82.
188. Azizi F, Braverman E. Management of postpartum thyrotoxicosis. Curr Opinion Endocrinol Diab 2005; 12: 471-6.
189. Bazrafshan HR, Mohammadian S, Ordookhani A, Abedini A, Davoudy R, Pearce EN, Hedayati M, Azizi F, Breverman LE. An assessment of urinary and breast-milk iodine concentrations in lactating mothers from gorgan, Iran 2003. Thyroid 2005; 15: 1165-8.
190. Bazrafshan HR, Mohammadian S, Ordookhani A, Farhidmehr F, Hedayati M, Abdolahi N, Azizi F, Braverman LE, Pearce EN. Prevalence of goiter among schoolchildren from Gorgan, Iran, a decade after national iodine supplementation: association with age, gender, and thyroperoxidase antibodies. J Endocrinol Invest 2005; 28: 727-33.
191. Azadbakht L, Mirmiran P, Azizi F: Dietary diversity score is favorably associated with the metabolic syndrome in Tehranian adults. Int J Obes 2005; 29: 1361-7.
192. Azizi F, Ataie L, Hedayati M, Mehrabi Y, Sheikholeslami F: Effect of long-term contininuous methimazole treatment of thyrotoxicosis: comparison with radioiodine. Europ J Endocrinol 2005; 152: 695-701.
193. Azizi F, Mirmiran P, Hedayati M, Slarkia N, Noohi S: Effect of 10 yr of the iodine supplementation on the hearing threshold of iodine deficient schoolchildren. J Endocrinol Invest 2005; 28: 595-8.
194. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi F: Dairy consumption is inversely associated with the prevalence of the metabolic syndrome in Tehranian adults. Am J Clin Nutr 2005; 82: 523-30.
195. Mirmiran P, Azadbakht L, Azizi F: Dietary quality-adherence to the dietary guidelines in Tehranian adolescents: TLGS. Int J Vitam Nutr Res. 2005; 75: 195-200.
196. Azadbakht L, Mirmiran P, Azizi F: Variety scores of food groups contribute to the specific nutrient adequacy in Tehranian men. Eur J Clin Nutr 2005; 59: 1233-40.
197. Azadbakht L, Mirmiran P, Hosseini F, Azizi F: Diet quality status of most Tehranian adults needs improvement. Asia Pac J Clin Nutr 2005; 14: 163-8.
198. Shekholeslami F, Ataie L, Hedayati M, Mehrabi Y, Azizi F: Comparison of outcome in radioiodine induced euthyroid and hypothyroid patients Int J Endocrinol Metab 2005; 4: 174-83.
199. Esmaillzadeh A, Mirmiran P, Azizi F. Evaluation of waist circumference of predicts cardiovascular risk factors in overweight Tehranian population. Int J Vitam Nutr Res 2005; 75: 347-56.
200. Mirsaeid Ghazi AA, Ordookhani A, Pourafkari M, Fallahian M, Bahar A, Hedayati M, Hafizi A, Azizi F: Intrauterine diagnosis and management of fetal goitrous hypothyroidism: a report of an Iranian family with three consecutive pregnancies complicated by fetal goiter. Thyroid 2005; 15: 1341-7.
201. Saadat N, Salehi P, Emami H Azizi F: The relationship between glucose intolerance and blood pressure, body mass index, and waist to hip ratio in Tehran urban population: Tehran Lipid and Glucose Study. Int J Endocrinol Meta 2005; 3: 37-47.
202. Azizi F: Diabetes care and prevention. Diabetes Voice 2005; 50: 15-17.
203. Heydarian P, Azizi F: The frequency of thyroid autoanibodies is higher in the upper bound of normal TSH values. Int J Endocrinol Metab 2005; 3: 10-7.
204. Mohammad Alizadeh AH, Fallahian F, Alavian SM, Ranjbar M, Hedayati M, Rahimi F, Khedmat H, Azizi F: Insulin resistance in chronic hepatitis B and C. Indian J Gastroenterol 2006; 25: 286-9.
205. Ghanbarian A, Rezaei-Ghaleh N, Salehi P, Azizi F: Blood pressure distribution in an Iranian adolescent population: "Tehran lipid and glucose study". Med J Malaysia 2006; 61: 433-7.
206. Azizi F, Mirmiran P, Sheikholeslam R: Major success stories in the global fight against IDD: Iran and China. Sustained elimination of iodine deficiency in the Islamic Republic of Iran: an update. IDD Newsletter, August 2006.
207. Esmaillzadeh A, Mirmiran P, Azizi F: Clustering of metabolic abnormalities in adolescents with the hypertriglyceridemic waist phenotype. Am J Clin Nutr 2006; 83: 36-46.
208. Azizi F: Author’s response. Eastem Mediterranean Health Journal 2006; 12: 251.
209. Azizi F: The safety and efficacy of antithyroid drugs. Expert Opin Drug Saf 2006; 5: 107-16.
210. Esmaillzadeh A, Mirmiran P, Azizi F: Metabolic abnormalities identified by anthropometric measures in elderly men. Am J Clin Nutr 2006; 83: 173.
211. Mirmiran P, Esmaillzadeh A, Azizi F: Under-reporting of energy intake affects estimates of nutrient intake. Asia Pac J Clin Nutr 2006; 15: 459-64.
212. Esmaillzadeh A, Mirmiran P, Azadbakht L, Azizi F: Prevalence of the hypertriglyceridemic waist phenothype in Iranian adolescents. Am J Prev Med 2006; 30: 52-8.
213. Esmaillzadeh A, Mirmiran P, Azadbakht L, Etemadi A, Azizi F: High prevalence of the metabolic syndrome phenotype in Iranian adolescents. Obes Res 2006; 14: 377-82.
214. Esmaillzadeh A, Mirmiran P, Azizi F: Comparative evaluation of anthropometric measures to predict cardiovascular risk factors in Tehranian adult women. Public Health Nutr 2006; 9: 61-9.
215. Azadbakht L, Mirmiran P, Azizi F: Predictors of cardiovascular risk factors in Tehranian adults: diet and lifestyle. East Medit Health J 2006; 12: 88-97.
216. Daneshpour M, Hedayati M, Azizi F: Hepatic Lipase C-514T polymorphism and its association with high-density lipoprotein cholesterol level in Tehran. Europ Soc Cardiol 2006; 13: 101-3.
217. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi F: Dietary diversity score and cardiovascular risk factors in Tehranian adults. Pub Health Nutr 2006; 9: 728-36.
218. Esmaillzadeh A. Mirmiran P, Habibi Moeini S, Azizi F: Larger hip circumference independently contributed to reduced metabolic risks in Tehranian adult women. Int J Cardiol 2006; 108: 338-45.
219. Ainy E, Ghazi AAM, Azizi F: Changes in calcium, 25(OH)vitamin D3 and other biochemical factors during pregnancy. J Endocrinol Invest 2006; 29: 303-7.
220. Hadaegh F, Harati H, Ghanbarian A, Azizi F: Association of total cholesterol versus other seryum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Europ J Cardiovas Preven Rehab 2006; 13: 571-7.
221. Mirmiran P, Esmaillzadeh A, Amiri P, Azizi F: Independent and inverse association of hip circumference with metabolic risk factors in Tehranian adult men. Inter J Obesity 2006; 42: 354-7.
222. Hadagh F, Zabetian Z, Harati H, Azizi F: Waist/height ratio as a better predictor of type 2 diabetes compared to body mass index in tehranian adult men- a 3.6 year prospective study. Exper Clin Endocrinol Diabet 2006; 114: 310-5.
223. Hosseinpanah F, Ghaffari H, Rambod M, Azizi F: Predicting isolated postchallenge hyperglycemia: a new approach; Tehran Lipid and Glucose Study (TLGS). Diabe Med 2006; 23: 982-9.
224. Azizi F: Treatment of post-partum thyrotoxicosis. J Endocrinol Invest 2006; 29: 244-7.
225. Mirmiran P, Azadbakht L, Azizi F. Dietary diversity within food groups: an indicator of specific nutrient adequacy in Tehranian women. J Am Coll Nutr 2006; 25: 354-61.
226. Mirmiran P, Esmaillzadeh A, Azizi F: Diet composition and body mass index in Tehranian adults. Asia Pac J Clin Nutr 2006; 15: 224-30.
227. Hedayati M, Nabipour I, Rezaei-Ghaleh N, Azizi F: Germline RET mutations in exons 10 and 11: An Iranian survey of 57 medullary thyroid carcinoma cases. Med J Malaysia 2006; 61: 564-9.
228. Hadaegh F, Harati H, Zabetian A, Azizi F: Seasonal variability of serum lipids in adults: Tehran Lipid and Glucose Study. Med J Malaysia 2006; 61: 332-8.
229. Ainy E, Ordookhani A, Hedayati M, Azizi F: Assessment of interrimester and seasonal variations of urinary iodine concentration during pregnancy in an iodine-repete area. Clin Endocrinol 2007; 67: 577-81.
230. Azizi F: Iodine nutrition in pregnancy and lactation in Iran. Public Health Nutrition 2007; 10: 1596-1599.
231. Zabetian A, Hadaegh F, Azizi F: Prevalence of metabolic sybndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabet Res Clin Pract. 2007; 77: 251-7.
232. Ainy E, Mirmiran P, Zahedi Asl S, Azizi F: Prevalence of metabolic syndrome during menopausal transition Tehranian women: Tehran Lipid and Glucose Study (TLGS). Maturiats 2007; 58: 150-5.
233. Eshraghi P, Hedayati M, Daneshpour MS, Mirmiran P, Azizi F: Association of body mass index and Trp64Arg polymorphism of the β3-adrenoreceptor gene and leptin level in Tehran Lipid and Glucose Study. British J Biomed Science 2007; 64: 117-20.
234. Pournajafi-Nazarloo H, Partoo L, Sanzenbacher L, Azizi F, Carter CS. Modulation of corticotropin-releasing hormone type 2 receptor and urocortin 1 and urocortin 2 mRNA expression in the cardiovascular system of prairie voles following acute or chronic stress. Neuroendocrinology 2007; 86: 17-25.
235. Daneshpour M, Hedayati M, Azizi F: Taql B1/B2 and -629 A/C cholesteryl ester transfer protein (CETP) gene polymorphisms and their association with CETP activity and high-density lipoprotein cholesterol levels in a Tehranian population. Part of the Tehran Lipid and Glucose Study (TLGS). Genetics and Molecular Bilogy 2007; 30: 1039-46.
236. Azadbakht L, Mirmiran P, Hedayati M, Esmaillzadeh A, Shiva N, Azizi F: Particle size of LDL is affected in dyslipidemic adolescents by the National Cholesterol Education Program (NCEP) step II diet. Br J Nutr 2007; 20: 1-6.
237. Ordookhani A, Mirmiran P, Walfish PG, Azizi F. Transient neonatal hypothyroidism is associated with elevated serum anti-thyroglobulin antibody levels in newborns and their mothers. J Pediatr. 2007; 150: 315-7.
238. Rashidi A, Ghanbarian A, Azizi F, Adler DS. Is chronic kidney disease comparable to diabetes as a coronary artery disease risk factor? South Med Asso 2007; 100: 20-26.
239. Rezaei-Ghaleh M, Azizi F: The impact factor-based quality assessment of biomedical research institutes in Iran: effect of impact factor normalization by subject. Arch Iran Med 2007; 10: 182-9.
240. Mirmiran P, Azadbakht L, Azizi F: Dietary behavior of Tehranian adolescents does not accord to their nutiritonal knowledge. Public Health Nutr 2007; 10: 897-901.
241. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi F: Better dietary adherence and weight maintenance achieved by a long-term moderate-fat diet. Br J Nutr 2007; 97: 399-404.
242. Hadaegh F, Esmaillzadeh A, Azizi F: Metabolic risks is individuals with normal body mass index and normal waist circumference. Eur J Cardiovasc Prev Rehabil. 2007; 14: 200-7.
243. Hadaegh F, Zabetian A, Harati H, Azizi F: Metabolic syndrome in normal-weight Iranian adults. Ann Saudi Med 2007; 27: 18-24.
244. Hadaegh F, Zabetian A, Harati H, Azizi F: The prospective association of general and central obesity variables with incident type 2 diabetes in adults, Tehran lipid and glucose study. Diab Res Clin Pract 2007; 76: 449-54.
245. Pournajafi-Nazarloo H, Perry A, Partoo L, Papademeteriou E, Azizi F, Carter CS, Cushing BS. Neonatal oxytocin treatment modulates oxytocin receptor, atrial natriuretic peptide, nitric oxide synthase and estrogen receptor mRNAs expression in rat heart. J Homepage Peptides 2007; 28: 1170-7.
246. Mirmiran P, Hekmatdoost A, Azizi F: Metabolic syndrome is associated with adherence to an unhealthy diet. Diabetes Care 2007; 30: e93.
247. Ordookhani A, Pearce EN, Mirmiran P, Azizi F, Braverman LE: The effect of type of delivery and povidone-iodine application at delivery on cord dried-blood-specimen thyrotopin level and the rate of hyperthyrotropinemia in mature and normal-birth-weight neonates residing in an iodine-replete area: report of Tehran province, 1998-2005. Thyroid 2007; 17: 1097-102.
248. Rashidi A, Ghanbarian A, Azizi F. Are patients who have metabolic syndrome without diabetes at risk for developing chronic kidney disease? Evidence based on data from a large cohort screening population. Clin J Am Soc Nephrol 2007; 2: 976-83.
249. Salarkia N, Hedayati M, Azizi F. Retrospective analysis of a long term iodine intervention program in rural Iran. Int J Endocrinol Metab 2007; 1: 16-25.
250. Ainy E, Azizi F. Women, occupation and cardiovascular risk factors: Findings from the Tehran Lipid and Glucose Study. Public Health 2007; 121: 950-3.
251. Heydarian P, Ordookhani A, Azizi F: Goiter rate, serum thyrotropin, thyroid autoantibodies ad urinary iodine concentration in Tehranian adults before and after national salt iodization. J Endocrinol Invest 2007; 30: 404-10.
252. Hedayati M, Ordookhani A, Daneshpour MS, Azizi F: Rapid acid digestion and simple microplate method for milk iodine determination. J Clin Laborat Analy 2007; 21: 286-92.
253. Ainy E, Mehrabi Y, Azizi F: Comparison of menarche age between two generations (Theran Lipid and Glucost Study). Pak J Med Sci 2007; 4: 523-5.
254. Obesity in Asia Collaboration, Huxley R, Barzi F, Lee CM, Lear S, Shaw J, Lam TH, Caterson I, Azizi F, Patel J, Suriyawongpaisal P, Oh SW, Kang JH, Gill T, Zimmet P, James PT, Woodward M. Waist circumference thresholds provide an accurate and widely applicable method for the discrimination of diabetes. Diabetes Care 2007; 30: 3116-8.
255. Behrouzi Z, Rabei HM, Azizi F, Daftarian N, Mehrabi Y, Ardeshiri M, Mohammadpour M. Prevalence of open-angle glaucoma, glaucoma suspect, and ocular hypertension in thyroid-related immune orbitopathy. J Glaucoma 2007; 16: 358-62.
256. Hosseinpanah F, Rambod M, Azizi F. Population attributable risk for diabetes associated with excess weight in Iranian adults: a population-based cohort study. BMC Public Health 2007; 7: 328.
257. Hadaegh F, Harati H, Ghasemi A, Tohidi M, Zabetian A, Mehrabi Y, Azizi F: Using common clinical data improves the prediction of abnormal glucose tolerance by the new criteria of impaired fasting glucose: Tehran Lipid and Glucose Study. Diabetes Research Clin Pract 2007; 77: 459-64.
258. Azadbakht L, Mirmiran P, Hedayati M, Esmaillzadeh A, Shiva N, Azizi F. Particle size of LDL is affected by the National Cholesterol Education Program (NCEP) step II diet in dyslipidaemic adolescents. Br J Nutr. 2007; 98: 134-9.
259. Soltani A, Moayyeri A, Azizi F. Combination therapy of chloroquine and methimazole in Graves' disease: A pilot randomized controlled trial. Biomed Pharmacother 2007; 61: 241-243.
260. Bahar A, Azizi F: Insulin Resistance and b Cell Function in Patients with Chronic Hepatitis and Impaired Glucose Tolerance. Int J Endocrinol Metab 2007; 4: 125-33.
261. Rezaei-Ghaleh N, Hedayati M, Ordookhani A, Azizi F: Positive Interference in Triiodothyronine (T3) Assay Using a Radioimmunoassay Kit. Int J Endocrinol Metab 2007; 4: 142-6
262. Ordookhani A, Pearce EN, Hedayati M, Mirmiran P, Salimi S, Azizi F: Assessment of thyroid function and uriynary and breast milk iodine concentrations in healthy newborns and their mothers in Tehran. Clin Endocrinol 2007; 67: 175-9.
263. Azizi F: New developments in the management of thyroid disorders. Int J Endocrinol Metabol 2008; 3: 121-3.
264. Amouzegar A, Ghanei A, Azizi F. Cushing’s syndrome accompanied with adrenal and pancreatic mass: A case report. Int J Endocrinol Metabol 2008; 6: 154-7.
265. Saber M, Saberi Firouzi M, Azizi F: The logbook effect on clinical learning of interns in internal ward rotation in Shiraz University of Medical Science. J Med Eduction 2008; 12: 61-5.
266. Azizi F: Sub-specialty training of endocrinology in the Islamic Republic of Iran: Estimating the Need for Endocrinologist training. J Med Education 2008; 12: 105-8.
267. Gerailie B, Azizi F, Yazdani Sh, Amini A, Mortazavi A, Hossein­zadeh M. A Survey of University of Medical Sciences’ Administrators and GPs on the Current and Ideal Role of General Practitioners in Iran. J Med Eduction 2008; 12: 97-104.
268. Benvenga S, Ordookhani A, Pearce EN, Tonacchera M, Azizi F, Bravernab LE: Detection of circulating autoantibodies against thyroid hormones in an infant with permanent congenital hypothyroidism and her twin with transient congenital hypothyroidism: Possible contribution of thyroid hormone autoantibodies to neonatal and infant hypothyroidism. J Pediat Endocrinol Meatab 2008; 21: 1011-20.
269. Hosseinpanah F, Rambod M, Hossein-nejad A, Larijani B, Azizi F: Association between vitamin D and bone mineral density in Iranian postmenopausal women. J Bone Miner Metab 2008; 26: 86-92.
270. Ordookhani A, Pearce EN, Mirmiran P, Azizi F, Braverman LE: Transient neonatal hypothyroidism in an iodine-relete area is not related to parental consanguinity, mode of delivery, goitrogens, iodine exposure, or thyrotropin receptor autoantibodies. J Endocrinol Invest 2008; 31: 29-34.
271. Mirmiran P, Mirbolooki M, Heydarian P, Salehi P, Azizi F. Intrafamilial associations of lipid profiles and the role of nutrition: The Tehran Lipid and Glucose Study. Ann Nutr Metab 2008; 52: 68-73.
272. Hadaegh F, Bozorgmanesh MR, Ghasemi A, Harati H, Saadat N, Azizi F: High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran and Glucose Study. BMC Public Health 2008; 8: 176.
273. Tohidi M, Harati H, Hadaegh F, Mehrabi Y, Azizi F: Association of liver enzymes with incident type 2 diabetes: A nested case control study in an Iranian population. BMC Endocr Disord 2008; 8:5.
274. Azizi F, Mehran L, Sheikholeslam R, Ordookhani A, Naghavi M, Hedayati M, Padyab M, Mirmiran P. Sustainability of a well-monitored salt iodization program in Iran: marked reduction in goiter prevalence and eventual normalization of urinary iodine concentrations without alteration in iodine content of salt. J Endocrinol Invest 2008; 31: 422-31.
275. Mirmiran P, Ramezankhani A, Hekmatdoost A, Azizi F. Effect of nutrition intervention on non-communicable disease risk factors among Tehranian adults: Tehran lipid and glucose study. Ann Nutr Metab 2008; 52: 91-5.
276. Azizi F, Mirmiran P, Sherafat-Kazemzadeh R: Pediatric obesity: an impending catastrophe. Arch Iran Med 2008; 11: 242-5.
277. Hadaegh F, Ghasemi A, Padyab M, Tohidi M, Azizi F. The metabolic syndrome and incident diabetes: Assessment of alternative definitions of the metabolic syndrome in an Iranian urban population. Diabetes Res Clin Pract 2008; 80: 328-34.
278. Nabipour I, Vahdat K, Jafari SM, Beigi S, Assadi M, Azizi F, Sanjdideh Z. Elevated High Sensitivity C-Reactive Protein Is Associated with Type 2 Diabetes Mellitus: The Persian Gulf Healthy Heart Study. Endocr J 2008; 55: 717-22.
279. Koochek A, Mirmiran P, Azizi T, Padyab M, Johansson SE, Karlström B, Azizi F, Sundquist J. Is migration to Sweden associated with increased prevalence of risk factors for cardiovascular disease? Eur J Cardiovasc Prev Rehabil 2008; 15: 78-82.
280. Hosseinpanah F, Rambod M, Azizi F. Likelihood of having isolated postchallenge hyperglycemia in an Iranian urban population.Diabetes Res Clin Pract 2008; 79: 490-6.
281. Ghasemi A, Zahedi Asl S, Mehrabi Y, Saadat N, Azizi F: Serum nitric oxide metabolite levels in a general healthy population: relation to sex and age. Life Sciences 2008; 83: 326-31.
282. Zabetian A, Hadaegh F, Azizi F: Relationship between metabolic syndrome and its components with coronary heart disease in Iranian men and women. Exp Clin Endocrinol Diabetes 2008; 116: 525-31.
283. Zahedi Asl S, Ghasemi A, Azizi F. Serum nitric oxide metabolites in subjects with metabolic syndrome. Clin Biochem 2008; 41: 1342-7.
284. Bozorgmanesh MR, Hadaegh F, Padyab M, Mehrabi Y, Azizi F. Temporal changes in anthropometric parameters and lipid profile according to body mass index among an adult Iranian urban population. Ann Nutr Metab 2008; 53: 13-22.
285. Barnett AH, Krentz AJ, Strojek K, Sieradzki J, Azizi F, Embong M, Imamoglu S, Perusicová J, Uliciansky V, Winkler G. The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study). Diabetes Obes Metab 2008; 10: 1239-47.
286. Azizi F, Jahed A, Hedayati M, Lankarani M, Bejestani HS, Esfahanian F, Beyraghi N, Noroozi A, Kobarfard F. Outbreak of exogenous Cushing's syndrome due to unlicensed medications. Clin Endocrinol (Oxf) 2008; 69: 921-5.
287. Azizi F. Ethics in clinical research. Quarterly Journal of Medical Ethics 2008 ; 2 : 48-33 (in Farsi)
288. Mirmiran P, Noori N, Azizi F. A prospective study of determinants of the metabolic syndrome in adults. Nutr Metab Cardiovasc Dis 2008; 18: 567-73.
289. Hadaegh F, Khalili D, Fahimfar N, Tohidi M, Eskandari F, Azizi F. Glucose intolerance and risk of cardiovascular disease in Iranian men and women: results of the 7.6-year follow-up of the Tehran Lipid and Glucose Study (TLGS). J Endocrinol Invest 2009 32: 724-30.
290. Farshchi H, Shahnazi A, Azizi F: Effects of testosterone and gonadotropin therapy in men with hypogonadotropic hypogonadism. Inter J Endocrinol Metab 2009; 7: 242-7.
291. Hosseinpanah F, Hajiabdolrassouli L, Sarvghadi F, Azizahari S, Azizi F: Comparison between diabetes incidence using different cut points of IFG in Tehran. Int J Endocrinol Metab 2009; 4: 222-8.
292. Azizi F: Iodine Deficiency Disorders: Silent pandemic. Thyroid International 2009; 4: 1-13
293. Hadaegh F, Zabetian A, Sarbakhsh P, Khalili D, James WP, Azizi F: Appropriate cutoff values of anthropometric variables to predict cardiovascular outcomes: 7.6 years follow-up in an Iranian population. Int J Obes (Lond) 2009; 33: 1437-45.
294. Tehrani FR, Solaymani Dodaran M, Azizi F: A single test of antimullerian hormone in late reproductive-age women is a good predictor of menopause. Menopause 2009; 16: 797-802.
295. Daneshpour MS, Alfadhli S, Houshmand M, Zeinali S, Hedayati M, Zarkesh M, Momenan AA, Azizi F. Allele Frequency Distribution Data for D8S1132, D8S1779, D8S514, and D8S1743 in Four Ethnic Groups in Relation to Metabolic Syndrome: Tehran Lipid and Glucose Study. Biochem Genet 2009t; 47: 680-7.
296. Bahrami Z, Hedayati M, Taghikhani M, Azizi F. Effect of Testosterone on Thyroid Weight and Function in Iodine Deficient Castrated Rats. Horm Metab Res 2009;41: 762-6.
297. Mirmiran P, Hosseini Esfahani F, Mehrabi Y, Hedayati M, Azizi F. Reliability and Relative Validity of a Food Frequency Questionnaire for Nutrients in the Tehran Lipid and Glucose Study. Public Health Nutr 2009; 7: 1-9.
298. Kazemi B, Seyed N, Moslemi E, Bandehpour M, Bikhof Torbati M, Saadat N, Eidi A, Ghayoor E, Azizi F. Insulin Receptor Gene Mutations in Iranian Patients with Type II Diabetes Mellitus. Iran Biomed J 2009; 13: 161-8.
299. Nassiri AA, Hakemi MS, Soulati M, Marashian M, Rahbar K, Azizi F. Effects of heparin and dalteparin on oxidative stress during hemodialysis in patients with end-stage renal disease. Iran J Kidney Dis 2009; 3: 162-7.
300. Zarghi A, Ghodsi R, Azizi F, Daraie B, Hedayati M, Dadrass OG. Synthesis and biological evaluation of new 4-carboxyl quinoline derivatives as cyclooxygenase-2 inhibitors.Bioorg Med Chem 2009; 17: 5312-7.
301. Harati H, Hadaegh F, Tohidi M, Azizi F. Impaired fasting glucose cutoff value of 5.6 mmol/l combined with other cardiovascular risk markers is a better predictor for incident Type 2 diabetes than the 6.1 mmol/l value: Tehran lipid and glucose study. Diabetes Res Clin Pract 2009; 85: 90-5.
302. Hadaegh F, Khalili D, Ghasemi A, Tohidi M, Sheikholeslami F, Azizi F. Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men. Nutr Metab Cardiovasc Dis 2009; 19: 401-8.
303. Harati H, Hadaegh F, Saadat N, Azizi F. Population-based incidence of Type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran. BMC Public Health 2009; 9: 186.
304. Kahrizi K, Mohseni M, Nishimura C, Bazazzadegan N, Fischer SM, Dehghani A, Sayfati M, Taghdiri M, Jamali P, Smith RJ, Azizi F, Najmabadi H. Identification of SLC26A4 gene mutations in Iranian families with hereditary hearing impairment. Eur J Pediatr 2009; 168: 651-3.
305. Azizi F, Smyth P. Breastfeeding and maternal and infant iodine nutrition. Clin Endocrinol (Oxf) 2009; 70: 803-9.
306. Hadaegh F, Shafiee G, Azizi F. Anthropometric predictors of incident type 2 diabetes mellitus in Iranian women. Ann Saudi Med 2009; 29: 194-200.
307. Zabetian A, Hadaegh F, Sarbakhsh P, Azizi F. Weight change and incident metabolic syndrome in Iranian men and women; a 3 year follow-up study. BMC Public Health 2009; 9: 138.
308. Pournajafi-Nazarloo H, Partoo L, Sanzenbacher L, Esmaeilzadeh M, Paredes J, Hashimoto K, Azizi F, Carter CS. Social isolation modulates corticotropin-releasing factor type 2 receptor, urocortin 1 and urocortin 2 mRNAs expression in the cardiovascular system of prairie voles. Peptides 2009; 30: 940-6.
309. Mirmiran P, Ramezankhani A, Azizi F. Combined effects of saturated fat and cholesterol intakes on serum lipids: Tehran Lipid and Glucose Study. Nutrition 2009; 25: 526-31.
310. Noori N, Hosseinpanah F, Nasiri AA, Azizi F. Comparison of overall obesity and abdominal adiposity in predicting chronic kidney disease incidence among adults. J Ren Nutr 2009; 19: 228-37.
311. Mirmiran M, Noori N, Beheshti M, Azizi F. Fruit and vegetable consumption and risk factors for cardiovascular disease. Metabolisem 2009; 58: 460-8.
312. Pournajafi-Nazarloo H, Partoo L, Sanzenbacher L, Paredes J, Hashimoto K, Azizi F, Stress differentially modulates mRNA expression for corticotrophin-releasing hormone receptors in hypothalamus, hippocampus and pituitary of praitie voles. Neuropeptides 2009; 43: 113-23.
313. Tohidi M, Hadaegh F, Harati H, Azizi F. C-reactive protein in risk prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Int J Cardiol 2009; 132: 369-74.
314. Hadaegh F, Harati H, Ghanbarian A, Azizi F. Prevalence of coronary heart disease among Tehran adults: Tehran Lipid and Glucose Study. East Mediterr Health J 2009; 15: 157-66.
315. Hadaegh F, Zabetian A, Tohidi M, Sheikholeslami F, Azizi F. Prevalence of metabolic syndrome by the Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions and their Association with Coronary Heart Disease in an Elderly Iranian Population. Ann Acad Med Singapore 2009; 38: 142-9.
316. Hosseinpanah F, Kasraei F, Nassiri AA, Azizi F. High prevalence of chronic kidney disease in Iran: a large population-based study. BMC Public Health 2009; 9: 44.
317. Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, Mehrabi Y, Zahedi-Asl S, Tlgsg TL. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 2009; 10: 5.
318. Nabipour I, Burger A, Moharreri MR, Azizi F. Avicenna, the first to describe thyroid-related orbitopathy. Thyroid 2009; 19: 7-8.
319. Rambod M, Hosseinpanah F, Ardakani EM, Padyab M, Azizi F. Fine-tuning of prediction of isolated impaired glucose tolerance: A quantitative clinical prediction model. Diabetes Res Clin Pract 2009; 83: 61-8.
320. Asl SZ, Brojeni NK, Ghasemi A, Faraji F, Hedayati M, Azizi F. Alterations in osmotic fragility of the red blood cells in hypo- and hyperthyroid patients. J Endocrinol Invest 2009; 32: 28-32.
321. Ghazanfari T, Faghihzadeh S, Aragizadeh H, Soroush MR, Yaraee R, Mohammad Hassan Z, Foroutan A, Vaez-Mahdavi MR, Javadi MA, Moaiedmohseni S, Azizi F, Panahi Y, Mostafaie A, Ghasemi H, Shams J, Pourfarzam S, Jalali-Nadoushan MR, Fallahi F, Ebtekar M, Davoudi SM, Ghazanfari Z, Ardestani SK, Shariat-Panahi S, Moin A, Rezaei A, Kariminia A, Ajdary S, Mahmoudi M, Roshan R, Ghaderi S, Babai M, Naghizadeh MM, Ghanei MM.  Sardasht-Iran Cohort Study Research Group S. Sardasht-Iran cohort study of chemical warfare victims: design and methods. Arch Iran Med 2009; 12: 5-14.
322. Azizi F. Medical Education in the Islamic Republic of Iran: three decades of success. Iran J Pub Health 2009; 38: 19-26.
323. Azizi F. Workforce Needs for Internists in the Islamic Republic of Iran until 2021. J Med Eduction 2009; 13: 9-12.
324. Azizi F, Farahani ZK, Ghanbarian A, Sheikholeslami F, Mirmiran P, Momenan AA, Asl SZ, Hadaegh F, Eskandari F. Familial aggregation of the metabolic syndrome: Tehran Lipid and Glucose Study. Ann Nutr Metab 2009; 54: 189-96.
325. Hosseinpanah F, Barzin M, Eskandary PS, Mirmiran P, Azizi F. Trends of obesity and abdominal obesity in Tehranian adults: a cohort study. BMC Public Health 2009; 9: 426.
326. Norouzian MA, Valizadeh R, Azizi F, Hedayati M, Naserian AA, Eftekhari Shahroodi F. The Effect of Feeding Different Levels of Potassium Iodide on Performance, T-3 and T-4 Concentrations and Iodine Excretion in Holstein Dairy Cows. J Anim Veterin Advan 2009; 1: 111-4.
327. Aghaei Meybodi HR, Azizi F: Changes in body weight and fat distribution; risk factors for abnormal glucose homeostasis? Tehran Lipid and Glucose Study. Iran J Diabet Lipid disor 2009; 1-12.
328. Hosseinpanah F, Barzin M, Mirmiran P, Azizi F: Effect of changes in waist circumference on metabolic syndrome over a 6.6-year follow-up in Tehran. Eur J Clin Nutr 2010; 64: 879-86.
329. Daneshpour M, Zarkesh M, Hedayati M, Mesbah Namin S, Halalkhor S, Faam B, Azizi F: The G360T polymorphism in the APO AIV Gene and its Association with combined HDL/LDL-Cholesterol Phenotype: Tehran Lipid and Glucose Study. Intr J Endoc Metab 2010; 8: 32-8.
330. Anbari S, Isazadeh D, Safavi A, Alaie M, Azizi F. The role of dyslipidemia in sensorineural hearing loss in children. Int J Pediatr Otorhinolaryngol 2010; 74: 32-6.
331. Hosseinpanah F, Sorouri M, Rambod M, Azizi F: Total duration of breastfeeding is associated with low bone mineral density in Iranian postmenopausal women. Int J Endocrinol Metab 2010; 8: 153-8,
332. Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M, Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr 2010; 13: 654-62
333. Amouzegar A, Delshad H, Mehraein M, Mehran L, Safarkhani M, Azizi F: Continuous adequate iodine supplementation in fars province: The 2007 goiter and urinary iodine excretion survey in schooldhidren. I`ran J Med Sciences 2010; 35: 16-20.
334. Hosseinpanah F, Hashemi Pour SH, Heibatollahi M, Moghbel N, Asefzade S, Azizi F: The effects of air pollution on vitamin D status in healthy women: A cross sectional study. BMC public Health 2010; 10: 519.
335. Rostami F, Hajhosseini R, Sharifi K, Daneshpour M, Azizi F, Hedayati M: Association of G-174C polymorphism of the interleukin 6 gene promoter with obesity in Iranian population. Proceedings of World Academy of Science, Engineering and Technology 2010; 70: 99-263.
336. Ghasemi A, Syedmoradi L, Zahediasl S, Azizi F: Pediatric reference values for serum magnesium levels in Iranian subjects. Scan J Clin Lab Invest 2010; 70: 415-20.
337. Amiri P, Ardakani E, Jalali-Farahani S, Hosseinpanah F, Varmi JW, Ghofranipour F, Montazeri A, Azizi F: Reliability and validity of the Iranian version of the pediatric Quality of Life Inventory^TM 4.0 Generic cor escales in adolescents. Quality Life Res 2010; 19: 1501-8.
338. Amiri P, Hosseinpanah F, Rambod M, Montazeri A, Azizi F: Metabolic syndrome predicts poor health-related quality of life in women but not in men: Tehran Lipid and Glucose study. J Women’s Health 2010; 19: 1201-7.
339. Bozorgmanesh M, Hadaegh F, Azizi F: Transportability of the updated diabetes prediction model from atherosclerosis risk in communities study to a middle Eastern adult population: Community-based cohort study. Acta Diabetol 2010; 1-7
340. Hajsheikholeslami F, Hatami M, Hadaegh F, Ghanbarian A, Azizi F: Association of educational status with cardiovascular disease: Tehran Lipid and Glucose Study. Int J Public Health 2010; 56: 281-7.
341. Ghasemi A, Zahediasl S, Azizi F. Nitric oxide and clustering of metabolic syndrome components in pediatrics. Eur J Epidemiol 2010; 25: 45-53.
342. Tohidi M, Hatami M, Hadaegh F, Safarkhani M, Harati H, Azizi F. Lipid measures for prediction of incident cardiovascular disease in diabetic and non-diabetic adults: results of the 8.6 years follow-up of a population based cohort study. Lipid Health Dis 2010; 9: 6-9.
343. Azizi F: Islamic Fasting and Health. Ann Nutr Metab 2010;56: 273-82
344. Mirmiran P, Fazeli MR, Asghari G, Shafiee A, Azizi F: Effect of pomegranate seed oil on hyperlipidaemic subjects: a double-blind placebo-controlled clinical trial. Br J Nutr. 2010; 25:1-5.
345. Rostambeigi N, Shaw JE, Atkins RC, Ghanbarian A, Cameron AJ, Forbes A, Momenan A, Hadaegh F, Mirmiran P, Zimmet PZ, Azizi F, Tonkin AM. Waist circumference has heterogeneous impact on development of diabetes in different populations: Longitudinal comparative study between Australia and Iran. Diabetes Res Clin Pract 2010; 88: 117-24.
346. Hadaegh F,  Shafiee G, Ghasemi A, Sarbakhsh P, Azizi F: Impact of metabolic syndrome, diabetes and prediabetes onb cardiovascular events: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract. 2010; 87: 342-7.
347. Esfahani FH, Asghari G, Mirmiran P, Azizi F. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran Lipid and Glucose Study. J Epidemiol 2010; 20: 150-8.
348. Mirmiran P, Mohammadi-Nasrabadi F, Omidvar N, Hosseini-Esfahani F, Hamayeli-Mehrabani H, Mehrabi Y, Azizi F. Nutritional knowledge, attitude and practice of Tehranian adults and their relation to serum lipid and lipoproteins: Tehran lipid and glucose study. Ann Nutr Metab 2010; 56: 233-40.
349. Sherafat-Kazemzadeh R, Egtesadi S, Mirmiran P, Gohari M, Farahani SJ, Esfahani FH, Vafa MR, Hedayati M, Azizi F. Dietary patterns by reduced rank regression predicting changes in obesity indices in a cohort study: Tehran lipid and glucose study. Asia Pac J Clin Nutr 2010; 19: 22-32.
350. Ghasemi A, Syedmoradi L, Momenan AA, Zahediasl S, Azizi F. The influence of cigarette and qalyan (hookah) smoking on serum nitric oxide metabolite concentration. Scand J Clin Lab Invest 2010; 70: 116-21.
351. Harati H, Hadaegh F, Momenan AA, Ghanei L, Bozorgmanesh MR, Ghanbarian A, Mirmiran P, Azizi F. Reduction in incidence of type 2 diabetes by lifestyle intervention in a middle eastern community. Am J Prev Med 2010; 38: 628-36.
352. Bozorgmancesh M, Hadaegh F, Azizi F: Diabetes prediction, lipid accumulation product, and adiposity measures; 6- year follow-up: Tehran Lipid and Glucose Study. Lipids  Health Dis 2010; 9: 45.
353. Azizi F: Current status of iodine nutrition in Iraq. IDD Newsletter 2010; 36: 1-3.
354. Mirmiran P, Sherafat-Kazemzadeh R, Farahani SJ, Asghari G, Niroomand M, Momenan A, Azizi F. Performance of different definitions of metabolic syndrome for children and adolescents in a 6-year follow-up: Tehran Lipid and Glucose Study (TLGS). Diabetes Res Clin Pract. 2010; 89: 327-33.
355. Tehrani FR. Mirmiran P, Zahedi S, Nakhoda K, Azizi F: Menarcheal age of mothers and daughters: Tehran Lipid and Glucose Study. WHO 2010; 16: 391-5.
356. Mirmiran P, Sherafat-Kazemzadeh R, Jalali-Farahani S, Azizi F. Childhood obesity in the Middle East: a review. East Mediterr Health J 2010; 16: 1009-17.
357. Tehrani FR, Solaymani-Dodaran M, Hedayati M, Azizi F. Is polycystic ovary syndrome an exception for reproductive aging? Hum Reprod 2010; 25: 1775-81.
358. Azizi F, Khalili D, Aghajani H, Esteghamati A, Hosseinpanah F, Delavari A, Larijani B, Mirmiran P, Mehrabi Y, Kelishadi R, Hadaegh F. Appropriate waist circumference cutt-off points among Iranian adults : the first report of the Iranian National Committee of Obesity. Arch Iran Med 2010; 13: 243-4.
359. Talebian M, Azizi F, Zahedipour H. Selenium and iodine status of sheep in the Markazi province, Iran. Iran J Veterin Res 2010; 11: 78-83.
360. Hosseini-Esfahani F, Jessri M, Mirmiran P, Bastan S, Azizi F. Adherence to dietary recommendations and risk of metabolic syndrome: Tehran Lipid and Glucose Study. Metabolism 2010; 59: 1833-42.
361. Mirmiran P, Mohammadi F, Omidvar N, Hosseini Esfahani F, Hamayeli  Mehrabani H, Mehrabi Y, Azizi F. Nutrition knowledge, attitude and behavior or Tehranian and their relation to serum lipid and lipoproteins: Tehran Lipid and Glucose Study (TLGS). Annal Nutr Metab 2010; 56: 233-40.
362. Bozorgmanesh M, Hadaegh F, Zabetian A, Azizi F. San Antonio heart study diabetes prediction model applicable to a Middle Eastern population? Tehran glucose and lipid study. Int J Public Health. 2010; 55: 315-23.
363. Daneshpour M, Hedayati M, Eshraghi P, Azizi F: Association of Apo E gene polymorphism with HDL level in a Tehranian population. Eur J Lipid Sci 2010; 112: 810-6.
364. Ghasemi A, Zahediasl S, Siadmoradi L, Azizi F. Low serum magnesium levels in elderly subjects with metabolic syndrome. Biol Trace Elem Res 2010; 136: 18-25.
365. Hosseini Esfahani F, Mirmiran P, Asghari G, Azizi F. Reproducibility and relative of foods intake in a food frequency questionnaire developed for Tehran Lipid and Glucose Study. J Epidemiol 2010; 20: 150-8.
366. Kashani Farid MH, Azizi F, Hedayati M, Daneshpour MS, Shamshiri AR, Siassi F. Association between CETP Taq1B and LIPC -514C/T polymorphisms with the serum lipid levels in a group of Tehran’s population: a cross sectional study. Lipids Health Dis 2010; 9: 96.
367. Sheibaninia A, Valaiee N, Tavakoli B, Azizi F, Mohamadsadeghi SH, Nourbakhsh M. Quality of research articles published in Iranian dental journals. Pak J Med Sci 2010; 26: 1-5.
368. Bozorgmanesh M, Hadaegh F, Azizi F. Predictive performances of lipid accumulation products vs. Adiposity measures for cardiovascular diseases and all-cause mortality, 8.6-year follow-up: Tehran Lipid and Glucose Study. Lipids Health Dis 2010; 9: 1-13.
369. Heidari Z, Hosseinpanah F, Mehrabi Y, Safarkhani M, Azizi F. Predictive power of the components of metabolic syndrome in its development: a 6.5-year follow-up in the Tehran Lipid and Glucose Study (TLGS). Eur J Clin Nutr 2010; 64: 1207-14.
370. Ordookhani A, Padyab M, Goldasteh A, Mirmiran P, Richter J, Azizi F. Seasonal variation of neonatal transient hyperthyrotropinemia in Tehran province, 1998-2005. Chronobiol Int 2010; 27: 1854-69.
371. Azizi F, Hadaegh F, Khalili D, Esteghamati A, Hosseinpanah F, Delavari A, Mirmiran P, Zabetian A, Mehrabi Y, Kelishadi R, Aghajani H. Appropriate waist circumference cut-off points among Iranian adults: the first report of the Iranian national committee of obesity. Arch Iran Med 2010; 13: 243-4.
372. Azizi F, Hadaegh F, Khalili D, Esteghamati A, Hosseinpanah F, Delavari A, Mirmiran P, Zabetian A, Mehrabi Y, Kelishadi R, Aghajani H. Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian national committee of obesity. Arch Iran Med 2010; 13: 426-8.
373. Nazeri P, Mirmiran P, Mehrabi Y, Hedayati M, Delshad H, Azizi F. Evaluation of iodine Nutritional Status in Tehran, Iran: Iodine deficiency within iodine sufficiency. Thyroid 2010; 20: 1399-406.
374. Delshad H, Mehran L, Azizi F: Appropriate iodine nutrition in Iran: 20 years of success. Acta Medica Iranica 2010; 48: 361-66.
375. Tonekaboni SH, Mostaghimi P, Mirmiran P, Abbaskhanian A, Abdollah Gorji F, Ghofrani M, Azizi F. Efficacy of the Atkins diet as therapy for intractable epilepsy in children. Arch Iran Med 2010; 13: 492-7.
376. Ghasemi A, Zahediasl S, Azizi F. Reference values for serum nitric oxide metabolites in an adult population. Clin Biochem. Nitric Oxide 2010; 23: 264-8.
377. Hadaegh F, Hatami M, Tohidi M, Sarbakhsh P, Saadat N, Azizi F. Lipid ratios and appropriate cut off values for prediction of diabetes: a cohort of Iranian men and women. Lipids Health Dis 2010; 9: 85.
378. Hadaegh F, Hatami M, Sheikholeslami F, Azizi F. Pulse Pressure and Systolic Blood Pressure are Powerful Independent Predictors of Cardiovascular Disease in Diabetic Adults: Results of an 8.4 years Follow-up of Tehran Lipid and Glucose Study (TLGS). Exp Clin Endocrinol Diabetes 2010; 118: 638-43.
379. Ghazi AA, Hosseinpanah F, M Ardakani E, Ghazi S, Hedayati M, Azizi F. Effects of different doses of oral cholecalciferol on serum 25(OH)D, PTH, calcium and bone markers during fall and winter in schoolchildren. Eur J Clin Nutr 2010; 64: 1415-22.
380. Afkhami-Ardekani M, Zahedi-Asl S, Rashidi M, Atifah M, Hosseinpanah F, Azizi F. Incidence and trend of a metabolic syndrome phenotype among Tehranian adolescents: findings from the Tehran Lipid and Glucose Study, 1998-2001 to 2003-2006. Diabetes Care 2010; 33: 2110-2.
381. Hadaegh F, Fahimfar N, Khalili D, Sheikholeslami F, Azizi F: New and known type 2 diabetes and coronary heart disease equivalent: results from 7.6 year follow up in a middle east population. Cardiovascular Diabetology 2010; 9: 84.
382. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, Nixon A, Pearce EN, Soldin OP, Sullivan S, Wiersinga W: Guidelines of the American thyroid association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011; 21: 1-45.
383. Hosseinpanah F, Barzin M, Ramezani F, Azizi F: The lack of association between polycystic ovary syndrome and metabolic syndrome: Iranian PCOS Prevalence Study. Clin Endocrinol 2011; 75: 692-7.
384. Bozorgmanesh M, Hadaegh F, Zabetian A, Azizi F: Impact of hip cirumference and height on incident diabetes: results from 6-year follow-up in the Tehran Lipid and Glucose Study. Diabet Med 2011; 28: 1330-6.
385. Nazeri P, Mirmiran P, Asghari G, Delshad H, Mehrabi Y, Hedayati M, Azizi F: Differences between subjects with sufficient and deficient urinary iodine in an area pf iodine sufficiency. J Endocrinol Invest 2011; 34: e302-e07.
386. Hekmatdoost A, Mirmiran P, Hosseini-Esfahani F, Azizi F. Dietary fatty acid composition and metabolic syndrome in Tehranian adults. Nutrition 2011; 27: 1002-7.
387. Bozorgmanesh M, Hadaegh F, Ghaffari S, Harati H, Azizi F. A simple risk score effectively predicted type 2 diabetes in Iranian adult population: population-based cohort study. Eur J Public Health 2011; 21: 554-9.
388. Mirmiran P, Hosseini Esfahani1 F, Jessri M, Mahan LK, Shiva N, Azizi F. Does dietary intake by tehranian adults align with the 2005 dietary guidelines for Americans? Observations from the Tehran Lipid and Glucose Study. J Health Poul Nutr 2011; 29: 39-52
389. Hosseinpanah F, Barzin M, Sheilholeslami F, Azizi F: Effect of different obesity phenotypes on cardiovascular events in Tehran Lipid and Glucose Study (TLGS). Am J Cardiol 2011; 107: 412-6.
390. Ramezankhani A, Mehrabi Y, Mirmiran P, Azizi F: Comparison of anthropometric and biochemical indices of adolescents born during and after the Iran-Iraq war; Theran Lipid and Glucose Study. Arch Iran Med 2011; 14: 27-31.
391. Hedayati M, Yazdanparast R, Zarif Yeganeh M, Hoghooghi Rad L, Azizi F: N new diterpene extracted from daphne mucronata, effects on human K562 and CCRF-CEM cell lines. J Cancer Therapy 2011; 2: 71-5.
392. Azizi F, Hosseini MS, Amouzegar A, Tohidi M, Ainy E: Neonatal thyroid status in an area of iodine sufficiency. J Endocrinol Invest 2011; 34: 197-200.
393. Syedmoradi L, Ghasemi A, Zahediasl S, Azizi F. Prevalence of hypo- and hypermagnesemia in an Iranian urban population. Ann Hum Biol 2011; 38: 150-5.
394. Barzin M, Hosseinpanah F, Fekri S, Azizi F. Predictive value of body mass index and waist circumference for metabolic syndrome in 6-12-year-olds. Acta Paediatr 2011; 100: 722-7.
395. Bozorgmanesh M, Hadaegh F, Azizi F. Predictive accuracy of the 'Framingham's general CVD algorithm' in a Middle Eastern population: Tehran Lipid and Glucose Study. Int J Clin Pract 2011; 65: 264-73.
396. Azizi F, Amouzegar A. Management of hyperthyroidism during pregnancy and lactation. Eur J Endocrinol. 2011; 164: 871-6.
397. Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol 2011; 9: 39.
398. Mirmiran P, Hosseinpour-Niazi S, Mehrabani HH, Kavian F, Azizi F. Validity and reliability of a nutrition screening tool in hospitalized patients. Nutrition 2011; 27: 647-52.
399. Ramezankhani R, Mehrabi Y, Mirmiran P, Azizi F. Comparison of Anthropometric and Biochemical Indices of Adolescents Born During and After the Iran-Iraq War; Tehran Lipid and Glucose Study. Arch Iran Med 2011, 14: 27-31.
400. Halalkhor S, Mesbah-namin S, Daneshpour M, Hedayati M, Azizi F: Association of ATP-binding cassette transporter-A1 polymorphism with apolipoprotein AI level in Tehranian population. J Genetics 2011; 90: 1-4.
401. Hosseinpanah F, Barzin M, Amiri P, Azizi F. The Trends of Metabolic Syndrome in Normal-Weight Tehranian Adults. Ann Nutr Metab 2011; 58: 126-32.
402. Daneshpour MS, Rebai A, Houshmand M, Alfadhli S, Zeinali S, Hedayati M, Zarkesh M, Azizi F. 8q24.3 and 11q25 chromosomal loci association with low HDL-C in metabolic syndrome. Eur J Clin Invest 2011 Eur J Clin Invest 2011; 41: 1105-12
403. Ramezani Tehrani F, Shakeri N, Solaymani-Dodaran M, Azizi F. Predicting age at menopause from serum antimüllerian hormone concentration. Menopause 2011; 18: 766-70.
404. Burns R, Azizi F, Hedayati M, Mirmiran P, O Herlihy C, Smyth P. Is placental iodine content related to dietary iodine intake? Clin Endocrinol 2011; 2: 261-4.
405. Bahadoran Z, Mirmiran P, Hosseinpanah F, Hedayati M, Hosseinpour-Niazi S, Azizi F. Broccoli sprouts reduce oxidative stress in type 2 diabetes: a randomized double-blind clinical trial. Eur J Clin Nutr. 2011; 65: 972-7.
406. Ghasemi A, Zahediasl S, Azimzadeh I, Azizi F. Increased serum nitric oxide metabolites in dysglycaemia. Ann Hum Biol. 2011; 38: 577-82.
407. Barzin M, Mirmiran P, Afghan M, Azizi F. Distribution of 10-year risk for coronary heart disease and eligibility for therapeutic approaches among Tehranian adults. Public Health. 2011; 125: 338-44.
408. Hosseini-Esfahani F, Mousavi Nasl Khameneh A, Mirmiran P, Ghanbarian A, Azizi F. Trends in Risk Factors for Cardiovascular Disease Among Iranian Adolescents: The Tehran Lipid and Glucose Study, 1999–2008. J Epidemiol J Epidemiol 2011; 21: 319-28.
409. Mohammadzadeh A, Heydari E, Azizi F: Speech impairment in primary hypothyroidism. J Endocrinol Invest 2011; 34: 431-3.
410. Koochek A, Mirmiran P, Sundquist K, Hosseini F, Azizi T, Moeini AS, Johansson S, Karlström B, Azizi F, Sundquist J. Dietary differences between elderly Iranians living in Sweden and Iran a cross-sectional comparative study. BMC Public Health 2011, 11: 411.
411. Ramezankhani A, Mirmiran P, Azizi F: Effect of nutritional intervention on the prevalence of metabolic syndrome and heart disease risk factors in urban Tehran (Tehran Lipid and Glucose Study). East Mediter Health J 2011; 17: 501-8.
412. Kiani J, Yusefi V, Tohidi M, Mehrabi Y, Azizi F:. Evaluation of glucose tolerance in methimazole and radioiodine treated Graves’ patients. Int J Endocriol Metab 2011; 8: 132-7.
413. Bozorgmanesh M, Hadaegh F, Mehrabi Y, Azizi F. A point-score system superior to blood pressure measures alone for predicting incident hypertension: Tehran Lipid and Glucose Study. J Hypertens 2011; 29: 1486-93.
414. Bozorgmanesh M, Hadaegh F, Azizi F. Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: Type 2 Diabetes. Lipids Health Dis 2011; 10: 88.
415. Hadaegh F, Bozorgmanesh M, Safarkhani M, Khalili D, Azizi F. Predictability of body mass index for diabetes: Affected by the presence of metabolic syndrome? BMC Public Health 2011; 11: 383.
416. Behrooz HG, Tohidi M, Mehrabi Y, Behrooz EG, Tehranidoost M, Azizi F. Subclinical hypothyroidism in pregnancy: intellectual development of offspring. Thyroid 2011; 21: 1143-7.
417. Hosseini-Esfahani F, Bahadoran Z, Mirmiran P, Hosseinpour-Niazi S, Hosseinpanah F, Azizi F: Dietary fructose and risk of metabolic syndrome in adults: Tehran Lipid and Glucose Study. NutrMetabol 2011; 8: 50
418. Ghasemi A, Zahedi Asl S, Syedmoradi L, Azizi F: Association between serum nitritc oxide metabolic and hypertension in a general population. Intern Angiolo 2011; 30: 380-7.
419. Ghasemi A, Zahedi Asl S, Azizi F: Reference values for fasting serum glucose levels in healthy Iranian adult subjects. Clin Lab 2011; 57: 343-9.
420. Hosseinpour-Niazi S, Mirmiran P, Sohrab G, Hosseini-Esfahani F, Azizi F: Inverse association between fruit, legume, and cereal fiber and the risk of metabolic syndrome: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 2011; 94: 276-83.
421. Hosseinpanah F, Yarjani M, Sheikholeslami F, Heibatollahi M, Sarbakhsh Eskandary P, Azizi F: Associations between vitamin D and cardiovascular outcomes; Tehran Lipid and Glucose Study. Atherosclerosis 2011; 218: 238– 42.
422. Jessri M, Mirmiran P, Jessri M, Johns N, Rashidkhani B, Amiri P, Barfmal N, Azizi F: A qualitative difference. Patients’ views of hospital food service in Iran. Appetite 2011; 530-3.
423. Hajsheikholeslami F, Hatami M, Hadaegh F, Ghanbarian A, Azizi F. Association of educational status with cardiovascular disease: Teheran Lipid and Glucose Study. Int J Public Health 2011; 56: 281-7.
424. Tehrani FR, Rashidi H, Azizi F. The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study. Reprod Biol Endocrinol 2011; 9: 144.
425. Azizi F, Yousefi V, Bahrainian A, Sheikholeslami F, Tohidi M, Mehrabi Y: Long-term continuous methimazole or radioiodine treatment for hyperthyroidism. Arch Iran Med 2012; 18: 477-84.
426. Asghari G, Hosseinpanah F, Nazeri P, Mirmiran P, Hajsheikholeslami F, Azizi F. Adult Height and Risk of Coronary Heart Disease: Tehran Lipid and Glucose Study. J Epidemiol 2012; 22: 348-52.
427. Hosseinpanah F, Barzin M, Golkashani HA, Nassiri AA, Sheikholeslami F, Azizi F. Association between moderate renal insufficiency and cardiovascular events in a general population: Tehran lipid and glucose study. BMC Nephrol 2012; 13: 59.
428. Bahadoran Z, Golzarand M, Mirmiran P, Shiva N, Azizi F. Dietary total antioxidant capacity and the occurrence of metabolic syndrome and its components after a 3-year follow-up in adults: Tehran Lipid and Glucose Study. Nutr Metab (Lond) 2012; 9: 70.
429. Mirmiran P, Bahadoran Z, Golzarand M, Shiva N, Azizi F. Association between dietary phytochemical index and 3-year changes in weight, waist circumference and body adiposity index in adults: Tehran Lipid and Glucose study. Nutr Metab (Lond). 2012; 9: 108.
430. Hedayati M, Sharifi K, Rostami F, Daneshpour MS, Zarif Yeganeh M, Azizi F. Association between TNF-α promoter G-308A and G-238A polymorphisms and obesity. Mol Biol Rep 2012; 39: 825-9.
431. Asghari G, Sheikholeslami S, Mirmiran P, Chary A, Hedayati M, Shafiee A, Azizi F: Effect of pomegranate seed oil on serum TNF-a level in dyslipidemic Patients. Int J Food Sci Nutr 2012; 63: 368-71.
432. Hatami M, Hadaegh F, Khalili D, Sheikholeslami F, Azizi F. Family history of diabetes modifies the effect of blood pressure for incident diabetes in Middle Eastern women: Tehran Lipid and Glucose Study. J Hum Hypertens 2012; 26: 84-90.
433. Mehran L, Amouzgar A, Delshad H, Azizi F: Association between Serum TSH Concentration and Body Mass Index in Euthyroid Subjects: The Role of Smoking. Arch Iran Med 2012; 15:400-3.
434. Hadaegh F, Shafiee G, Hatami M, Azizi F: Systolic and diastolic blood pressure, mean arterial pressure and pulse pressure for prediction of cardiovasulcar events and mortality in a Middle Eastern population. Blood Pressure 2012; 21: 12-8.
435. Asghari G, Rezazaeh A, Hosseini-Esfahani F, Mehrabi Y, Mir,iran P, Azizi F: Reliability, comparative validity and stability of dietary patterns derived from an FFQ in the Tehran Lipid and Glucose Study. Br J Nutr 2012; 108: 1109-17.
436. Amiri P, Eslamian G, Mirmiran P, Shiva N, Asghari Jafarabadi M, Azizi F. Validity and reliability of the Iranian version of the Pediatric Quality of Life InventoryTM 4.0 (PedsQLTM) Generic Core Scales in children. Health Qual Life Outcomes 2012; 10: 3.
437. Mirmiran P, Shab-Bidar S, Hosseini-Esfahani F, Asghari G, Hosseinpour-Niazi S, Azizi F. Magnesium intake and prevalence of metabolic syndrome in adults: Tehran Lipid and Glucose Study. Public Health Nutr 2012; 15: 693-701.
438. Daneshpour MS, Faam B, Mansournia MA, Hedayati M, Halalkhor S, Mesbah-Namin SA, Shojaei S, Zarkesh M, Azizi F. Haplotype analysis of Apo AI-CIII-AIV gene cluster and lipids level: Tehran lipid and glucose study. Endocrine 2012; 41: 103-10.
439. Farahmand M, Ramezani Tehrani F, Azizi F: Whether age of menarche is influenced by nody mass index and lipoproteins profile? A retrospective study. Iran J Reprod Med 2012; 10: 337-342.
440. Hadaegh F, Mohebi R, Cheraghi L, Tohidi M, Bozorgmanesh M, Sheikholeslami F, Afshar H, Azizi F: Do Different metabolic syndrome definitions predict stroke events independent of their components? 9 years follow up in a Middle East cohort. J Amer Heart Assoc 2012; 43: 1669-71.
441. Mirmiran P, Hajifaraji M, Bahadoran Z, Sarvghadi F, Azizi F: Dietary protein intake is associated with favorable cardiometabolic risk factors in adults: Tehran Lipid and Glucose Study. Nutr Res 2012; 32:169–76.
442. Bozorgmanesh M, Hadaegh F, Khalili D, Azizi F. Prognostic significance of the Complex "Visceral Adiposity Index" vs. simple anthropometric measures: Tehran Lipid and Glucose Study. Cardiovasc Diabetol 2012; 11: 20.
443. Hadaegh F, Mohebi R, Bozorgmanesh M, Saadat N, Sheikholeslami F, Azizi F. Electrocardiographic abnormalities improve classification of coronary heart disease risk in women: Tehran Lipid and Glucose Study. Atherosclerosis 2012; 222: 110-5.
444. Khalili D, Mosavi-Jarrahi A, Eskandari F, Mousavi-Jarrahi Y, Hadaegh F, Mohagheghi M, Azizi F. Evaluation of cause of deaths' validity using outcome measures from a prospective population based cohort study in Tehran, Iran. PLoS One 2012; 7: e31427.
445. Faam B, Daneshpour MS, Azizi F, Salehi M, Hedayati M. Association between TPO gene polymorphisms and Anti-TPO level in Tehranian population: TLGS. Gene 2012; 498: 116–19.
446. Khalili S, Hatami M, Hadaegh F, Sheikholeslami F, Azizi F. Prediction of Cardiovascular Events with Consideration of General and Central Obesity Measures in Diabetic Adults: Results of the 8.4-Year Follow-Up. Metab Syndr Relat Disord 2012; 10: 218-24.
447. Golzarand M, Mirmiran P, Jessri M, Toolabi K, Mojarrad M, Azizi F. Dietary trends in the Middle East and North Africa: an ecological study (1961 to 2007). Public Health Nutr 2012; 9: 1-10.
448. Delshad H, Amouzegar A, Mirmiran P, Mehran L, Azizi F. Eighteen years of continuously sustained elimination of iodine deficiency in the Islamic Republic of Iran: The vitality of periodic monitoring. Thyroid 2012; 4: 415-21.
449. Zadeh-Vakili A, Faam B, Daneshpour M, Hedayati M, Azizi F: Association of CD36 Gene variants and metabolic syndrome in Iranians. Genet Test Mol Biomarkers 2012; 16: 234-8.
450. Zadeh-vakili A, Ramezani Tehrani F, Hashemi S, Amouzegar A, Azizi F: Relationship between sex hormone binding globulin, thyroid stimulating hormone, prolactin and serum androgens with metabolic syndrome parameters in Iranian women of reproductive age. Diabetes Metab 2012; S2-008.
451. Khalili D, Hadaegh F, Soori H, Steyerberg EW, Bozorgmanesh M, Azizi F: Clinical usefulness of the Framingham cardiovasculsr risk profile beyond its statistical performance. Am J Epidemiol 2012; 176: 177-86.
452. Momenan AA, Delshad M, Sarbazi N, Rezaei Ghaleh N, Ghanbarian A, Azizi F. Reliability and Validity of the Modifiable Activity Questionnaire (MAQ) in an Iranian Urban Adult Population. Arch Iran Med 2012; 15: 279-82.
453. Delshad H, Mehran L, Tohidi M, Assadi M, Azizi F. The incidence of thyroid function abnormalities and natural course of subclinical thyroid disorders, Tehran, I. R. Iran. J Endocrinol Invest 2012; 35: 516-21.
454. Bozorgmanesh M, Hadaegh F, Azizi F, Sheikholeslami F, Ghanbarian A. Shadow of Diabetes Over Cardiovascular Disease: Comparative Quantification of Population-Attributable All-cause and cardiovascular Mortality. Cardiovasc Diabetol 2012 15; 11:69.
455. Tehrani FR, Hashemi S, Hasheminia M, Azizi F. Follow-up of women with gestational diabetes in the Tehran Lipid and Glucose Study (TLGS): a population-based cohort study. J Obstet Gynaecol Res 2012; 38: 698-704.
456. Bahadoran Z, Mirmiran P, Golzarand M, Hosseini-Esfahani F, Azizi F. Fast food consumption in Iranian adults; dietary intake and cardiovascular risk factors: Tehran lipid and glucose study. Arch Iran Med. 2012; 15: 346-51.
457. Daneshpour MS, Hosseinzadeh N, Zarkesh M, Azizi F. Haplotype frequency distribution for 7 microsatellites in chromosome 8 and 11 in relation to the metabolic syndrome in four ethnic groups: Tehran Lipid and Glucose Study. Gene 2012; 495: 62-4.
458. Bahadoran Z, Mirmiran P, Hosseinpanah F, Rajab A, Asghari G, Azizi F. Broccoli sprouts powder could improve serum triglyceride and oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial. Diabetes Res Clin Pract. 2012; 96: 348-54.
459. Bozorgmanesh M, Hadaegh F, Sheikholeslami F, Azizi F. Cardiovascular risk and all-cause mortality attributable to diabetes: Tehran lipid and glucose study. J Endocrinol Invest 2012; 35: 14-20.
460. Hadaegh F, Zabetian A, Khalili D, Safarkhani M, Philip T James W, Azizi F. A new approach to compare the predictive power of metabolic syndrome defined by a joint interim statement versus its components for incident cardiovascular disease in Middle East Caucasian residents in Tehran. J Epidemiol Community Health 2012; 66: 427-32.
461. Mehran L, Nazeri P, Delshad H, Mirmiran P, Mehrabi Y, Azizi F: Does a text messaging intervention improve knowledge, attitudes and practice regarding iodine deficiency and iodized salt consumption? Public Health Nutr 2012; 2: 1-6.
462. Hatami M, Tohidi M, Mohebi R, Khalili D, Azizi F, Hadaegh F. Adolescent lipoprotein classifications according to National Health and Nutrition Examination Survey (NHANES) vs. National Cholesterol Education Program (NCEP) for predicting abnormal lipid levels in adulthood in a Middle East population. Lipids Health Dis 2012; 11: 107.
463. Hosseinpour-Niazi S, Mirmiran P, Amiri Z, Hosseini-Esfahani F, Shakeri N, Azizi F. Legume intake is inversely associated with metabolic syndrome in adults. Arch Iran Med 2012; 15: 538-44.
464. Shafiei B, Hoseinzadeh S, Fotouhi F, Malek H, Azizi F, Jahed A, Hadaegh F, Salehian M, Parsa H, Javadi H, Assadi M. Preoperative 99mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism and concomitant nodular goiter: comparison of SPECT-CT, SPECT, and planar imaging. Nucl Med Commun 2012; 33: 1070-6.
465. Bozorgmanesh M, Hadaegh F, Azizi F. A simple clinical model predicted diabetes progression among prediabetic individuals. Diabetes Res Clin Pract 2012; 97: e34-6.
466. Vahdat K, Azizi F, Zandi K, Assadi M, Nabipour I. Chronic inflammation is correlated with percentage of body fat independent of the burden of infection. Inflammation 2012; 35: 1322-9.
467. Asghari G, Mirmiran P, Rashidkhani B, Asghari-Jafarabadi M, Mehran M, Azizi F. The association between diet quality indices and obesity: Tehran Lipid and Glucose Study. Arch Iran Med 2012; 15: 599-605.
468. Hosseinpanah F, Borzooei S, Barzin M, Farshadi M, Sarvghadi F, Azizi F. Diagnostic values of metabolic syndrome definitions for detection of insulin resistance: Tehran Lipid and Glucose Study (TLGS). Arch Iran Med 2012; 15: 606-10.
469. Mehran L, Amouzgar A, Delshad H, Azizi F. The association of cigarette smoking with serum TSH concentration and thyroperoxidase antibody. Exp Clin Endocrinol Diabetes 2012; 120: 80-3.
470. Tohidi M, Hasheminiaي M, Mohebi R, Khalili D, Hosseinpanah F, Yazdani B, Nasiri AA, Azizi F, Hadaegh F. Incidence of chronic kidney disease and its risk factors, results of over 10 year follow up in an Iranian cohort. PLoS One 2012; 7: e45304.
471. Mirmiran P, Golzarand M, Serra-Majem L, Azizi F. Iron, iodine and vitamin a in the middle East; a systematic review of deficiency and food fortification. Iran J Public Health 2012; 41: 8-19
472. Khalili D, Hadaegh F, Fahimfar N, Shafiee G, Sheikholeslami F, Ghanbarian A, Azizi F. Does an electrocardiogram add predictive value to the rose angina questionnaire for future coronary heart disease? 10-year follow-up in a Middle East population. J Epidemiol Community Health 2012; 66: 1104-9.
473. Bahadoran Z, Tohidi M, Nazeri P, Mehran M, Azizi F, Mirmiran P. Effect of broccoli sprouts on insulin resistance in type 2 diabetic patients: a randomized double-blind clinical trial. Int J Food Sci Nutr 2012; 63: 767-71.
474. Bozorgmanesh M, Hadaegh F, Saadat N, Azizi F. Fasting glucose cutoff point: where does the risk terminate? Tehran lipid and glucose study. Acta Diabetol 2012; 49: 341-8.
475. Tohidi M, Hatami M, Hadaegh F, Azizi F: Triglycerides and triglycerides to high-density lipoprotein cholesterol ratio are strong predictors of incident hypertension in Middle Eastern women. J Human Hypertension 2012; 26: 525-532.
476. Sabet Z, Azizi F, Amouzegar A: Serum testosterone, free testosterone index and SHBG concentration for reduction of metabolic syndrome in Tehranian men. Endocrine Care 2012; VIII: 453-466.
477. Zarkesh M, Daneshpour MS, Faam B, Hedayati M, Azizi F. Is there any association of apolipoprotein E gene polymorphism with obesity status and lipid profiles? Tehran Lipid and Glucose Study (TLGS). Gene 2012; 509: 282-5.
478. Fahimfar N, Khalili D, Mohebi R, Azizi F, Hadaegh F. Risk factors for ischemic stroke; results from 9 years of follow-up in a population based cohort of Iran. BMC Neurol 2012; 12: 117.
479. Mirmiran P, Hosseinpour-Niazi S, Naderi Z, Bahadoran Z, Sadeghi M, Azizi F. Association between interaction and ratio of ω-3 and ω-6 polyunsaturated fatty acid and the metabolic syndrome in adults. Nutrition 2012; 28: 856-63.
480. Ghasemi A, Zahediasl S, Hosseini-Esfahani F, Syedmoradi L, Azizi F. Pediatric reference values for serum zinc concentration in Iranian subjects and an assessment of their dietary zinc intakes. Clin Biochem 2012; 45: 1254-6.
481. Hadaegh F, Hatami M, Mohebi R, Hasheminia M, Bozorgmanesh M, Sheikholeslami F, Azizi F. Electrocardiography-defined silent CHD and risk of cardiovascular events among diabetic patients in a Middle Eastern population. Eur J Prev Cardiol 2012; 19: 1227-33.
482. Hosseini-Esfahani F, Djazaieri SA, Mirmiran P, Mehrabi Y, Azizi F. Which food patterns are predictors of obesity in Tehranian adults? J Nutr Educ Behav 2012; 44: 564-73.
483. Hadaegh F, Jahangiri Noudeh Y, Tohidi M, Vatankhah N, Khalili D, Mohebi R, Azizi F. Change in general and central adiposity measures in prediction of incident dysglycemia; Tehran Lipid and Glucose Study. Prev Med 2012; 55: 608-12.
484. Ghasemi A, Zahediasl S, Hosseini-Esfahani F, Azizi F. Reference values for serum zinc concentration and prevalence of zinc deficiency in adult Iranian subjects. Biol Trace Elem Res 2012; 149: 307-14.
485. Zarkesh M, Faam B, Daneshpour MS, Azizi F, Hedayati M. The Relationship between Metabolic Syndrome, Cardiometabolic Risk Factors and Inflammatory Markers in a Tehranian Population: The Tehran Lipid and Glucose Study. Intern Med 2012; 51: 3329-35.
486. Ghasemi A, Zahediasl S, Azizi F. High serum nitric oxide metabolites and incident metabolic syndrome. Scand J Clin Lab Invest 2012; 72: 523-30.
487. Farahmand M, Tehrani FR, Amiri P, Azizi F. Barriers to healthy nutrition: perceptions and experiences of Iranian women. BMC Public Health 2012; 12: 1064.
488. Hosseinpour-Niazi S, Mirmiran P, Azizi F: Nutritional management of disturbances in lipoprotein concentrations, Intech 2012; 303-26.
489. Atashi Shirazi H, Hedayati M, Daneshpour M, Shafiee A, Azizi F: Analysis of loss of heterozygsity effect on thyroid tumor with oxyphilia cell locus in familial non medullary thyroid carcinoma in Iranian families. Indian J Human Genetics 2012; 18: 290-94.
490. Zarkesh M, Daneshpour M, Faam B, Fallah MS, Hosseinzadeh N, Guity K , Hosseinpanah F, Momenan AA, Azizi F. Heritability of the metabolic syndrome and its components in the Tehran Lipid and Glucose Study (TLGS). Genet. Res, Camb 2012; 94: 331–337.
491. Barzin M, Hosseinpanah F, Saber H, Sarbakhsh P, Nakhoda K, Azizi F. Gender Differences Time Trends for Metabolic Syndrome and Its Components among Tehranian Children and Adolescents. Cholesterol. Hindawi Publishing Corporation Cholesterol Volume 2012; 2012: Article ID 804643, 6 pages, doi:10.1155/2012/804643.
492. Ramezani Tehrani F, Daneshpour M, Hashemi S, Zarkesh M, Azizi F: Relationship between polymorphism of insulin receptor gene, and adiponectin gene with PCOS. Iran J Reproduct Med 2013; 11: 185-194.
493. Shab-Bidar S, Hosseini-Esfahani F, Mirmiran P, Mehran M, Azizi F: Dietary intakes of zinc and copper and cardiovascular risk factors in Tehranian adults: Tehran Lipid and Glucose Study. Nutrition & Dietetics 2013; 70: 218-226.
494. Tehrani FR, Solaymani-Dodaran M, Tohidi M, Gohari MR, Azizi F. Modeling age at menopause using serum concentration of anti-mullerian hormone. J Clin Endocrinol Metab 2013; 98: 729-35.
495. Azizi F: Bariatric Surgery for Obesity and Diabetes. AIM 2013; 16: 182-86.
496. Amouzegar A, Azizi F. Variations of urinary iodine during the first trimesterof pregnancy in an iodine-replete area. Comparison with non-pregnant women. Hormones 2013; 12: 110-117.
497. Azizi F, Mehran L, Amouzegar A, Delshad H, Tohidi M, Askari S, Hedayati M. Establishment of the trimester-specific reference range for free thyroxine index. Thyroid 2013; 23: 354-59.
498. Rahmani M, Earp MA, Ramezani Tehrani F, Ataee M, Wu J, Treml M, Nudischer R, P-Behnami S; ReproGen Consortium, Perry JR, Murabito JM, Azizi F, Brooks-Wilson A. Shared genetic factors for age at natural menopause in Iranian and European women. Hum Reprod 2013; 28: 1987-94.
499. Khazan M, Hedayati M, Askaria S, Azizi F: Adulteration of products sold as Chinese Herbal medicines for weight loss with thyroid hormones and PCP. j Herbal Medicine 2013; 3: 39-43.
500. Tohidi M, Mohebi R, Cheraghi L, Hajsheikholeslami F, Aref S, Nouri S, Azizi F, Hadaegh F. Lipid profile components and incident cerebrovascular events versus coronary heart disease; the result of 9years follow-up in Tehran Lipid and Glucose Study. Clin Biochem 2013;46: 716-21.
501. Mohebi R, Bozorgmanesh M, Azizi F, Hadaegh F. Effects of Obesity on the Impact of Short-Term Changes in Anthropometric Measurements on Coronary Heart Disease in Women. Mayo Clin Proc 2013; 88: 487-94.
502. Mehran L, Tohidi M, Sarvghadi F, Delshad H, Amouzegar A, Soldin OP, Azizi F. Management of thyroid peroxidase antibody euthyroid women in pregnancy: comparison of the american thyroid association and the endocrine society guidelines. J Thyroid Res 2013; 2013: 542692.
503. Bozorgmanesh M, Hadaegh F, Mohebi R, Ghanbarian A, Eskandari F, Azizi F. Diabetic population mortality and cardiovascular risk attributable to hypertension: A decade follow-up from the Tehran Lipid and Glucose Study. Blood Pressure 2013; 22: 317–324.
504. Bahadoran Z, Mirmiran P, Hosseini-Esfahani F, Azizi F. Fast food consumption and the risk of metabolic syndrome after 3-years of follow-up: Tehran Lipid and Glucose Study. Eur J Clin Nutr 2013; 67: 1303-9.
505. Norouzian MA, Azizi F: Factors Affecting Iodine Content in Dairy Cow’s Milk – a Review. European Journal of Food Research & Review 2013; 3: 63-73.
506. Alamdari S, Azizi F, Delshad H, Sarvghadi F, Amouzegar A, Mehran L. Management of Hyperthyroidism in Pregnancy: Comparison of Recommendations of American Thyroid Association and Endocrine Society. J Thyroid Res 2013; 2013: 878467.
507. Samadi S, Bozorgmanesh M, Khalili D, Momenan A, Sheikholeslami F, Azizi F, Hadaegh F. Hypertriglyceridemic waist: The point of divergence for prediction of CVD vs. mortality: Tehran Lipid and Glucose Study. Int J Cardiol 2013; 165: 260-65.
508. Bozorgmanesh M, Hadaegh F, Azizi F. Transportability of the updated diabetes prediction model from Atherosclerosis Risk in Communities Study to a Middle Eastern adult population: community-based cohort study. Acta Diabetol 2013; 50: 175-81.
509. Mohebi R, Bozorgmanesh M, Sheikholeslami F, Azizi F, Hadaegh F. Contribution of glomerular filtration rate to 10-year cardiovascular and mortality risk among hypertensive adults: tehran lipid and glucose study. J Clin Hypertens (Greenwich) 2013;15: 350-8.
510. Malboosbaf R, Hosseinpanah F, Mojarrad M, Jambarsang S, Azizi F. Relationship between goiter and gender: a systematic review and meta-analysis. Endocrine 2013;43: 539-47
511. Moradi S, Azizi F. Trends in cardiovascular disease risk factors in children and adolescents: Tehran Lipid and Glucose Study. EMHJ 2013; 19: 720-26.
512. Yadegari H, Bozorgmanesh M, Hadaegh F, Azizi F. Non-linear contribution of glucose measures to cardiovascular diseases and mortality: Reclassifying the Framingham's risk categories: A decade follow-up from the Tehran lipid and glucose study. Int J Cardiol 2013; 167: 1486-1494.
513. Bahadoran Z, Mirmiran P, Azizi F. Dietary polyphenols as potential nutraceuticals in management of diabetes: a review. J Diabetes Metab Disord 2013; 12: 43.
514. Barzin M, Hosseinpanah F, Malboosbaf R, Hajsheikholeslami F, Azizi F. Isolated post-challenge hyperglycaemia and risk of cardiovascular events: Tehran Lipid and Glucose Study. Diab Vasc Dis Res Diab Vasc Dis Res 2013;10:324-9.
515. Tohidi M, Bozorgmanesh M, Mohebi R, Khalili D, Saadat N, Khorrami N, Azizi F, Hadaegh F. Non-linear association between 25-hydroxyvitamin D and the incidence of Type 2 diabetes: a community-based nested case-control study. Diabet Med 2013; 30: 934-8.
516. Farahmand M, Tehrani FR, Pourrajabi L, Najafi M, Azizi F. Factors associated with menopausal age in Iranian women: Tehran Lipid and Glucose Study. J Obstet Gynaecol Res. Obstet Gynaecol Res 2013; 39: 836-41.
517. Hosseinpanah F, Asghari G, Barzin M, Golkashani HA, Azizi F. Prognostic impact of different definitions of metabolic syndrome in predicting cardiovascular events in a cohort of non-diabetic Tehranian adults. Int J Cardiol 2013; 168: 369-74.
518. Ghasemi A, Zahediasl S, Azizi F. Elevated Nitric Oxide Metabolites are Associated with Obesity in Women. Arch Iran Med 2013; 16: 521-5.
519. Ramezani Tehrani F, Noroozzadeh M, Zahediasl S, Ghasemi A, Piryaei A, Azizi F. Prenatal testosterone exposure worsen the reproductive performance of male rat at  adulthood. PLoS One 2013; 8: e71705.
520. Asghari G, Mirmiran M, Hosseni-Esfahani F, Nazeri P, Mehran M, Azizi F. Dietary Quality among Tehranian Adults in Relation to Lipid Profile: Findings from the Tehran Lipid and Glucose Study. J Health Popul Nutr 2013; 31: 37-48
521. Asghari G, Mirmiran P, Rashidkhani B, Asghari-Jafarabadi M, Mehran M, Azizi F. Authors' reply. Arch Iran Med 2013; 16: 443-4.
522. Sadat Hosseini M, Ramezani Tehrani F, Azizi F. The lack of association between idiopathic hirsutism and metabolic disturbances: Iranian PCOS Prevalence Study. Gynecol Endocrinol 2013; 29: 821-5.
523. Hosseinpour-Niazi S, Sohrab G, Asghari G, Moslehi N, Azizi F. Dietary Glycemic Index, Glycemic Load, and Cardiovascular Disease Risk Factors: Tehran Lipid and Glucose Study. Archives of Iranian Medicine 2013; 16: 401-7.
524. Faam B, Hosseinpanah F, Amouzegar A, Ghanbarian A, Asghari G, Azizi F. Leisure-Time Physical Activity and Its Association With Metabolic Risk Factors in Iranian Adults: Tehran Lipid and Glucose Study, 2005–2008. Public Health Research, Practice, and Policy 2013; 10: 1-8.
525. Bahar A, Hosseini Esfahani F, Asghari Jafarabadi M, Mehrabi Y, Azizi F. The structure of metabolic syndrome components across follow-up survey from childhood to adolescence. Int J Endocrinol Metab 2013; 11: 16-22.
526. Azizi F, Amouzegar A, Delshad H, Tohidi M, Mehran L, Mehrabi Y. Natural course of thyroid disease profile in a population in nutrition transition: Tehran Thyroid Study. Arch Iran Med 2013; 16: 418-23.
527. Zadeh-Vakili A, Ramezani Tehrani F, Daneshpour MS, Zarkesh M, Saadat N, Azizi F. Genetic polymorphism of vitamin D receptor gene affects the phenotype of PCOS. Gene 2013; 515: 193-6.
528. Mirmiran P, Nazeri P, Amiri P, Mehran L, Shakeri N, Azizi F. Iodine nutrition status and knowledge, attitude, and behavior in tehranian women following 2 decades without public education. J Nutr Educ Behav 2013; 45: 412-9.
529. Jahangiri Noudeh Y, Hadaegh F, Vatankhah N, Momenan AA, Saadat N, Khalili D, Azizi F. Wrist Circumference as a Novel Predictor of Diabetes and Prediabetes: Results of Cross-Sectional and 8.8-Year Follow-up Studies. J Clin Endocrinol Metab 2013; 98: 777-84.
530. Sohrab G, Hosseinpour-Niazi S, Hejazi J, Yuzbashian E, Mirmiran P, Azizi F. Dietary polyphenols and metabolic syndrome among Iranian adults. Int J Food Sci Nutr 2013; 64: 661-7.
531. Amirbaigloo A, Hosseinpanah F, Sarvghadi F, Tohidi M, Eskandary PS, Azizi F.Absence of association between vitamin d deficiency and incident metabolic syndrome: tehran lipid and glucose study. Metab Syndr Relat Disord 2013; 11: 236-42.
532. Hashemi S, Ramezani Tehrani F, Mehrabi Y, Azizi F. Hypertensive pregnancy disorders as a risk factor for future cardiovascular and metabolic disorders (Tehran Lipid and Glucose Study). J Obstet Gynaecol Res 2013; 39: 891-7.
533. Mirmiran P, BahadoranMS Z, Golzarand M, Rajab A, Azizi F: Ardeh (Sesamum indicum) Could Improve Serum Triglycerides and atherogenic lipid parameters in type 2 diabetic patients: A Randomized Clinical Trial. Archives of Iranian Medicine 2013; 16: 652-56.
534. Bahadoran Z, Mirmiran P, Azizi F. Potential efficacy of broccoli sprouts as a unique supplement for management of type 2 diabetes and its complications. J Med Food. 2013; 16: 375-82.
535. Hadaegh F, Mohebi R, Khalili D, Hasheminia M, Sheikholeslami F, Azizi F. High normal blood pressure is an independent risk factor for cardiovascular disease among middle-aged but not in elderly populations: 9-year results of a population-based study. J Hum Hypertens. 2013; 27: 18-23.
536. Rashidi H, Ramezani Tehrani F, Bahri Khomami M, Tohidi M, Azizi F. To what extent does the use of the Rotterdam criteria affect the prevalence of polycystic ovary syndrome? A community-based study from the Southwest of Iran. Eur J Obstet Gynecol Reprod Biol. 2013 Dec 18. pii: S0301-2115.
537. Mirmiran P, Moslehi N, Asghari G, Jambarsang S, Mehrabi Y, Azizi F. Secular trends in size at birth of Iranian neonates: Meta-analyses of published and unpublished studies. Ann Hum Biol 2013; 40: 75-82.
538. Azizi F, Mirmiran P, Momenan AA, Hadaegh F, Habibi Moeini A, Hosseini F, Zahediasl S, Ghanbarian A, Hosseinpanah F; Members of Tehran Lipid and Glucose Study Group. The effect of community-based education for lifestyle intervention on the prevalence of metabolic syndrome and its components: tehran lipid and glucose study. Int J Endocrinol Metab 2013; 11: 145-53.
539. Fam B, Amouzegar A, Arzhan S, Ghanbariyan A, Delshad M, Hosseinpanah F, Azizi F. Association between Physical Activity and Metabolic Risk Factors in Adolescents: Tehran Lipid and Glucose Study. Int J Prev Med 2013; 4: 1011-7.
540. Hadaegh F, Hasheminia M, Lotfaliany M, Mohebi R, Azizi F, Tohidi M. Incidence of metabolic syndrome over 9 years follow-up; the importance of sex differences in the role of insulin resistance and other risk factors. PLoS One 2013; 8: e76304.
541. Bandarian F, Hedayati M, Daneshpour MS, Naseri M, Azizi F. Genetic polymorphisms in the APOA1 gene and their relationship with serum HDL cholesterol levels. Lipids 2013; 48: 1207-16.
542. Hosseinpanah F, Asghari G, Barzin M, Ghareh S, Azizi F. Adolescence metabolic syndrome or adiposity and early adult metabolic syndrome. J Pediatr 2013; 163: 1663-1669.
543. Amouzegar A, Delshad H, Mehran L, Tohidi M, Khafaji F, Azizi F. Reference limit of thyrotropin (TSH) and free thyroxine (FT4) in thyroperoxidase positive and negative subjects: A population based study. J Endocrinol Invest 2013; 36: 950-54.
544. Bahadoran Z, Golzarand M, Mirmiran P, Saadati N, Azizi F. The association of dietary phytochemical index and cardiometabolic risk factors in adults: Tehran Lipid and Glucose Study. J Hum Nutr Diet 2013; 1: 145-53.
545. Mehran L, Amouzegar A, Delshad H, Askari S, Hedayati M, Amirshekari G, Azizi F. Trimester-specific reference ranges for thyroid hormones in Iranian pregnant women. J Thyroid Res 2013; 2013: 651517.
546. Ramezani Tehrani F, Moslehi N, Asghari G, Gholami R, Mirmiran P, Azizi F. Intake of dietary products, calcium, magnesium, and phosphorus in childhood and age at menarche in the Tehran lipid and glucose study. Plosone 2013; 8: e57696.
547. Ejtahed H, Sarsharzadeh  M, Mirmiran P, Asghari G, Yuzbashian E, Azizi F. Leemoo, a Dietary Assessment and Nutritional Planning Software, Using Fuzzy Logic. Inter J Endocrinol Metab 2013; 11: e10169.
548. Bahadoran Z, Mirmiran P, Hosseini-Esfahani F, Azizi F. Dietary protein, protein to carbohydrate ratio and subsequent changes in lipid profile after a 3-year follow-up: Tehran Lipid and Glucose Study. Iran JPub Health 2013; 42: 1232-1241.
549. Hashemi S, Ramezani Tehrani F, Noroozzadeh M, Azizi F. Normal cut-off values for hyperandrogenaemia in Iranian women of reproductive age. Eur J Obstet Gynecol Reprod Biol 2014; 172:51-5.
550. Moghaddam MM, Mohebi R, Hosseini F, Lotfaliany M, Azizi F, Saadat N, Hadaegh F. Distribution of ideal cardiovascular health in a community-based cohort of Middle East population. Ann Saudi Med 2014; 34: 134-42.
551. Ramezani Tehrani F, Minooee S, Azizi F. Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study. Eur J Endocrinol 2014; 171: 199-207.
552. Naseri M, Hedayati M, Daneshpour MS, Bandarian F, Azizi F: Identification of genetic variants of lecithin cholesterol acyltransferase in individuals with high HDL‑C levels. Molecular Medicine Reports 2014; 10: 496-502.
553. Mozaffary A, Bozorgmanesh M, Sheikholeslami F, Azizi F, Eskandar F, Hadaegh F. Added value of different metabolic syndrome definitions for predicting cardiovascular disease and mortality events among elderly population: Tehran Lipid and Glucose Study. Eur J Clin Nutr 2014; 68:853-8.
554. Steinthorsdottir V, Thorleifsson G, Sulem P, Helgason H, Grarup N, Sigurdsson A, Helgadottir HT, Johannsdottir H, Magnusson OT, Gudjonsson SA, Justesen JM, Harder MN, Jørgensen ME, Christensen C, Brandslund I, Sandbæk A, Lauritzen T, Vestergaard H, Linneberg A, Jørgensen T, Hansen T, Daneshpour MS, Fallah MS, Hreidarsson AB, Sigurdsson G, Azizi F, Benediktsson R, Masson G, Helgason A, Kong A, Gudbjartsson DF, Pedersen O, Thorsteinsdottir U, Stefansson K. Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes. Nat Genet. Nat Genet 2014; 46: 294-8.
555. Ehteshami-Afshar S, Momenan A, Hajshekholeslami F, Azizi F, Hadaegh F. The impact of smoking status on 9.3 years incidence of cardiovascular and all-cause mortality among Iranian men. Ann Hum Biol. 2014; 41: 249-54.
556. Ramezani Tehrani F, Behboudi-Gandevani S, Ghanbarian A, Azizi F. Effect of menopause on cardiovascular disease and its risk factors: a 9-year follow-up, population-based, cohort study. Climacteric. Climacteric. 2014; 17: 164-72.
557. Tohidi M, Ghasemi A, Hadaegh F, Derakhshan A, Chary A, Azizi F. Age- and sex-specific reference values for fasting serum insulin levels and insulin resistance/sensitivity indices in healthy Iranian adults: Tehran Lipid and Glucose Study. Clin Biochem 2014; 47: 432-8.
558. Amouzegar A, Ainy E, Khazan M, Hedayati M, Azizi F: Local versus international recommended TSH references in the assessment of thyroid function during pregnancy. Hormone Metab Res 2014; 46: 206-210.
559. Rashidi H, Ramezani Tehrani F, Bahri Khomami M, Tohidi M, Azizi F: To what extent does the use of the Rotterdam criteria affect the prevalence of polycystic ovary syndrome? A community-based study from the Southwest of Iran. Eur J Obstet Gynecol Reprod Biol 2014; 174: 100-5.
560. Tehrani FR, Mirmiran P, Gholami R, Moslehi N, Azizi F: Factors influencing menarcheal age: Results from the cohort of Tehran Lipid and glucose study. International Journal of Endocrinology and Metabolism 2014; 12: e16130.
561. Kheirandish M, Asgari S, Lotfaliany M, Bozorgmanesh M, Saadat N, Tohidi M, Azizi F, Hadaegh F. Secular trends in serum lipid levels of a Middle Eastern adult population; 10 years follow up in Tehran lipid and glucose study. Lipids Health Dis 2014; 13: 20.
562. Shab-Bidar S, Hosseini-Esfahani F, Mirmiran P, Hosseinpour-Niazi S, Azizi F. Metabolic syndrome profiles, obesity measures and intake of dietary fatty acids in adults: Tehran Lipid and Glucose Study. J Hum Nutr Diet 2014; 27: 98-108.
563. Ramezani Tehrani F, Minooee S, Azizi F. Validation of a simplified method to assess hirsutism in the Iranian population. Eur J Obstet Gynecol Reprod Biol 2014; 174: 91-5.
564. Hosseinpanah F, Nazeri P, Ghareh S, Tohidi M, Azizi F. Predictors of the incident metabolic syndrome in healthy obese subjects: a decade of follow-up from the Tehran Lipid and Glucose Study. Eur J Clin Nutr 2014; 68: 295-9.
565. Amouzegar A, Khazan M, Hedayati M, Azizi F. An assessment of the iodine status and the correlation between iodine nutrition and thyroid function during pregnancy in an iodine sufficient area. Eur J Clin Nutr 2014; 68: 397-400.
566. Ramezani Tehrani F, Momenan AA, Khomami MB, Azizi F. Does lactation protect mothers against metabolic syndrome? Findings from the Tehran Lipid and Glucose Study. J Obstet Gynaecol Res 2014; 40: 736-42.
567. Mirmiran P, Rezaei M, Asghari G, Mehrabi Y, Azizi F: Association of Metabolic Syndrome with Body Fat Percent, Anthropometric Indices in 10 To 18 Year Old Adolescents.  Iranian J Publ Health 2014; 43: 193-201.
568. Khazan M, Hedayati M, Kobarfard F, Askari S, Azizi F. Identification and Determination of Synthetic Pharmaceuticals as Adulterants in Eight Common Herbal Weight Loss Supplements.  Iran Red Crescent Med J 2014; 16: e15344.
569. Ghasemi A, Azimzadeh I, Zahediasl S, Azizi F. Reference Values for Serum Creatinine with Jaffe-compensated Assay in Adult Iranian Subjects: Tehran Lipid and Glucose Study. Arch Iran Med 2014; 17: 394-9.
570. Amouzegar A, Beigy M, Gharibzadeh S, Azizi F. Underestimation of Thyroid Dysfunction Risk due to Regression Dilution Bias in a Long-term Follow-up: Tehran Thyroid Study (TTS). Horm Metab Res 2014; 46: 440-444.
571. Azizi F: Tehran Lipid and Glucose Study: A Legacy for Prospective Com-munity-based Research. Archives Iranian Medicine (AIM) 2014; 17: 392-393.
572. Amiri P, Deihim T, Hosseinpanah F, Barzin M, Hasheminia M, Montazeri A, Azizi F. Research: Educational and Psychological Aspects Diagnostic values of different definitions of metabolic syndrome to detect poor health status in Iranian adults without diabetes. Diabet Med 2014; 31: 854-861.
573. Ejtahed H, Asghari G, Mirmiran P, Hosseinpour-Niazi S, Sherafat-KazemZadeh R, Azizi F: Body Mass Index as a Measure of Percentage Body Fat Predictionand Excess Adiposity Diagnosis among Iranian Adolescents. Archives Iranian Medicine (AIM) 2014; 17: 400-405.
574. Ramezani Tehrani F, Bahri M, Gholami R, Hashemi S, Nakhoda K, Azizi F. Secular Trend of Menopausal Age and Related Factors among Tehrani Women Born from 1930 to 1960; Tehran Lipid and Glucose Study. Archives Iranian Medicine (AIM) 2014; 17: 406-410.
575. Zarkesh M, Hosseinpanah F, Barzin M, Hosseinzadeh N, Guity K, Daneshpour M, Azizi F:  Recurrence Risk Ratio of Siblings and Familial Aggregation of the Metabolic Syndrome among Tehranian Population. Archives Iranian Medicine (AIM) 2014; 17: 411-416.
576. Eslamian G, Mirmiran P, Asghari G, Hosseini-Esfahani F, Youzbashian E, Azizi F: Low Carbohydrate Diet Score does not Predict Metabolic Syndrome in Children and Adolescents: Tehran Lipid and Glucose Study. Archives Iranian Medicine (AIM) 2014; 17: 417-422.
577. Amiri P, Deihim T, Nakhoda K, Hasheminia M, Montazeri A, Azizi F. Metabolic Syndrome and Health-related Quality of Life in Reproductive Age and Post-menopausal Women: Tehran Lipid and Glucose Study. Archives Iranian Medicine (AIM) 2014; 17: 423-428.
578. عزیزی ف، دلشاد ح، آموزگار ع، مهران ل، میرمیران پ، زاهدی اصل ص: کنترل گواتر و صدمات مغزی ناشی از کمبود ید در جمهوری اسلامی ایران. مجله غدد درون‌ریز و متابولیسم ایران، دانشگاه علوم پزشکی شهید بهشتی، دوره 15، شماره 5، صفحات 429-411، دی 1392.
579. Bahadoran Z, Mirmiran P, Delshad H, Azizi F White Rice Consumption is a Risk Factor for Metabolic Syndrome in Tehrani Adults: A Prospective Approach in Tehran Lipid and Glucose Study: Archives Iranian Medicine (AIM) 2014; 17: 435-440.
580. Askar S, Asghari G, Ghanbarian A, Khazan M, Alamdari SH, Azizi F: Seasonal Variations of Blood Pressure in Adults: Tehran Lipid and Glucose Study. Archives Iranian Medicine (AIM) 2014; 17: 441-443.
581. Ahmadzadeh AR, Azizi F. Genes Associated with Low Serum High-density Lipoprotein Cholesterol. Archives Iranian Medicine (AIM) 2014; 17: 444-450.
582. Derakhshan A, Sardarinia M, Khalili D, Momenan AA, Azizi F, Hadaegh F. Sex Specific Incidence Rates of Type 2 Diabetes and Its Risk Factors over 9 Years of Follow-Up: Tehran Lipid and Glucose Study. PLoS One 2014; 9: e102563.
583. Bozorgmanesh M, Ghoreishian H, Mohebi R, Azizi F, Hadaegh F.Sex-specific predictors of the prehypertension-to-hypertension progression: community-based cohort of a West-Asian population. Eur J Prev Cardiol 2014; 21: 956-963.
584. Mohebi R, Mohebi A, Ghanbarian A, Momenan A, Azizi F, Hadaegh F. Is systolic blood pressure below 150 mm Hg an appropriate goal for primary prevention of cardiovascular events among elderly population? J Am Soc Hypertens 2014; 8: 491-7.
585. Hosseinpour-Niazi S; Mirmiran P; Hosseinpanah F; Fallah-ghohroudy A; Azizi F. Association of Marital Status and Marital Transition With Metabolic Syndrome: Tehran Lipid and Glucose Study. Int J Endocrinol Metab 2014; 12: e18980.
586. Bozorgmanesh M, Arshi B, Sheikholeslami F, Azizi F, Hadaegh F: No Obesity paradox-BMI incapable of adequately capturing the relation of obesity with all-cause mortality: an inception diabetes with all-cause mortality: An inception diabetes cohort study. Internal J Endocrinol 2014; 2014: ID 282089.
587. Nejat A, Mirbolouk M, Mohebi R, Hasheminia M, Tohidi M, Saadat N, Azizi F, Hadaegh F. Changes in lipid measures and incident coronary heart disease: Tehran Lipid & Glucose Study. Clin Biochem 2014; 47: 1239-1244.
588. Khalili D, Haj Sheikholeslami F, Bakhtiyari M, Azizi F, Momenan AA, Hadaegh F. The incidence of coronary heart disease and the population attributable fraction of its risk factors in Tehran: a 10-year population-based cohort study. PLoS One 2014; 9: e105804.
589. Hosseini-Esfahani F, Mirmiran P, Daneshpour MS, Mehrabi Y, Hedayati M, Zarkesh M, Azizi F. Western Dietary Pattern Interaction with APOC3 Polymorphism in the Risk of Metabolic Syndrome: Tehran Lipid and Glucose Study. J Nutrigenet Nutrigenomics 2014; 7: 105-117.
590. Delshad H, Amouzegar A, Mehran L, Azizi F: Comparison of two guidelines on management of thyroid nodules and thyroid cancer during pregnancy. Archiv Iran Med (AIM) 2014; 17: 670-73.
591. Ejtahed HS, Niasari Naslaji A, Mirmiran P, Zraif Yeganeh M, Hedayati M, Azizi F, Moosavi Movahedi A. Effect of Camel Milk on Blood Sugar and Lipid Profile of Patients With Type 2 Diabetes: A Pilot Clinical Trial. Int J Endocrinol Metab 2014; 13(1): e21160.
592. Amouzegar A, Mehran L, Sarvghadi F, Delshad H, Azizi F, Lazarus JH. Comparison of the American Thyroid Association with the Endocrine Society practice guidelines for the screening and treatment of hypothyroidism during pregnancy. Hormones (Athens) 2014; 13: 307-13.
593. Azizi F, Amouzegar A, Mehran L, Alamdari S, Subekti I, Vaidya B, Poppe K, Sarvghadi F, San Luis T Jr, Akamizu T. Management of hyperthyroidism during pregnancy in Asia. Endocr J 2014; 61: 751-8.
594. Mohebi R, Mohebi A, Sheikholeslami F, Azizi F, Hadaegh F. Wrist circumference as a novel predictor of hypertension and cardiovascular disease: results of a decade follow up in a West Asian cohort. J Am Soc Hypertens 2014; 8: 800-7.
595. Azizi F, Amouzegar A, Mehran L, Alamdari S, Subekti I, Vaidya B, Poppe K, San Luis T Jr, Akamizu T. Screening and management of hypothyroidism in pregnancy: results of an Asian survey. Endocr J 2014; 61: 697-704.
596. Farahmand M, Ramezani Tehrani F, Simbar M, Mehrabi Y, Khalili D, Azizi F: Does metabolic syndrome or its components differ in naturally and surgically menopausal women? Climacteric 2014; 17: 348-55.
597. Khazan M, Amouzegar A, Gharibzadeh S, Mehran L, Tohidi M, Azizi F. Prevalence of Hypothyroidism in Patients with Dyslipidemia: Tehran Thyroid Study (TTS). Horm Metab Res 2014; 46: 980-4.
598. Azizi F: Early Detection and Optimized Management of Thyroid Disease in Pregnancy. Int J Endocrinol Metab 2014; 13: e25728.
599. Hedayati M, Zarif Yeganeh M, Sheikhol Eslami S, Rezghi Barez S, Hoghooghi Rad L, Azizi F. Predominant RET Germline Mutations in Exons 10, 11, and 16 in Iranian Patients with Hereditary Medullary Thyroid Carcinoma. J Thyroid Res 2014; 2011: 264248.
600. Ramezankhani A, Pournik O, Shahrabi J, Khalili D, Azizi F, Hadaegh F. Applying decision tree for identification of a low risk population for type 2 diabetes. Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 2014; 105: 391-8.
601. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects), Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G, Azizi F, Hadaegh F, Khalili D: Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1•8 million participants. Lancet 2014; 383(9921): 970-83.
602. Tehrani FR, Rashidi H, Khomami MB, Tohidi M, Azizi F. The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran. Reprod Biol Endocrinol 2014; 12: 89.
603. Jahangiri-Noudeh Y, Akbarpour S, Lotfaliany M, Zafari N, Khalili D, Tohidi M, Mansournia MA, Azizi F, Hadaegh F. Trends in Cardiovascular Disease Risk Factors in People with and without Diabetes Mellitus: A Middle Eastern Cohort Study. PLoS One 2014; 9: e112639.
604. Daneshpour M, Houshmand M, Alfadhli S, Zarkesh M. Zeinali S, Hedayati M, Azizi M: Allele Frequency of D12S1632, D12S329, D12S96, D16S3096 and D16S2624 in four Ethnic Groups and Its Relationship With Metabolic Syndrome in Tehran Lipid and Glucose Study. Gene Cell Tissue 2014; 1: e24756.
605. Hosseinpanah F, Barzin M, Erfani H, Serahati S, Ramezani Tehrani F, Azizi F. Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study. Clin Endocrinol (Oxf) 2014; 81: 52-7.
606. Hosseinpanah F, Barzin M, Keihani S, Tehrani FR, Azizi F. Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study. Clin Endocrinol (Oxf) 2014; 81: 93-9.
607. Ghasemi A, Zahediasl S, Hosseini-Esfahani F, Azizi F. Gender differences in the relationship between serum zinc concentration and metabolic syndrome. Ann Hum Biol 2014; 41: 436-42.
608. Mirmiran P1, Bahadoran Z, Mirzaei S, Azizi F. Dietary Intake, Changes in Lipid Parameters and the Risk of Hypertriglyceridemia: A Prospective Approach in the Tehran Lipid and Glucose Study. Int J Vitam Nutr Res 2014; 84: 269-76.
609. Ramezani Tehrani F, Noroozzadeh M, Zahediasl S, Piryaei A, Hashemi S, Azizi F. The time of prenatal androgen exposure affects development of polycystic ovary syndrome-like phenotype in adulthood in female rats. Int J Endocrinol Metab 2014; 12: e16502.
610. Mirmiran P, Bahadoran Z, Golzarand M , Zojaji H, Azizi F. A comparative study of broccoli sprouts powder and standard triple therapy on cardiovascular risk factors following H.pylori eradication: a randomized clinical trial in patients with type 2 diabetes. J Diabet & Metabol Disord 2014; 13: 64.
611. Mirmiran P, Bahadoran Z, Azizi F. Functional foods-based diet as a novel dietary approach for management of type 2 diabetes and its complications: A Review. World J Diabetes 2014; 5: 267-281.
612. Mohseni-Takalloo S, Mirmiran P, Hosseini-Esfahani F, Azizi F. Dietary Fat Intake and Its Relationship with Serum Lipid Profiles in Tehranian Adolescents. J Food Nutrition Research 2014; 2: 330-334.
613. Golzarand M, Mirmiran P, Bahadoran Z, Alamdari SH, Azizi F. Dietary phytochemical index and subsequent changes of lipid profile: A 3-year follow-up in Tehran Lipid and Glucose Study.ARYA atheroscler 2014; 10: 203-210.
614. Tehrani FR, Erfani H, Cheraghi L, Tohidi M, Azizi F. Lipid profiles and ovarian reserve status: a longitudinal study. Hum Reprod 2014; 29: 2522-9.
615. Bahadoran Z, Mirmiran P, Zarif Yeganeh M,  Hosseinpanah  F, Zojaji H, Azizi F. Complementary and alternative medicinal effects of broccoli sprouts powder on Helicobacter pylori eradication rate in type 2 diabetic patients: A randomized clinical trial. J Functional Foods 2014; 7: 390-397.
616. Mohseni-Takalloo S, Mirmiran P, Hosseini-Esfahani F, Mehrabi Y, Azizi F. Metabolic Syndrome and its Association with Healthy Eating Index-2005 in Adolescents: Tehran Lipid and Glucose Study. J Food Nutrition Research 2014; 2: 155-161.
617. Mirmiran p, Fallah Ghohroudy A, Hosseinpour Niazi S, Ahmadi B, Nayeri F, Azizi F. Dietary Patterns and Non Communicable Disease Among Iranian Women: A Systematic Review. Womens Health Bull 2014; 1: e21358.
618. Hosseini Esfahani F, Ejtahed H, Mirmiran P, Delshad H, Azizi F: Alterations in food group intakes and subsequent weight changes in adults: Tehran Lipid And Glucose Study. Int J Endocrinol Metab 2014; 12: e17236.
619. Faam B, Daneshpour MS, Hedayati M, Halalkhor S, Mansournia MA, Zarkesh M, Azizi F. The age effect on the association between the scavenger receptor class B type I (SR-BI) polymorphism and HDL-C level: Tehran Lipid and Glucose Study. Endocr Res 2014; 39: 91-3.
620. Faam B, Zarkesh M, Daneshpour M, Azizi F, Hedayati M:  The association between inflammatory markers and obesity-related factors in Tehranian adults: Tehran lipid and glucose study. Iran J Basic Med Sci 2014; 17: 8: 577-582.
621. Hosseinpour-Niazi S, Mirmiran P, Hedayati M, Azizi F. Substitution of red meat with legumes in the therapeutic lifestyle change diet based on dietary advice improves cardiometabolic risk factors in overweight type 2 diabetes patients: a cross-over randomized clinical trial. European Journal of Clinical Nutrition 2014; doi: 10.1038/ejcn.2014. 228.
622. Mirmiran P, Bahadoran Z, Azizi F. Lipid Accumulation Product Is Associated with Insulin Resistance, Lipid Peroxidation, and Systemic Inflammation in Type 2 Diabetic Patients. Endocrinol Metab (Seoul) 2014; 29: 443-449.
623. Mehran L, Amouzegar A, Tohidi M, Moayedi M, Azizi F: Serum Free Thyroxine Concentration is Associated with Metabolic Syndrome in Euthyroid Subjects. Thyroid 2014; 24: 1-9.
624. Tehrani FR, Mansournia MA, Solaymani-Dodaran M, Azizi F. Age-specific serum anti-Müllerian hormone levels: estimates from a large population-based sample. Climacteric 2014; 17: 591-7.
625. Amiri P, Hosseinpanah F, Jalali-Farahani S, Mehrabi Y, Montazeri A, Azizi F. Is persistence of metabolic syndrome associated with pool health-related quality of life in non diabetic adults? Tehran Lipid and Glucose study. J Diabetes Investig 2014; 5: 683-693.
626. Rostami Dovom M, Ramezani Tehrani F, Amiri P, Amirshekari G, Farahmand M, Azizi F: Main Facilitators of Smoking Among Young Males in Tehran: Tehran Lipid and Glucose Study. Iran Red Crescent Med J 2014; 16: e9531.
627. Bahadoran Z, Mirmiran P, Tohidi M, Azizi F: Dietary phytochemical index and the risk of insulin resistance and b-cell dysfunction: a prospective approach in Tehran lipid and glucose study. Int J Food Sci Nutr 2015; 66: 950–955.
628. Hadaegh F, Ehteshami-Afshar S, Hajebrahimi MA, Hajsheikholeslami F, Azizi F. Silent coronary artery disease and incidence of cardiovascular and mortality events at different levels of glucose regulation; results of greater than a decade follow-up. Int J Cardiol 2015; 182C:334-339.
629. Keihani S, Hosseinpanah F, Barzin M, Serahati S, Doustmohamadian S, Azizi F: Abdominal obesity phenotypes and risk of cardiovascular disease in a decade of follow-up: The Tehran Lipid and Glucose Study. Atherosclerosis 2015; 238: 256e263.
630. Faam B, Ghaffari MA, Ghadiri A, Azizi F. Epigenetic modifications in human thyroid cancer. Biomed Rep 2015; 3: 3-8.
631. Mirmiran P, Bahadoran Z, Delshd H, Azizi F. Author's response re. "Predictors of the incidence of metabolic syndrome in general inhabitants. Nutrition 2015; 31: 259.
632. Derakhshan A, Tohidi M, Arshi A, Khalili D, Azizi F, Hadaegh F: Relationship of hyperinsulinaemia, insulin resistance and b-cell dysfunction with incident diabetes and pre-diabetes: the Tehran Lipid and Glucose Study. Diabet Med 2015; 32: 24–32.
633. Tehrani FR, Behboudi-Gandevani S, Ghasemi A, Azizi F. Menopause status as the main factor explaining the gender differences of serum nitric oxide concentrations in middle-aged population. Arch Gynecol Obstet 2015; 291: 159-63.
634. Nazeri P, Mirmiran P, Asghari G, Shiva N, Mehrabi Y, Azizi F. Mothers' behaviour contributes to suboptimal iodine status of family members: findings from an iodine-sufficient area. Public Health Nutr Public Health Nutr 2015; 18: 686-94.
635. Mirmiran P, Golzarand  M, Bahadoran Z, Mirzaei S, Azizi F. High-fat dairy is inversely associated with the risk of hypertension in adults: Tehran lipid and glucose study. International Dairy Journal 2015; 43: 22-26.
636. Bahadoran Z, Mirmiran P, Hosseinpour-Niazi S, Azizi F. A sesame seeds-based breakfast could attenuate sub-clinical inflammation in type 2 diabetic patients: A randomized controlled trial. Inter J Nutr Food Scien 2015; 4: 1-5.
637. Heidari Z, Hosseinpanah F, Barzin M, Safarkhani M, Azizi F. Mother-Daughter Correlation of Central Obesity and Other Noncommunicable Disease Risk Factors: Tehran Lipid and Glucose Study. Asia Pac J Public Health 2015; 27: NP341-NP349.
638. Azimi S, Khalili D, Hadaegh F, Yavari P, Mehrabi Y, Azizi F. Calculating Population Attributable Fraction for Cardiovascular Risk Factors Using Different Methods in a Population Based Cohort Study. JRHS 2015; 15: 22-27.
639. Khalili D, Asgari S, Hadaegh F, Steyerberg EW, Rahimi K, Fahimfar N, Azizi F. A new approach to test validity and clinical usefulness of the 2013 ACC/AHA guideline on statin therapy: A population-based study. Int J Cardiol 2015; 184: 587-594.
640. Hajifathalian K, Ueda P, Lu Y, Woodward M, Ahmadvand A, Aguilar-Salinas CA, Azizi F, Cifkova R, Di Cesare M, Eriksen L, Farzadfar F, Ikeda N, Khalili D, Khang YH, Lanska V, León-Muñoz L, Magliano D, Msyamboza KP, Oh K, Rodríguez-Artalejo F, Rojas-Martinez R, Shaw JE, Stevens GA, Tolstrup J, Zhou B, Salomon JA, Ezzati M, Danaei G. A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys. Lancet Diabetes Endocrinol 2015 pii: S2213-8587(15)00081-9.
641. Mirbolouk MH, Asgari S, Sheikholeslami F, Mirbolouk F, Azizi F, Hadaegh F. Different obesity phenotypes, and incident cardiovascular disease and mortality events in elderly Iranians: Tehran lipid and glucose study. Geriatr Gerontol Int 2015; 15: 449–456.
642. Arshi B, Tohidi M, Derakhshan A, Asgari S, Azizi F, Hadaegh F. Sex-specific relations between fasting insulin, insulin resistance and incident hypertension: 8.9 years follow-up in a Middle-Eastern population. Journal of Human Hypertension 2015; 29: 260–267.
643. Azizi F: Letter to Editor about "hypothyroidism and Ramadan fasting". J Fasting Health 2015; 3: 1-3.
644. Azizi F: Islamic Fasting and Thyroid Hormones.  Int J Endocrinol Metab 2015; 13: e29248.
645. Yuzbashian E, Asghari G, Mirmiran P, Hosseini FS, Azizi F. Associations of dietary macronutrients with glomerular filtration rate and kidney dysfunction: Tehran lipid and glucose study. J Nephrol 2015; 28: 173-180.
646. Hosseini-Esfahani F, Mirmiran P, Daneshpour M, Mehrabi Y, Hedayati M, Soheilian-Khorzoghi M, Azizi F: Dietary patterns interact with APOA1/APOC3 polymorphisms to alter the risk of the metabolic syndrome: the Tehran Lipid and Glucose Study. British Journal of Nutrition 2015; 2015; 113: 644-653.
647. Lotfaliany M, Akbarpour S, Mozafary AH, Rajab Boloukat R, Azizi F, Hadaegh F: Hypertension phenotypes and incident cardiovascular disease andmortality events in a decade follow-up of a Middle East cohort. J Hypertension 2015; 33:1153–1161.
648. Nazeri P, Mirmiran P, Shiva N, Mehrabi Y, Mojarrad M, Azizi F: Iodine Nutrition Status in Lactating Mothers Residing in Countries with Mandatory and Voluntary Iodine Fortification Programs: An Updated Systematic Review. Thyroid 2015; 25: 611-20.
649. Bahadoran Z, Ghasemi A, Mirmiran P, Azizi F, Hadaegh F. Beneficial effects of inorganic nitrate/nitrite in type 2 diabetes and its complications. Nutrition & Metabolism 2015; 12:16.
650. Mirmiran P; Moslehi N, Mahmoudof H; Sadeghi M; Azizi F: A Longitudinal Study of Adherence to the Mediterranean Dietary Pattern and Metabolic Syndrome in a Non-Mediterranean Population.  Int J Endocrinol Metab 2015; 13: e26128.
651. Naseri N, Hedayati M, Daneshpour M, Bandarian F, Azizi F: Association of Lecithin Cholesterol Acyltransferase rs5923 Polymorphism in Iranian Individuals with Extremely Low High-Density Lipoprotein Cholesterol: Tehran Lipid and Glucose Study. Iranian Biomedical Journal 2015; 19: 172-176.
652. Ramezankhani A; Pournik O; Shahrabi J; Azizi F; Hadaegh F: An Application of Association Rule Mining to Extract Risk Pattern for Type 2 Diabetes Using Tehran Lipid and Glucose Study Database.  Int J Endocrinol Metab 2015; 13: e25389.
653. Hashemi Nazari S, Shakiba M, Khalili D, Hadaegh F, Tohidi M, Azizi F. High-density lipoprotein cholesterol, a protective or a risk factor for developing coronary heart disease? Tehran Lipid and Glucose Study. Journal of Clinical Lipidology 2015; 9: 553–558.
654. Bahadoran Z, Mirmiran P, Ghasemi A, Kabir A, Azizi F, Hadaegh F: Is dietary nitrate/nitrite exposure a risk factor for development of thyroid abnormality? A systematic review and meta-analysis. Nitric Oxide - Biology and Chemistry 2015; 47: 65-76.
655. Farahmand M, Amiri P, Ramezani Tehrani F, Momenan AA, Mirmiran P, Azizi F. What are the main barriers to healthy eating among families? A qualitative exploration of perceptions and experiences of Tehranian men. Appetite 2015; 89: 291–297.
656. Mirmiran P, Bahadoran Z, Moslehi N, Bastan S, Azizi F. Colors of fruits and vegetables and 3-year changes of cardiometabolic risk factors in adults: Tehran lipid and glucose study. European Journal of Clinical Nutrition 2015; doi:10.1038/ejcn.
657. Mohebi R, Simforoosh A, Tohidi M, Azizi F, Hadaegh F. Obesity Paradox and Risk of Mortality Events in Chronic Kidney Disease Patients: A Decade of Follow-up in Tehran Lipid and Glucose Study. J Ren Nutr 2015; 1. pii: S1051-2276(14)00259-3.
658. Moslehi N, Shab-Bidar S, Mirmiran P, Sadeghi1 M, Azizi F. Associations between dairy products consumption and risk of type 2 diabetes: Tehran lipid and glucose study. Int J Food Sci Nutr, Early 2015; 6:1-8.
659. Hosseinpanah F, Salehpour M, Asghari G, Barzin M, Mirmiran P, Hatami H, Azizi F. Adolescent metabolic phenotypes and early adult metabolic syndrome: Tehran lipid and glucose study.Diabetes Res Clin Pract. 2015 May 16. pii: S0168-8227(15)00252-1. doi: 10.1016/j.diabres.2015.05.022.
660. Hosseinpour-Niazi S, Mirmiran P, Fallah-Ghohroudi A, Azizi F. Non-soya legume-based therapeutic lifestyle change diet reduces inflammatory status in diabetic patients: a randomised cross-over clinical trial. British Journal of Nutrition 2015; 114: 213–219.
661. Zarkesh M, Daneshpour M, Ehsandar SH, Bandehpour M, Alfadhli S, Azizi F, Hedayati M: Association of Human Adenovirus-36 With Dyslipidemia in Tehranian Children and Adolescent; TLGS. Scimetr 2015 April; 3: e23927.
662. Ramezani Tehrani F, Behboudi-Gandevani S, Ghasemi A, Azizi F: Association between serum concentrations of nitric oxide and transition to menopause. Acta Obstet Gynecol Scand 2015; 94: 708-714.
663. Khomami MB, Tehrani FR, Hashemi S, Farahmand M, Azizi F: Of PCOS Symptoms, Hirsutism Has the Most Significant Impact on the Quality of Life of Iranian Women. PLOS One 2015; 10: e0123608.
664. Mirmiran P, Yuzbashian E, Asghari G, Hosseinpour-Niazi S, Azizi F. Consumption of sugar sweetened beverage is associated with incidence of metabolic syndrome in Tehranian children and adolescents. Nutr Metab (Lond). 2015; 12: 25. doi: 10.1186/s12986-015-0021-6. eCollection 2015.
665. Ghotboddin Mohammadi S, Mirmiran P, Bahadoran Z, Mehrabi Y, Azizi F. The Association of Dairy Intake With Metabolic Syndrome and Its Components in Adolescents: Tehran Lipid and Glucose Study. Int J Endocrinol Metab 2015; 13(3): e25201.
666. Hosseinpour-Niazi S, Mirmiran P, Fallah-Ghohroudi A, Azizi F. Combined effect of unsaturated fatty acids and saturated fatty acids on the metabolic syndrome: Tehran Lipid and Glucose Study. Journal of Health, Population and Nutrition 2015; 33: 5.
667. Shab-Bidar S, Hosseini-Esfahani F, Delshad H, Asghari G, Mirmiran P, Azizi F. Dietary intake of vitamin D and metabolic syndrome after 3-year follow-up: Tehran lipid and glucose study. JNSD 2015; 1: 71-79.
668. Golzarand M, Bahadoran Z, Mirmiran P, Sadeghian-Sharif S, Azizi F. Dietary phytochemical index is inversely associated with the occurrence of hypertension in adults: a 3-year follow-up (the Tehran Lipid and Glucose Study). Eur J Clin Nutr 2015; 69: 392-398.
669. -Masudi S, Yavari P, Mehrabi Y, Khalili D, Azizi F. Regression Dilution Bias in Blood Pressure and Body Mass Index in a Longitudinal Population-Based Cohort Study.J Res Health Sci 2015; 15: 77-82.
670. Kazemijaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, Hosseinpanah F, Khalili D, Azizi F. The Prevalence and Causes of Primary Infertility in Iran: A Population-Based Study. Glob J Health Sci 2015; 7: 226-232.
671. Kazemi H, Ramezani Tehrani F, Minooee S, Khalili D, Azizi F. Women self-perception of excess hair growth, as a predictor of clinical hirsutism: a population-based study. J Endocrinol Invest 2015; 38: 923-6238.
672. Mousavi SV, Mohebi R, Mozaffary A, Sheikholeslami F, Azizi F, Hadaegh F. Changes in body mass index, waist and hip circumferences, waist to hip ratio and risk of all-cause mortality in men. Eur J Clin Nutr 2015; 69: 927-932.
673. Bahadoran Z, Mirmiran P, Azizi F. Undesirable Cardiometabolic Outcomes of Fast-Food Patterns (Letter to the Editor) Iran J Public Health 2015; 44: 1160-1161.
674. Mottaghi A, Hojjat P, Mirmiran P, Azizi F. The effect of unhealthy snacks on incidence of hypertension in adults during 3 years follows up: Tehran Lipid and Glucose Study. Bull. Env.Pharmacol. Life Sci 2015; 4: 84-86.
675. Ghasemi A, Tohidi M, Derakhshan A, Hasheminia M, Azizi F, Hadaegh F. Cut-off points of homeostasis model assessment of insulin resistance, betacell function, and fasting serum insulin to identify future type 2 diabetes: Tehran Lipid and Glucose Study. Acta Diabetol 2015; 52: 905–915
676. Hadaegh F, Hasheminia M, Abdi H, Khalili D, Bozorgmanesh MR, Arshi B, Azizi F: Prehypertension Tsunami: A Decade FollowUp of an Iranian Adult Population. PLOS ONE  2015; DOI:10.1371/journal.pone.0139412.
677. Ghoreishian H, Tohidi M, Derakhshan A, Hajsheikholeslami F, Azizi F, Kazempour-Ardebili S, Hadaegh F. Presence of hypertension modifies the impact of insulin resistance on incident cardiovascular disease in a Middle Eastern population: the Tehran Lipid and Glucose Study. Diabet Med 2015; 32: 1311-8.
678. Ejtahed H, Bahador Z, Mirmiran P, Azizi F. Sugar-Sweetened Beverage Consumption Is Associated with Metabolic Syndrome in Iranian Adults: Tehran Lipid and Glucose Study. Endocrinol Metab 2015; 30: 334-342.
679. Bahadoran Z, Mirmiran P, Zarif-yeaganeh M, Zojaji H, Azizi F. Helicobacter pylori Stool Antigen Levels and Serological Biomarkers of Gastric Inflammation are Associated with Cardio-Metabolic Risk Factors in Type 2 Diabetic Patients. Endocrinol Metab 2015; 30: 280-287.
680. Asghari G, Yuzbashian E, Mirmiran P, Mahmoodi B, Azizi F. Fast Food Intake Increases the Incidence of Metabolic Syndrome in Children and Adolescents: Tehran Lipid and Glucose Study. PLOS ONE 2015; DOI: 10.1371.
681. Ghomi MH, Ejtahed H, Mirmiran P, Hosseini‑Esfahani F, Sarbazi N, Azizi F, Sadeghian S. Relationship of Food Security with Type 2 Diabetes and Its Risk Factors in Tehranian Adults. International J Preven Med 2015; 6: 98
682. Ayubi A, Khalimi D, Depisheh A, Hadaegh F, Azizi F: Factor analysis of metabolic syndrome components and predicting type 2 diabetes: Results of 10-year follow-up in a Middle Eastern population. J Diabetes 5015; 7: 830–838.
683. Hosseinpour-Niazi S, Mirmiran P, Hedayati M, Azizi F. Substitution of red meat with legumes in the therapeutic lifestyle change diet based on dietary advice improves cardiometabolic risk factors in overweight type 2 diabetes patients: a cross-over randomized clinical trial. Eur J Clin Nutr 2015; 69: 592-7.
684. Noroozzadeh M, Ramezani Tehrani F, Sedaghat K, Godini A, Azizi F: The impact of prenatal exposure to a single dose of testosterone on insulin resistance, glucose tolerance and lipid profile of female rat's offspring in adulthood. J Endocrinol vInvest 2015; 38: 489-495.
685. Azizi F: Prevention of Iodine Deficiency: Difficult to Implement, More Difficult to Sustain. Nutr Food Sciences Research 2015; 2: 1-2.
686. Moslehi N, Shab-Bidar S, Mirmiran P, Hosseinpanah F, Azizi F. Determinants of parathyroid hormone response to vitamin D supplementation: a systematic review and meta-analysis of randomised controlled trials. Br J Nutr 2015; 114: 1360-74.
687. Azizi F: Diabetes Management during Ramadan. J Fasting Health 2015; 3: 140-143.
688. Bahadoran Z, Mirmiran P, Ghasemi A, Azizi F. Serum nitric oxide metabolites are associated with the risk of hypertriglyceridemic-waist phenotype in women: Tehran Lipid and Glucose Study. Nitric Oxide 2015; 50: 52–57.
689. Farahmand M, Ramezani Tehrani F, Bahri Khomami M, Noroozzadeh M, Azizi F: Surgical menopause versus natural menopause and cardio-metabolic disturbances: A 12-year population-based cohort study. J Endocrinol Invest 2015; 38: 761-767.
690. Bahadoran Z, Mirmiran P, Khosravi H, Azizi F. Associations between Dietary Acid-Base Load and Cardiometabolic Risk Factors in Adults: The Tehran Lipid and Glucose Study. Endocrinol Metab (Seoul) 2015; 30: 201-207.
691. Ramezani Tehrani F, Behboudi-Gandevani S, Simbar M, Azizi F: A population-based study of the relationship between idiopathic hirsutism and metabolic disturbances. J Endocrinol Invest. 2015; 38: 155-162.
692. Hosseinpour-Niazi S, Mirmiran P, Mirzaei S, Azizi F. Cereal, fruit and vegetable fibre intake and the risk of the metabolic syndrome: a prospective study in the Tehran Lipid and Glucose Study. J Hum Nutr Diet 2015; 28: 236-245.
693. Delshad M, Ghanbarian A, Ghaleh NR, Amirshekari G, Askari S, Azizi F. Reliability and validity of the modifiable activity questionnaire for an Iranian urban adolescent population. Int J Prev Med 2015; 6: 3.
694. Eshtiaghi R, Keihani S, Hosseinpanah F, Barzin M, Azizi F. Natural course of metabolically healthy abdominal obese adults after 10 years of follow-up: the Tehran Lipid and Glucose Study. Int J Obes (Lond) 2015; 39: 514-519.
695. Masudi S, Yavari P, Mehrabi Y, Azizi F, Khalili D, Hadaegh F:  Underestimating the Effect of Lipids on Cardiovascular Events: Regression Dilution Bias in the Population-Based Cohort of Tehran Lipid and Glucose Study. Int J Endocrinol Metab 2015; 13: e27528.
696. Nazeri P, Norouzian M.A, Mirmiran P, Hedayati M, Azizi F: Heating Process in Pasteurization and not in Sterilization Decreases the Iodine Concentration of Milk.  Int J Endocrinol Metab 2015; 13: e27995.
697. Nozhat Z, Hedayati M, Azizi F: Thyroid Cancer Epidemic: A Peril or an Alarm? Int J Endocrinol Metab 2015; 13: e28491.
698. Ghasemi A, Azimzadeh I, Afghan M, MomenanA, Bagheripour F, AziziF: Pediatric Reference Values for Serum Creatinine and Estimated Glomerular Filtration Rate in Iranians: Tehran Lipid and Glucose Study. Archives of Iranian Medicine 2015; 18: 753-9.
699. Barzin M, Keihani S, Hosseinpanah F, Serahati S, Ghareh S, Azizi F. Rising trends of obesity and abdominal obesity in 10 years of follow-up among Tehranian adults: Tehran Lipid and Glucose Study (TLGS). Public Health Nutr 2015; 18: 2981-9.
700. Sarkhail P, Mehran L, Askari S, Tahmasebinejad Z, Tohidi M, Azizi F. Maternal Thyroid Function and Autoimmunity in 3 Trimesters of Pregnancy and their Offspring's Thyroid Function. Horm Metab Res 2016; 48: 20-6.
701. Ramezankhani Z, Pournik O, Shahrabi J, Azizi F, Hadaegh F, Khalili D. The Impact of Oversampling with SMOTE on the Performance of 3 Classifiers in Prediction of Type 2 Diabetes. Med Decis Making 2016; 36: 137-44.
702. Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M, AlaviMajd H, Azizi F: Comparison of universal screening with targeted high-risk case finding for diagnosis of thyroid disorders. EJE 2016; 174: 77-83.
703. Fallah MS, Sedaghatikhayat B, Guity K, Akbari F, Azizi F, Daneshpour M: The Relation between Metabolic Syndrome Risk Factors and Genetic Variation in Apolipoprotein V in Relation with Serum Triglyceride and HDL-C Level. AIM 2016; 19: 32-36.
704. Barzin M; Hosseinpanah F, Motamedi MA, Shapoori P, Arian P, Daneshpour M, Asghari G, Teymoornejad A, Eslamifar A, Khalili D, Jodeiri B, Alamdari Sh, Azizi F, KhalajAR. Bariatric Surgery for Morbid Obesity: Tehran Obesity Treatment Study (TOTS) Rationale and Study Design. JMIR Res Protoc 2016; 5: e8.
705. Hosseinpanah F, Mirbolouk M, Mossadeghkhah A, Barzin M, Serahati S, Delshad H, Azizi F. Incidence and potential risk factors of obesity among Tehranian adults. Prev Med 2016; 82: 99-104.
706. Bozorgmanesh M, Sardarinia M, Hajsheikholeslami F, Azizi F, Hadaegh F. CVD-predictive performances of "a body shape index" versus simple anthropometric measures: Tehran lipid and glucose study. Eur J Nutr 2016; 55: 147-157.
707. Bagherzadeh-Khiabani F, Ramezankhani A, Azizi F, Hadaegh F, W.Steyerberg E, Khalili D. A tutorial on variable selection for clinical prediction models: feature selection methods in data mining could improve the results. Journal of Clinical Epidemiology 2016; 71: 76e85.
708. Afghan M, Ghasemi A, Momenan A, Ghanbarian A, Azizi F: Seven-year Changes of leisure-time and occupational physical activity among Iranian adults (Tehran Lipid and Glucose Study). Iranian Journal of Public Health 2016; 45: 41-47.
709. Hadaegh F, Derakhshan A, Mozaffary AH, Hasheminia M, Khalili D, Azizi F: Twelve-Year Cardiovascular and Mortality Risk in Relation to Smoking Habits in Type 2 Diabetic and Non-Diabetic Men: Tehran Lipid and Glucose Study. PLOS ONE 2016; 11: e0149780.
710. Bagheripuor F, Gharibzadeh S, Ghanbari M, Amouzegar A, Tohidi M, Azizi F, Ghasemi A. Association between serum nitric oxide metabolites and thyroid hormones in a general population: Tehran Thyroid Study. Endocr Res 2016; 11: 193-199.
711. Nazeri P, Mirmiran P, Hedayati M, Mehrabi Y, Delshad H, Azizi F. Can postpartum maternal urinary iodine be used to estimate iodine nutrition status of newborns? Br J Nutr 2016; 9: 1226-1231.
712. Angoorani P, Ejtahed HS, Mirmiran P, Mirzaei S, Azizi F. Dietary consumption of advanced glycation end products and risk of metabolic syndrome. Int J Food Sci Nutr 2016; 67: 170-6.
713. Hosseinpour-Niazi S, Mirmiran P, Hosseini-Esfahani F, Azizi F. Is the metabolic syndrome inversely associates with butter, non-hydrogenated- and hydrogenated-vegetable oils consumption: Tehran lipid and glucose study. Diabetes Res Clin Pract 2016; 112: 20-9.
714. Bandarian F, Daneshpour MS, Hedayati M, Naseri M, Azizi F. Identification of Sequence Variation in the Apolipoprotein A2 Gene and Their Relationship with Serum High-Density Lipoprotein Cholesterol Levels. Iran Biomed J 2016; 20: 84-90.
715. Bahadoran Z, Mirmiran P, Azizi F. Fast Food Pattern and Cardiometabolic Disorders: A Review of Current Studies. Health Promot Perspect 2016; 5: 231-40.
716. Hosseinpanah F, Barzin M, Mirbolouk M, Abtahi H, Cheraghi L, Azizi F. Lipid accumulation product and incident cardiovascular events in a normal weight population: Tehran Lipid and Glucose Study. Eur J Prev Cardiol 2016; 23: 187-93.
717. Hadaegh F, Asgari S, Bozorgmanesh MR, Jeddi S, Azizi F, Ghasemi A: Added value of total serum nitrate/nitrite for prediction of cardiovascular disease in middle east caucasian residents in Tehran. Nitric Oxide 2016; 54: 60e66.
718. Safavi A, Azizi F, Jafari R, Chaibakhsh S, Safavi AA. Thyroid Cancer Epidemiology in Iran: a Time Trend Study. Asian Pac J Cancer Prev 2016; 17: 407-412.
719. Farhadnejad H, Asghari G, Mirmiran P, Yuzbashian E, Azizi F: Micronutrient Intakes and Incidence of Chronic Kidney Disease in Adults: Tehran Lipid and Glucose Study 2016; 8: 217.
720. Mozaffary AH, Asgari S, Tohidi M, Kazempour-Ardebili S, Azizi F, Hadaegh F. Change in fasting plasma glucose and incident type 2 diabetes mellitus: results from a prospective cohort study. BMJ Open 2016; 6:e010889.
721. Barkhordari M, Padyab M, Hadaegh F, Azizi F, Bozorgmanesh MR. Stata Modules for Calculating Novel Predictive Performance Indices for Logistic Models.  Int J Endocrinol Metab. 2016; 14(1): e26707.
722. Asgari S, Khalili D, Mehrabi Y, Kazempour-Ardebili S, Azizi F, Hadaegh F. Incidence and risk factors of isolated systolic and diastolic hypertension: a 10 year follow-up of the Tehran Lipids and Glucose Study. Blood Press 2016; 25(3): 177-83.
723. Azizi F, Mehran L, Amouzegar A, Alamdari SH, Subetki I, Saadat N, Moini S, Sarvghadi F. Prevalent Practices of Thyroid Diseases During Pregnancy Among Endocrinologists, Internists and General Practitioners. Int J Endocrinol Metab 2016; 14: e29601.
724. Alamdari SH, Amouzegar A, Tohidi M, Gharibzadeh S, Kheirkhah P, Kheirkhah P, Azizi F: Hypothyroidism and Lipid Levels in a Community Based Study (TTS).  Int J Endocrinol Metab 2016; 14: e22827.
725. Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M, Azizi F: Thyroid and Pregnancy in Tehran, Iran: Objectives and Study Protocol. Int J Endocrinol Metab 2016; 14: e33477.
726. Bahadoran Z, Mirmiran P, Tahmasebi Nejad Z, Ghasemi A, Azizi F. Serum nitric oxide is associated with the risk of chronic kidney disease in women: Tehran lipid and glucose study. Scand J Clin Lab Invest 2016; 76: 304-8.
727. Derakhshan A, Eslami |A, Bozorgmanesh M, Sheikholeslami F, Azizi F, Hadaegh F: Wrist circumference as a novel negative risk factor for cardiovascular disease among adult men: a median follow‑up of 9 years. J Endocrinol Invest 2016; 39: 763-8.
728. Ghasemzadeh Z, Abdi H, Asgari S, Tohidi M, Khalili D, Valizadeh D, Moeini S, Eidkhani V, Azizi F, Hadaegh F: Divergent pathway of lipid profile components for cardiovascular disease and mortality events: Results of over a decade follow-up among Iranian population. Nutrition & Metabolism 2016; 13: 43.
729. NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet 2016; 387 (10026):1377-1396.
730. Ramezani Tehrani F, Mansournia MA, Solaymani-Dodaran M, Steyerberg E, Azizi F. Flexible parametric survival models built on age-specific antimüllerian hormone percentiles are better predictors of menopause. Menopause 2016; 23: 676-81.
731. Hosseinzadeh-Attar MJ, Golpaie A, Foroughi M, Hosseinpanah F, Zahediasl S, Azizi F.The relationship between visfatin and serum concentrations of C-reactive protein, interleukin 6 in patients with metabolic syndrome. J Endocrinol Invest 2016; 39: 917-22.
732. Amouzegar A, Bakhtiyari M, Mansournia MA, Etemadi A, Mehran L, Tohidi M, Azizi F. Sex- and Age-Specific Reference Values and Cutoff Points for TPOAb: Tehran Thyroid Study. Thyroid 2016; 26: 458-65.
733. Minooee S, Ramezani Tehrani F, Azizi F. Hirsutism region and the likelihood of metabolic syndrome: is there a link? Endocrine 2016; 53: 607-9.
734. Nazeri P, Zarghani NH, Mirmiran P, Hedayati M, Mehrabi Y, Azizi F. Iodine Status in Pregnant Women, Lactating Mothers, and Newborns in an Area with More Than Two Decades of Successful Iodine Nutrition. Biol Trace Elem Res 2016; 172: 79-85.
735. Bahadorana Z, Mirmirana P, Jeddib S, Azizi F, Ghasemi A, Hadaegh F. Nitrate and nitrite content of vegetables, fruits, grains, legumes, dairy products, meats and processed meats. Journal of Food Composition and Analysis 2016; 51: 93–105.
736. Asgari S, Barzin M, Hosseinpanah F, Hadaegh F, Azizi F, Khalili D.Obesity Paradox and Recurrent Coronary Heart Disease in a Population-Based Study: Tehran Lipid and Glucose Study. See comment in PubMed Commons below. Int J Endocrinol Metab 2016; 14: e37018.
737. Nazarpour S, Ramezani Tehrani F, Simbar M, Azizi F. Thyroid autoantibodies and the effect on pregnancy outcomes. J Obstet Gynaecol. 2016; 36: 3-9.
738. Amouzegar A, Heidari A, Gharibzadeh S, Mehran L, Tohidi M, Azizi F: The Association Between Blood Pressure and Normal Range Thyroid Function Tests in a Population Based Tehran Thyroid Study. Horm Metab Res 2016; 48: 151-156.
739. Golzarand M, Bahadoran Z, Mirmiran P, Zadeh-Vakili A, Azizi F. Consumption of nitrate-containing vegetables is inversely associated with hypertension in adults: a prospective investigation from the Tehran Lipid and Glucose Study. J Nephrol 2016; 29: 377-84.
740. Yuzbashian E, Asghari G, Mirmiran P, Zadeh-Vakili A, Azizi F. Sugar-sweetened beverage consumption and risk of incident chronic kidney disease: Tehran lipid and glucose study. Nephrology (Carlton) 2016; 21: 608-16.
741. Moslehi N, Hosseini-Esfahani F, Hosseinpanah F, Mirmiran P, Azizi F. Patterns of food consumption and risk of type 2 diabetes in an Iranian population: A nested case–control study. Nutrition & Dietetics 2016; 73: 169–176.
742. Mirmiran P, Khaliliamoghadam S, Bahadoran Z, Tohidi M, Azizi F. Association of dietary carotenoids and the incidence of insulin resistance in adults: Tehran lipid and glucose study. Nutrition & Dietetics 2016; 73: 162–168.
743. Motamed B, Eftekharzadeh A, Hosseinpanah F, Tohidi M, Hasheminia M, Azizi F. The relation between changes in thyroid function and anthropometric indices during long-term follow-up of euthyroid subjects: the Tehran Thyroid Study (TTS). European J Endocrinol 2016; 175: 247–253.
744. Derakhshan A, Bagherzadeh-Khiabani F, Arshi B, Ramezankhani A, Azizi F, Hadaegh F: Different Combinations of Glucose Tolerance and Blood Pressure Status and Incident Diabetes, Hypertension, and Chronic Kidney Disease. J Am Heart Assoc 2016; 5, pii: e003917.
745. Hatami H, Deihim T, Amiri P, Cheraghi L, Azizi F. Association between Metabolic Syndrome and Health-related Quality of Life between Individuals with Normal and Impaired Glucose Regulation: Findings from Tehran Lipid and Glucose Study. Archives of Iranian Medicine 2016; 19: 577-583.
746. Ghazi AA, Hosseinpanah F, Abdi H, Hedayati M, Hasheminia M, Ghazi S, Azizi F. Effect of Different Doses of Oral Cholecalciferol on Serum 1,25(OH)2D in Vitamin D Deficient Schoolchildren. Horm Metab Res 2016; 48: 394-8.
747. Ramezani Tehrani F, Montazeri SA, Khalili D, Cheraghi L, Broekmans FJ, Momenan AA, de Kat AC, Azizi F. Age-specific anti-Müllerian hormone and electrocardiographic silent coronary artery disease. Climacteric 2016; 19: 344-8.
748. Ramezankhani A, Kabir A, Pournik O, Azizi F, Hadaegh F: Classification-based data mining for identification of risk patterns associated with hypertension in Middle Eastern population A 12-year longitudinal study. Medicine 2016; 95: 35.
749. Afsharian S, Akbarpour S, Abdi H, Sheikholeslami F, Moeini AS, Khalili D, Momenan AA, Azizi F, Hadaegh F. Risk factors for cardiovascular disease and mortality events in adults with type 2 diabetes: a 10 year follow-up: Tehran lipid and glucose study. Diabetes Metab Res Rev 2016; 32: 596-606.
750. Moghadam SK, Bahadoran Z, Mirmiran P, Tohidi M, Azizi F. Association between Dietary Acid Load and Insulin Resistance: Tehran Lipid and Glucose Study. Prev Nutr Food Sci 2016; 21: 104-9.
751. Golzarand M, Bahadoran Z, Mirmiran P, Azizi F. Protein Foods Group and 3-Year Incidence of Hypertension: A Prospective Study from Tehran Lipid and Glucose Study. J Ren Nutr 2016; 26: 219-25.
752. Ramezani Tehrani F, Bahri Khomami M, Amouzegar A, Azizi F. Thyroperoxidase antibodies and polycystic ovarian morphology. Int J Gynaecol Obstet 2016; 134: 197-201.
753. Minooee S, Ramezani Tehrani F, Mirmiran P, Azizi F. Low birth weight may increase body fat mass in adult women with polycystic ovarian syndrome. Int J Reprod Bio Med 2016; 14: 335-340.
754. Hashemi S, Ramezani Tehrani F, Mohammadi N, Rostami Dovom M, Torkestani F, Simbar M, Azizi F. Comparison of Metabolic and Hormonal Profiles of Women With and Without Premenstrual Syndrome: A Community Based Cross-Sectional Study. International Journal of Endocrinology and Metabolism 2016; 14: e28422.
755. Behboudi-Gandevani S, Ramezani Tehrani F, Cheraghi L, Azizi F. Could "a body shape index" and "waist to height ratio" predict insulin resistance and metabolic syndrome in polycystic ovary syndrome? Eur J Obstet Gynecol Reprod Biol 2016; 205: 110-114.
756. Farahmand M, Ramezani Tehrani F, Rostami Dovom M, Hashemi S, Azizi F. The impact of oral contraceptives on cardiometabolic parameters. J Endocrinol Invest 2016; 39: 277-83.
757. Behboudi-Gandevani S, Ramezani Tehrani F, Rostami Dovom M, Farahmand M, Bahri Khomami M, Noroozzadeh M, Kabir A, Azizi F. Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies. Gynecol Endocrinol 2016; 32: 343-53.
758. Gohari MR, Ramezani Tehrani F, Chenouri SH, Solaymani-Dodaran M, Azizi F. Individualized predictions of time to menopause using multiple measurements of antimüllerian hormone. Menopause 2016; 23: 839-45.
759. Bahri Khomami M, Ramezani Tehrani F, Hashemi S, Mohammadi N, Rashidi H, Azizi F. Does the risk of metabolic disorders increase among women with polycystic ovary morphology? A population-based study. Hum Reprod 2016; 31: 1339-46.
760. Ramezani Tehrani F, Montazeri SA, Khalili D, Cheraghi L, Broekmans FJ, Momenan AA, de Kat AC, Azizi F. Age-specific anti-Müllerian hormone and electrocardiographic silent coronary artery disease. Climacteric 2016; 19: 344-8.
761. Hatami H, Deihim T, Amiri P, Cheraghi L, Azizi F. Association between Metabolic Syndrom and Health-related Quality of Life between Individuals with Normal and Impaired Glucose Regulation: Findings from Tehran Lipid and Glucose Study. Arch Iran Med 2016; 19: 577-83.
762. Mirmiran P, Yuzbashian E, Bahadoran Z, Asghari G, Azizi F. Dietary Acid-Base Load and Risk of Chronic Kidney Disease in Adults: Tehran Lipid and Glucose Study. Iran J Kidney Dis 2016; 10: 119-25.
763. Asghari G, Yuzbashian E, Mirmiran P, Hooshmand F, Najafi R, Azizi F. Dietary Approaches to Stop Hypertension (DASH) Dietary Pattern Is Associated with Reduced Incidence of Metabolic Syndrome in Children and Adolescents. J Pediatr 2016; 174: 178-184.e1.
764. Ehsani B, Moslehi N, Mirmiran P, Ramezani Tehrani F, Tahmasebinejad Z, Azizi F. A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome. Clin Nutr 2016; 35: 1181-7.
765. Bahadoran Z, Mirmiran P, Tahmasebinejad Zh, Azizi F. Dietary L-arginine intake and the incidence of coronary heart disease: Tehran lipid and glucose study. Nutrition and Metabolism 2016; 13: 23.
766. Mirmiran P, Bahadoran Z, Ghasemi A, Azizi F. The Association of Dietary l-Arginine Intake and Serum Nitric Oxide Metabolites in Adults: A Population-Based Study. Nutrients 2016; 8: 311; doi:10.3390/nu8050311.
767. Mirmiran P, Esfandiari S, Bahadoran Z, Tohidi M, Azizi F. Dietary insulin load and insulin index are associated with the risk of insulin resistance: a prospective approach in Tehran lipid and glucose study. J Diabe  Metab Disor 2016; 15: 23
768. Mohseni-Takalloo S, Hosseini-Esfahani F, Mirmiran P, Azizi F. Associations of Pre-Defined Dietary Patterns with Obesity Associated Phenotypes in Tehranian Adolescents. Nutrients 2016; 8(8). pii: E505.
769. Koochakpoor G, Daneshpour MS, Mirmiran P, Hosseini SA, Hosseini-Esfahani F, Sedaghatikhayat B, Aziz F. The effect of interaction between Melanocortin-4 receptor polymorphism and dietary factors on the risk of metabolic syndrome. Nutr Metab (Lond) 2016; 13: 35.
770. Doostvandi T, Bahadoran Z, Mozaffari-Khosravi H, Mirmiran P, Azizi F. Food intake patterns are associated with the risk of impaired glucose and insulin homeostasis: a prospective approach in the Tehran Lipid and Glucose Study. Public Health Nutrition 2016; 19: 2467-74.
771. Asghari G, Yuzbashian E, Mirmiran P, Bahadoran Z, Azizi F. Prediction of metabolic syndrome by a high intake of energy-dense nutrient-poor snacks in Iranian children and adolescents. Pediatr Res 2016; 79: 697-704.
772. Ejtahed HS, Angoorani P, Asghari G, Mirmiran P, Azizi F. Dietary Advanced Glycation End Products and Risk of Chronic Kidney Disease. J Ren Nutr 2016; 26: 308-14.
773. Mirmiran P, Asghari G, Farhadnejad H, Alamdari S, Dizavi A, Azizi F. The Relationship Between Occupation Transition Status and Metabolic Syndrome in Adult Women: Tehran Lipid and Glucose Study. Metab Syndr Relat Disord 2016; 14: 265-71.
774. Mirmiran P, Bahadoran Z, Golzarand M, Asghari G, Azizi F. Consumption of nitrate containing vegetables and the risk of chronic kidney disease: Tehran Lipid and Glucose Study. Ren Fail 2016; 38: 937-44.
775. Mirmiran P, Golzarand M, Bahadoran Z, Ataee M, Azizi F. Paradoxical association of dairy intake between men and women with the incidence of hypertension: A three-year follow up in Tehran Lipid and Glucose Study. Nutrition and Dietetics 2016; 73: 153-161.
776. Hatami H, Deihim T, Amiri P, Cheraghi L, Azizi F. Association between Metabolic Syndrome and Health-related Quality of Life among Individuals with Normal and Impaired Glucose Regulation: Findings from Tehran Lipid and Glucose Study. Arch Iran Med 2016; 19: 577-83.
777. Asghari G, Yuzbashian E, Mirmiran P, Hooshmand F, Najafi R, Azizi F. Reply.J Pediatr 2016. pii: S0022-3476(16)30569-8. [Epub ahead of print]
778. Delshad H, Touhidi M, Abdollahi Z, Hedayati M, Salehi F, Azizi F. Inadequate iodine nutrition of pregnant women in an area of iodine sufficiency. J Endocrinol Invest 2016; 39: 755-62.
779. Ejtahed HS, Shab-Bidar S, Hosseinpanah F, Mirmiran P, Azizi F. Estimation of Vitamin D Intake Based on a Scenario for Fortification of Dairy Products with Vitamin D in a Tehranian Population, J Am Coll Nutr 2016; 35: 383-91.
780. Bahadoran Z, Ghasemi A, Mirmiran P, Azizi F, Hadaegh F: Nitrate-nitrite-nitrosamines exposure and the risk of type 1 diabetes: A review of current data. World J Diabetes 2016; 7: 433-440.
781. Mirbolouk M, Derakhshan A, Charkhchi P, Guity K, Azizi F, Hadaegh F. Incidence and predictors of early adulthood pre-diabetes/type 2 diabetes, among Iranian adolescents: the Tehran Glucose and Lipid Study. Pediatr Diabetes 2016; 17: 608-616.
782. Moslehi N, Ehsani B, Mirmiran P, Shivappa N, Tohidi M, Hebert JR, Azizi F: Inflammatory properties of diet and glucose-insulin homeostasis in a cohort of Iranian Adults. Nutrients 2016; 8. pii: E735.
783. Ramezankhani A, Hadavandi E, Pournik O, Shahrabi J, Azizi F, Hadaegh F: Decision tree-based modelling for identification of potential interactions between type 2 diabetes risk factors: a decade follow-up in a Middle East prospective cohort study. BMJ 2016; 6: e013336.
784. Azizi F: Endocrinology Is Fascinating. Int J Endocrinol Metab 2016; 14: e42228.
785. Sardarinia M, Akbarpour S, Lotfaliany M, Bagherzadeh-Khiabani F, Bozorgmanesh M, Sheikholeslami F, Azizi F, Hadaegh F. Risk Factors for Incidence of Cardiovascular Diseases and All-Cause Mortality in a Middle Eastern Population over a Decade Follow-up: Tehran Lipid and Glucose Study. PLoS One 2016; 11: e0167623.
786. Mottaghi A, Mirmiran P, Delshad H, Azizi F. Effect of Different Obesity Phenotypes on Incidence of Chronic Kidney Disease in Tehranian Adults. J Am Coll Nutr 2016; 7: 587–596.
787. Bahadoran Z, Mirmiran M, Ghasemi A, Carlström M, Azizi F, Hadaegh F: Association between Dietary Intakes of Nitrate and Nitrite and the Risk of Hypertension and Chronic Kidney Disease: Tehran Lipid and Glucose Study. Nutrients 2016, 8: 811; doi:10.3390/nu8120811.
788. Mirbolouk M, Hajebrahimi MA, Akbarpour S, Tohidi M, Azizi F, Hadaegh F: Different glucose tolerance status and incident cardiovascular disease and all-cause mortality among elderly Iranians. Geriatr Gerontol Int 2016; 16: 1263–1271.
789. Barkhordari M, Padyab M, Sardarinia M, Hadaegh F, Azizi F, Bozorgmanesh MR. Survival Regression Modeling Strategies in CVD Prediction. Int J Endocrinol Metab 2016; 14(2): e32156.
790. Mirmiran P, Bahadoran Z, Khalili Moghadam S, Zadeh Vakili A, Azizi F. A Prospective Study of Different Types of Dietary Fiber and Risk of Cardiovascular Disease: Tehran Lipid and Glucose Study. Nutrients 2016; 8, pii: E686.
791. Panahi MH, Hadaegh F, Yavari P, Kazempour-Ardebili S, Mehrabi Y, Azizi F, Khalili D. A Challenging Interaction of Chronic Kidney Disease with Other Metabolic Disorders: Paradoxes in Cardiometabolic Risk Factors. Iran J Kidney Dis 2016; 10: 274-281.
792. Azizi F: Precision Medicine for Endocrinology. Int J Endocrinol Metab. 2016; 14(3): e40283.
793. Delshad H, Touhidi M, Abdollahi Z, Hedayati M, Salehi F, Azizi F:.Inadequate iodine nutrition of pregnant women in an area of iodine sufficiency. J Endocrinol Invest 2016; 39: 755-62.
794. Nazeri P, Mirmiran P, Kabir A, Azizi F. Neonatal thyrotropin concentration and iodine nutrition status of mothers: A systematic review and meta-analysis. Am J Clin Nutr 2016; 104: 1628-1638.
795. Zarkesh M, Asghari G, Amiri P, Hosseinzadeh, Hedayati M, Ghanbarian A, Azizi F. Familial Aggregation of Metabolic Syndrome with DifferentSocio-Behavioral Characteristics: The fourth Phase of Tehran Lipid andGlucose Study. Iran Red Crescent Med J 2016; 18(8): e30104.
796. Bahadoran Z, Mirmiran P, Tohidi M, Azizi F. Longitudinal Associations of High-Fructose Diet with Cardiovascular Events and Potential Risk Factors: Tehran Lipid and Glucose Study. Nutrients 2017; 9: 872.
797. Hadaegh F, Derakhshan A, Zafari N, Khalili D, Mirbolouk M, Saadat S, Azizi F: Pre-diabetes tsunami: incidence rates and risk factors of pre-diabetes and its different phenotypes over 9 years of follow-up. Diabet Med 2017; 34: 69-78.
798. Eslami A, Mozaffary A, Derakhshan A, Azizi F, Khalili D, Hadaegh F. Sex-specific incidence rates and risk factors of premature cardiovascular disease. A long term follow up of the Tehran Lipid and Glucose Study.Int J Cardiol 2017; 227: 826-832.
799. Derakhshan A, Tohidi M, Hajebrahimi HS, Saadat S, Azizi F, Hadaegh F. Sex-specific incidence rates and risk factors of insulin resistance and b–cell dysfunction: a decade follow-up in a Middle Eastern population. Diabet Med 2017; 34: 245–252.
800. Bahadoran Z, Mirmiran P, Ghasemi A, Carlstrom M, Azizi F, Hadaegh F. Vitamin C intake modify the impact of dietary nitrite on the incidence of type 2 diabetes: A 6-year follow-up in Tehran Lipid and Glucose Study. Nitric Oxide 2017; 62: 24-31.
801. Sardarinia M, Ansari R, Azizi F, Hadaegh F, Bozorgmanesh M. Mortality prediction of a body shape index versus traditional anthropometric measures in an Iranian population: Tehran Lipid and Glucose Study. Nutrition 2017 33: 105-112.
802. Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M, Alavi Majd H, Azizi F:. Effects of levothyroxine treatment on pregnancy outcomes in pregnant women with autoimmune thyroid disease. Europ J Endocrinol 2017; 176: 253–265.
803. Golozar A, Khalili D, Etemadi A, Poustchi H, Fazeltabar A, Hosseini F, Kamangar D, Khoshnia M, Islami F, Hadaegh F, Brennan P, Boffetta P, Abnet CC, Dawsey SM, Azizi F, Malekzadeh R, Danaei G. White rice intake and incidence of type-2 diabetes: analysis of two prospective cohort studies from Iran. BMC Public Health 2017; 17: 133.
804. Ueda P, Woodward M, Lu Y, Hajifathalian K, Al-Wotayan R, Aguilar-Salinas CA, Ahmadvand A, Azizi F, Bentham J, Cifkova R, Di Cesare M, Eriksen L, Farzadfar F, Ferguson TS, Ikeda N, Khalili D, Khang YH, Lanska V, León-Muñoz L, Magliano DJ, Margozzini P, Msyamboza KP, Mutungi G, Oh K, Oum S, Rodríguez-Artalejo F, Rojas-Martinez R, Valdivia G, Wilks R, Shaw JE, Stevens GA, Tolstrup JS, Zhou B, Salomon JA, Ezzati M, Danaei G. Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys. Lancet Diabetes Endocrinol 2017; pii: S2213-8587(17)30015-3.
805. Amouzegar A, Gharibzadeh S, Kazemian E, Mehran L, Tohidi M, Azizi F. The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study. PLoS One 2017; 12: e0169283.
806. Asghari G, Farhadnejad H, Mirmiran P, Dizavi A, Yuzbashian E, Azizi F. Adherence to the Mediterranean diet is associated with reduced risk of incident chronic kidney diseases among Tehranian adults. Hypertens Res 2017; 40: 96-102.
807. Jalali-Farahani S, Amiri P, Karimi M, Gharibzadeh S, Mirmiran P, Azizi F. Socio-Behavioral Factors Associated with Overweight and Central Obesity in Tehranian Adults: a Structural Equation Model. Int J Behav Med 2017; 24: 110-119.
808. Amouzegar A, Mehran L, Hasheminia M, Kheirkhah Rahimabad P, Azizi F. The predictive value of metabolic syndrome for cardiovascular and all-cause mortality: Tehran Lipid and Glucose Study. Diabetes Metab Res Rev 2017; 33: e2819.
809. Asghari G, Eftekharzadeh A, Hosseinpanah F, Ghareh S, Mirmiran P, Azizi F. Instability of different adolescent metabolic syndrome definitions tracked into early adulthood metabolic syndrome: Tehran Lipid and Glucose Study (TLGS). Pediatr Diabetes 2017; 18: 59-66.
810. Nazeri P, Mirmiran P, Tahmasebinejad ZH, Hedayati M, Delshad H, Azizi F: The Effects of Iodine Fortified Milk on the Iodine Status of Lactating Mothers and Infants in an Area with a Successful Salt Iodization Program: A Randomized Controlled Trial. Nutrients 2017; 9(2).
811. Styrkarsdottir U, Helgason H, Sigurdsson A, Norddahl GL, Agustsdottir AB, Reynard LN, Villalvilla A, Halldorsson GH, Jonasdottir A, Magnusdottir A, Oddson A, Sulem G, Zink F, Sveinbjornsson G, Helgason A, Johannsdottir HS, Helgadottir A, Stefansson H, Gretarsdottir S, Rafnar T, Almdahl IS, Brækhus A, Fladby T, Selbæk G, Hosseinpanah F, Azizi F, Min Koh J, Tang NLS, Danesphour M, Mayordomo JI, Welt C, Braund PS, Samani NJ, Kiemeney LA, Lohmander LS, Christiansen C, Andreassen OA, Consortium A, Magnusson O, Masson G, Kong A, Jonsdottir I, Gudbjartsson D, Sulem P, Jonsson H, Loughlin J, Ingvarsson T, Thorsteinsdottir U, Stefansson K. Whole-genome sequencing identifies rare genotypes in COMP and CHADL associated with high risk of hip osteoarthritis. Nature America, Inc., part of Springer Nature. All rights reserved. 2017; published online doi:10.1038/ng.3816.
812. Kazempour-Ardebili S, Ramezankhani A, Eslami A, Akbarpour S, Azizi F, Hadaegh F: Metabolic mediators of the impact of general and central adiposity measures on cardiovascular disease and mortality risks in older adults: Tehran Lipid and Glucose Study. Geriatr Gerontol Int 2017; 17: 2017-2024.
813.  Mehran L, Amouzegar A, Rahimabad PK, Tohidi M, Tahmasebinejad Z, Azizi F. Thyroid Function and Metabolic Syndrome: A Population-Based Thyroid Study. Horm Metab Res 2017; 49: 192-200.
814. Mirmiran P, Bahadoran Z, Zadeh Vakili A, Azizi F: Western dietary pattern increases risk of cardiovascular disease in Iranian adults: a prospective population-based study. Appl. Physiol. Nutr. Metab 2017; 42: 326–332.
815. Riyahi-Alam S, Derakhshan A, Mansournia MA, Mansournia N, Almasi M, Azizi F, Hadaegh F. Blood pressure and cardiovascular morbidity risk in type 2 diabetes with hypertension over a decade of follow-up: evidence for J-shaped phenomenon. J Hum Hypertens 2017; 31: 415-421.
816. Ahi S, Amouzegar A, Gharibzadeh S, Kazempour-Ardebili S, Delshad H, Tohidi M, Azizi F: The Association Between Normal Range TSH and Lipid Profile. Horm Metab Res 2017; 49: 424-429.
817. Daneshpour M, Fallah MS, Sedaghati-Khayat B, Guity K, Khalili D, Hedayati M, Ebrahimi A, Hajsheikholeslami F, Mirmiran P, Ramezani Tehrani F, Momenan AB, Ghanbarian A, Amouzegar A, Amiri P, Azizi F: Rationale and Design of a Genetic Study on Cardiometabolic Risk Factors: Protocol for the Tehran Cardiometabolic Genetic Study (TCGS). JMIR Res Protoc 2017; 6: e28.
818. Lamyian M, Hosseinpour-Niazi S, Mirmiran P, Moghaddam Banaem L, Goshtasebi A, Azizi F: Pre-Pregnancy Fast Food Consumption Is Associated with Gestational Diabetes Mellitus among Tehranian Women. Nutrients 2017; 9: E216.
819. Eftekharzadeh A, Asghari G, Serahati S, Hosseinpanah F, Azizi A, Barzin M, Mirmiran P, Azizi F: Predictors of incident obesity phenotype in nonobese healthy adults. European Journal of Clinical Investigation 2017; 47: 357-365.
820. Doostvandi T, Bahadoran Z, Mozaffari-Khosravi H, Tahmasebinejad Z, Mirmiran P, Azizi F. The association of dietary patterns and the incidence of insulin resistance after a 3-year follow-up: Tehran Lipid and Glucose Study. Asia Pac J Clin Nutr 2017; 26: 531-538.
821. Amiri P, Asghari G, Sadrosadat H, Karimi M, Amouzegar A, Mirmiran P, Azizi F: Psychometric Properties of a Developed Questionnaire to Assess Knowledge, Attitude and Practice Regarding Vitamin D (D-KAP-38). Nutrients 2017, 9, E471.
822. Hosseini-Esfahani F, Mirmiran P, Koochakpoor G, Daneshpour M, Guity M, Azizi F: Some dietary factors can modulate the effect of the zinc transporters 8 polymorphism on the risk of metabolic syndrome. Scientific Reports 2017; 7: 1649, DOI: 10.1038/s41598-017-01762-9.
823. Hosseini-Esfahani F, Mirmiran P, Daneshpour M, Mottaghi A, Azizi F: The Effect of Interactions of Single Nucleotide Polymorphisms of APOA1/APOC3 with Food Group Intakes on the Risk of Metabolic Syndrome. Avicenna Journal of Medical Biotechnology 2017; 9: 94-103.
824. Asghari G, Yuzbashian E, Mirmiran P, Azizi F. The association between Dietary Approaches to Stop Hypertension and incidence of chronic kidney disease in adults: the Tehran Lipid and Glucose Study. Nephrol Dial Transplant 2017; 32 (suppl_2): ii224-ii230.
825. Ramezankhani A, Bagherzadeh-Khiabani F, Khalili D, Azizi F, Hadaegh F: A new look at risk patterns related to coronary heart disease incidence using survival tree analysis: 12 Years Longitudinal Study. Scientific Reports 2017; 7: 3237.
826. Parizadeh D, Ramezankhani A, Momenan AA, Azizi F. Dadaegh F: Exploring risk patterns for incident ischemic stroke during more than a decade of follow-up: A survival tree analysis. Computer Methods and Programs in Biomedicine 2017; 147: 29-35.
827. Abdi H, Kazemian E, Gharibzadeh S, Amouzegar A, Mehran L, Tohidi M, Rashvandi Z, Azizi F. Association between Thyroid Function and Body Mass Index: A 10-Year Follow-Up. Ann Nutr Metab 2017; 70: 338-345.
828. Mirmiran P, ejtahed HS, Angoorani P, Eslami F, Azizi F: Camel milk has beneficial effect on diabetes mellitus: A systematic review. Int J Endocrinol Metab 2017; 15: e2150.
829. Mansournia MA, Holakouie-Naieni K, Fahimfar N, Almasi-Hashiani A, Chergaghi Z, Ayubi E, Hadaegh F, Eskandari F, Azizi F, Khalili D. Risk of coronary heart events based on rose angina questionnaire and ECG besides diabetes and other metabolic risk factors: results of a 10 year follow-up in Tehran Lipdi and Glucose Study. Int J Endocrinol Metab 2017; 15: e42713.
830. Mirmiran P, Bahadoran Z, Ghasemi A, Azizi F: Contribution of dietary amino acids composition to incidence of cardiovascular outcomes: A prospective population-based study. Nutrition, Metabolism & Cardiovascular Diseases 2017; 27: 633-641.
831. Moslehi N, Mirmiran P, Ramezani Tehrani F, Azizi F: Current Evidence on Associations of Nutritional Factors with Ovarian Reserve and Timing of Menopause: A Systematic Review. American Society for Nutrition. Adv Nutr 2017; 8: 597–612.
832. Mirmiran P, Amirhamidi Z, Ejtahed HS, Bahadoran Z, Azizi F: Relationship between Diet and Non-alcoholic Fatty Liver Disease: A Review Article. Iran J Public Health 2017; 46:1007-1017.
833. Talaei B, Amouzegar A, Sahranavard Sh, Hedayati M, Mirmiran P, Azizi F. Effects of Cinnamon Consumption on Glycemic Indicators, Advanced Glycation End Products, and Antioxidant Status in Type 2 Diabetic Patients. Nutrients 2017; 9: 991.
834. Mirmiran P, Bahadoran Z, Esfandyari F, Azizi F. Dietary Protein and Amino Acid Profiles in Relation to Risk of Dysglycemia: Findings from a Prospective Population-Based Study. Nutrients 2017, 9: 971.
835. Kazemijaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, Khalili D, Hosseinpanah F, Azizi F. A Population-Based Study of the Prevalence of Abnormal Uterine Bleeding and its Related Factors among Iranian Reproductive-Age Women: An Updated Data. Arch Iran Med 2017; 20: 558-563.
836. Tehrani FR, Zarkesh M, Tohidi M, Azizi F, Zadeh-Vakili A. Is the association between insulin resistance and diabetogenic haematopoietically expressed homeobox (HHEX) polymorphism (rs1111875) affected by polycystic ovary syndrome status? Reprod Fertil Dev 2017; 29: 670-678.
837. Bahadoran Z, Mirmiran P, Golzarand M, Davudabadi-Farahani R, Azizi F. Dietary Animal-derived L-Arginine Intakes and Risk of Chronic Kidney Disease: a 6-year Follow-up of Tehran Lipid and Glucose Study. Iran J Kidney Dis 2017; 11: 352-359.
838. Gholampour Dehaki M, Amouzegar A, Delshad H, Mehrabi Y, Tohidi M, Azizi F. Thyroid dysfunction in patients with impaired glucose metabolism: 11 year follow up from the Tehran Thyroid Study. PLoS One 2017; 12(10):e0184808.
839. Esfandiari S, Bahadoran Z, Mirmiran P, Tohidi M, Azizi F. Adherence to the dietary approaches to stop hypertension trial (DASH) diet is inversely associated with incidence of insulin resistance in adults: the Tehran lipid and glucose study. J Clin Biochem Nutr 2017; 61:123-129.
840. Hosseini-Esfahani F, Koochakpoor G, Daneshpour MS, Sedaghati-Khayat B, Mirmiran P, Azizi F. Mediterranean Dietary Pattern Adherence Modify the Association between FTO Genetic Variations and Obesity Phenotypes. Nutrients 2017; 9: pii: E1064.
841. Hosseinpour-Niazi S, Hosseini S, Mirmiran P, Azizi F. Prospective Study of Nut Consumption and Incidence of Metabolic Syndrome: Tehran Lipid and Glucose Study. Nutrients 2017; 9(10). pii: E1056. doi: 10.3390/nu9101056.
842. Bozorg-Ghalati F, Hedayati M, Dianatpour M, Azizi F, Mosaffa N, Mehrabani D. Effects of a Phosphoinositide-3-Kinase Inhibitor on Anaplastic Thyroid Cancer Stem Cells. Asian Pac J Cancer Prev 2017; 18: 2287-2291.
843. Ivarsdottir EV, Steinthorsdottir V, Daneshpour MS, Thorleifsson G, Sulem P, Holm H, Sigurdsson S, Hreidarsson AB, Sigurdsson G, Bjarnason R, Thorsson AV, Benediktsson R, Eyjolfsson G, Sigurdardottir O, Olafsson, Zeinali S, Azizi F, Thorsteinsdottir U, Gudbjartsson DF, Stefansson K. Effect of sequence variants on variance in glucose levels predicts type 2 diabetes risk and accounts for heritability. Nat Genet 2017; 49: 1398-1402.
844. Hajebrahimi MA, Akbarpour S, Eslami A, Azizi F, Hadaegh F. Different combinations of glucose tolerance and blood pressure status and incident cardiovascular disease and all-cause mortality events. J Hum Hypertens 2017; 31: 744-749.
845. Amiri M, Ramezani Tehrani F, Nahidi F, Kabir A, Azizi F, Carmina E. Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: A meta-analysis comparing products containing cyproterone acetate with third generation progestins. olism 2017; 73: 22-35.
846. Ramezani Tehrani F, Mansournia MA, Solaymani-Dodaran M, Minooee S, Azizi F. Serum variations of anti-mullerian hormone and total testosterone with aging in healthy adult Iranian men: A population-based study. PLoS One 2017; 12: e0179634.
847. Parizadeh D, Ghahvehchian H, Asgari S, Momenan AA, Azizi F, Hadaegh F. The association between changes in blood pressure components and incident cardiovascular diseases. Blood Press 2017; 26: 341-349.
848. Azizi F, Malboosbaf R. Long-Term Antithyroid Drug Treatment: A Systematic Review and Meta-Analysis. Thyroid 2017; 27: 1223-1231.
849. Samadi R, Shafiei B, Azizi F, Ghasemi A. Radioactive Iodine Therapy and Glucose Tolerance. Cell J 2017; 19: 184-193.
850. Abdi H, Hosseinpanah F, Azizi F, Hadaegh F, Amouzegar A. Screening for Dysglycemia: A Comment on Classification and Diagnosis of Diabetes in American Diabetes Association Standards of Medical Care in Diabetes-2016. Arch Iran Med 2017; 20: 389.
851. Amiri M, Ramezani Tehrani F, Nahidi F, Bidhendi Yarandi R, Behboudi-Gandevani S, Azizi F. Association between biochemical hyperandrogenism parameters and Ferriman-Gallwey score in patients with polycystic ovary syndrome: A systematic review and meta-regression analysis. Clin Endocrinol (Oxf) 2017; 87: 217-230.
852. Mehran L, Amouzegar A, Bakhtiyari M, Mansournia MA, Rahimabad PK, Tohidi M, Azizi F. Variations in Serum Free Thyroxine Concentration Within the Reference Range Predicts the Incidence of Metabolic Syndrome in Non-Obese Adults: A Cohort Study. Thyroid 2017; 27: 886-893.
853. Minooee S, Ramezani Tehrani F, Rahmati M, Mansournia MA, Azizi F. Diabetes incidence and influencing factors in women with and without gestational diabetes mellitus: A 15year population-based follow-up cohort study. Diabetes Res Clin Pract 2017; 128: 24-31.
854. Makhzani P, Afghan M, Tohidi M, Bagheripour F, Azizi F, Ghasemi A. Are serum nitric oxide metabolites associated with fasting insulin among Iranian adults? (Tehran Lipid and Glucose Study). Endocr Res 2017; 42: 96-101.
855. Bahadoran Z, Mirmiran P, Momenan AA, Azizi F. Allium vegetable intakes and the incidence of cardiovascular disease, hypertension, chronic kidney disease, and type 2 diabetes in adults: a longitudinal follow-up study. J Hypertens 2017; 35: 1909-1916.
856. Mirzaei B, Abdi H, Serahati S, Barzin M, Niroomand M, Azizi F, Hosseinpanah F. Cardiovascular risk in different obesity phenotypes over a decade follow-up: Tehran Lipid and Glucose Study. Atherosclerosis 2017; 258: 65-71.
857. Doustmohamadian S, Serahati S, Barzin M, Keihani S, Azizi F, Hosseinpanah F. Risk of all-cause mortality in abdominal obesity phenotypes: Tehran Lipid and Glucose Study. Nutr Metab Cardiovasc Dis 2017; 27: 241-248.
858. Farahmand M, Tehrani FR, Dovom MR, Azizi F. Menarcheal Age and Risk of Type 2 Diabetes: A Community-Based Cohort Study. J Clin Res Pediatr Endocrinol 2017; 9: 156-162.
859. Amouzegar A, Ghaemmaghami Z, Beygi M, Gharibzadeh S, Mehran L, Tohidi M, Azizi F.Natural course of euthyroidism and clues for early diagnosis of thyroid dysfunctions: Tehran Thyroid Study (TTS). Thyroid 2017; 27: 616-625.
860. Samadi R, Ghanbari M, Shafiei B, Gheibi S, Azizi F, Ghasemi A. High dose of radioactive iodine per se has no effect on glucose metabolism in thyroidectomized rats. docrine 2017; 56: 399-407.
861. Noroozzadeh M, Ramezani Tehrani F, Bahri Khomami M, Azizi F. A Comparison of Sexual Function in Women with Polycystic Ovary Syndrome (PCOS) Whose Mothers Had PCOS During Their Pregnancy Period with Those Without PCOS. Arch Sex Behav 2017; 46: 2033-2042.
862. Behboudi-Gandevani S, Ramezani Tehrani F, Bidhendi Yarandi R, Noroozzadeh M, Hedayati M, Azizi F. The association between polycystic ovary syndrome, obesity, and the serum concentration of adipokines. J Endocrinol Invest 2017; 40: 859-866.
863. Behboudi-Gandevani S, Ramezani Tehrani F, Cheraghi L, Noroozzadeh M, Farahmand M, Azizi F. Trends of contraception use among married reproductive age women: Tehran lipid and glucose cohort study 2002-2011. Sex Reprod Healthc 2017; 12: 116-122.
864. Barzin M, Motamedi MA, Serahati S, Khalaj A, Arian P, Valizadeh M, Khalili D, Azizi F, Hosseinpanah F. Comparison of the Effect of Gastric Bypass and Sleeve Gastrectomy on Metabolic Syndrome and its Components in a Cohort: Tehran Obesity Treatment Study (TOTS). Obes Surg 2017; 27: 1697-1704.
865. Ramezankhani A, Azizi F, Ghanbarian A, Parizadeh D, Hadaegh F. The hypertriglyceridemic waist and waist-to-height ratio phenotypes and chronic kidney disease: Cross-sectional and prospective investigations. Obes Res Clin Pract 2017; 11: 585-596.
866. Minooee S, Ramezani Tehrani F, Tohidi M, Azizi F. Role of androgen ratios in the prediction of the metabolic phenotype in polycystic ovary syndrome. Int J Gynaecol Obstet 2017; 137: 110-115.
867. Mirmiran P, Asghari G, Farhadnejad H, Eslamian G, Hosseini-Esfahani F, Azizi F. Low carbohydrate diet is associated with reduced risk of metabolic syndrome in Tehranian adults. Int J Food Sci Nutr 2017; 68: 358-365.
868. Asghari G, Ghorbani Z, Mirmiran P, Azizi F. Nut consumption is associated with lower incidence of type 2 diabetes: The Tehran Lipid and Glucose Study. Diabetes Metab 2017; 43: 18-24.
869. Asghari G, Mirmiran P, Yuzbashian E, Azizi F. A systematic review of diet quality indices in relation to obesity. Br J Nutr 2017; 117: 1055-1065.
870. Amiri P, Hamzavi Zarghani N, Nazeri P, Ghofranipour F, Karimi M, Amouzegar A, Mirmiran P, Azizi F. Can an Educational Intervention Improve Iodine Nutrition Status in Pregnant Women? A Randomized Controlled Trial. Thyroid. 2017; 27: 418-425.
871. Jalali-Farahani S, Amiri P, Abbasi B, Karimi M, Cheraghi L, Daneshpour MS, Azizi F. Maternal Characteristics and Incidence of Overweight/Obesity in Children: A 13-Year Follow-up Study in an Eastern Mediterranean Population. Matern Child Health J 2017; 21: 1211-1220.
872. Depmann M, Eijkemans MJC, Broer SL, de Kat A, Ramezani Tehrani F, Olaymani Dodaran M, Azizi F, Solaymani M, Randolph JR, Harlow SD, Freeman EW, Sammel MD, Wellons M, Verschuren WMM, Van der Schouw YT, Mol BW, Broekmans FJM: How well does AMH relate to the timing of menopause? Results of an individual patient data meta-analysis. Maturitas 2017; 100: 201.
873. Zafari N, Asgari S, Lotfaliany M, Hadaegh AR, Azizi F, Hadaegh F: Impact of hypertension versus diabetes on cardiovascular and all-cause mortality in Iranian older adults: results of 14 years of follow-up. Sci Rep 2017; 7: 14220.
874. Azizi A, Heidari A. The Role of Doctors and Other Health Personnel in Promotion of the Community's Islamic Spiritual Health. Health, Spirituality and Medical Ethics 2017; 4: 2-5.
875. Kalantari S, Khalili D, Asgari S, Fahimfar N, Hadaegh F, Tohidi M, Azizi F: Predictors of early adulthood hypertension during adolescence: a population-based cohort study. BMC Public Health 2017; 17: 915-922.
876. Ramezankhani A, Tohidi M, Azizi F, Hadaegh F: Application of survival tree analysis for exploration of potential interactions between predictors of incident chronic kidney disease: a 15-year follow-up study. J Transl Med 2017; 15: 240-256.
877. Mirmiran P, Bahadoran Z, Ghasemi A, Jeddi S, Azizi F: High-sulforaphane broccoli sprout powder reduces serum nitric oxide metabolites in Helicobacter pylori infected patients. Journal of Functional Foods 2017; 34: 356–358.
878. Jalali-Farahani S, Amiri P, Bakht S, Shayeghian Z, Cheraghi L, Azizi F. Socio-Demographic Determinants of Health-Related Quality of Life in Tehran Lipid and Glucose Study (TLGS). Int J Endocrinol Metab 2017; 15(4): e14548.
879. Mehran L, Khalili D, Yarahmadi SH , Amouzegar A, Mojarrad M, Ajang N, Azizi F: Worldwide Recall Rate in Newborn Screening Programs for Congenital Hypothyroidism. Int J Endocrinol Metab 2017; 15: 25-34.
880. Ghazi AA, Zadeh-Vakili A, Zarif Yeganeh M, Alamdari SH, Amouzegar A, Khorsandi AA, Amirbaigloo AR, Azizi F. Hereditary Vitamin D Resistant Rickets: Clinical, Laboratory, and Genetic Characteristics of 2 Iranian Siblings. Int J Endocrinol Metab 2017; 15: 87-92.
881. Mirmiran P, Esfandiar Z, Hosseini-Esfahani F, Koochakpoor G, Daneshpour MS, Sedaghati-Khayat B, Azizi F: Genetic variations of cholesteryl ester transfer protein and eiet interactions in relation to lipid profiles and coronary heart disease: a systematic review. Nutrition & Metabolism 2017; 14: 77.
882. Gilani N, Kazemnejad A, Zayeri F, Hadaegh F, Azizi F, Khalili D. Anthropometric Indices as Predictors of Coronary Heart Disease Risk: Joint Modeling of Longitudinal Measurements and Time to Event. Iranian J Public Health 2017; 46: 1546-1554.
883. Amiri P, Jalali-Farahani S, Karimi M, Raherian R, Kazempour-Ardebili S, Hosseini-Esfahani F, Mirmiran P, Azizi F: Factors associated with pre-diabetes in Tehranian men and women: A structural equations modeling. Plos One 2017; 12: e0188898.
884. Azizi F, Amouzegar A. Controversies in Management of Hyperthyroidism during Pregnancy. Arch Iran Med 2017; 20: 657-658.
885. Asghari G, Yuzbashian E, Shahemi S, Gaeini Z, Mirmiran P, Azizi F. Dietary total antioxidant capacity and incidence of chronic kidney disease in subjects with dysglycemia: Tehran Lipid and Glucose Study. Eur J Nutr 2017; PP 1-9. (doi: 10.1007/s00394-017-1511-2).
886. Mottaghi A, Mirmiran P, Pourvali K, Tahmasbpour Z, Azizi F. Incidence and Prevalence of Childhood Obesity in Tehran, Iran in 2011. Iran J Public Health 2017; 46: 1395-1403.
887. Minooee S, Ramezani Tehrani F, Rahmati M, Mansournia MA, Azizi F. Dyslipidemia incidence and the trend of lipid parameters changes in women with history of gestational diabetes: a 15-year follow-up study. Endocrine 2017; 58: 228-235.
888. Teymoori F, Asghari G, Mirmiran P, Azizi F. Dietary amino acids and incidence of hypertension: A principle component analysis approach. Sci Rep 2017; 7: 16838.
889. Mirmiran P, Moghadam SK, Bahadoran Z, Ghasemi A, Azizi F. Dietary L-Arginine Intakes and the Risk of Metabolic Syndrome: A 6-Year Follow-Up in Tehran Lipid and Glucose Study. Prev Nutr Food Sci 2017; 22: 263-270.
890. Kazemi Jaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, Hosseinpanah F, Khalili D, Cheraghi L, Azizi F. Polycystic ovary syndrome is a risk factor for diabetes and prediabetes in middle-aged but not elderly women: a long-term population-based follow-up study. Fertil Steril 2017; 108: 1078-1084.
891. Hosseini-Esfahani F, Koochakpoor G, Daneshpour MS, Mirmiran P, Sedaghati-Khayat B, Azizi F. The interaction of fat mass and obesity associated gene polymorphisms and dietary fiber intake in relation to obesity phenotypes. Sci Rep 2017; 7: 18057.
892. Bahadoran Z, Mirmiran P, Kabir A, Azizi F, Ghasemi A. The Nitrate-Independent Blood Pressure-Lowering Effect of Beetroot Juice: A Systematic Review and Meta-Analysis. Adv Nutr 2017; 8: 830-838.
893. Mehran L, Yarahmadi S, Khalili D, Nazeri P, Delshad H, Abdollahi Z, Azhang N, Azizi F. The Impact of Iodine Status on the Recall Rate of the Screening Program for Congenital Hypothyroidism: Findings from Two National Studies in Iran. Nutrients 2017; 9: pii: E1194.
894. Ramezankhani A, Azizi F, Hadaegh F, Eskandari F. Sex-specific clustering of metabolic risk factors and their association with incident cardiovascular diseases: A population-based prospective study. Atherosclerosis 2017; 263: 249-256.
895. Taravatmanesh S, Khalili D, Khodakarim S, Asgari S, Hadaegh F, Azizi F, Sabour S. Determining the Factors Associated with Cardiovascular Disease Recurrence: Tehran Lipid and Glucose Study. J Tehran Heart Cent 2017; 12: 107-113.
896. Azizi F, Ghafouri-Fard S. Outer Dense Fiber Proteins: Bridging between Male Infertility and Cancer. Arch Iran Med 2017; 20: 320-325.
897. Boloukat RR, Ramezankhani A, Hasheminia M, Tasdighi E, Azizi F, Hadaegh F. Impact of blood pressure, cholesterol and glucose in the association between adiposity measures and coronary heart disease and stroke among Iranian population. Clin Nutr 2018; 37(6 Pt A): 2060-2067.
898. Mirmiran P, Hosseinpour-Niazi S, Azizi F. Therapeutic lifestyle change diet enriched in legumes reduces oxidative stress in overweight type 2 diabetic patients: a crossover randomised clinical trial. Eur J Clin Nutr 2018; 72: 174-176.
899. Tohidi M, Derakhshan A, Akbarpour S, Amouzegar A, Mehran L, Baghbani-Oskouei A, Azizi F, Hadaegh F. Thyroid Dysfunction States and Incident Cardiovascular Events: The Tehran Thyroid Study. Horm Metab Res 2018; 50: 37–43.
900. Jalali-Farahani S, Amiri P, Karimi M, Vahedi-Notash G, Amirshekari G, Azizi F. Perceived social support and health-related quality of life (HRQoL) in Tehranian adults: Tehran lipid and glucose study. Health Qual Life Outcomes 2018; 16(1):90.
901. Mansournia MA, Minooee S, Ramezani Tehrani F, Rahmati M, Azizi F: Authors' reply. Climacteric 2018; 21(2):196.
902. Zarkesh M, Zadeh-Vakili A, Azizi F, Foroughi F, Akhavan MM, Hedayati M. Altered Epigenetic Mechanisms in Thyroid Cancer Subtypes. Mol Diagn Ther 2018; 22: 41-56.
903. Ramezankhani A, Azizi F, Hadaegh F, Momenan AA. Diabetes and number of years of life lost with and without cardiovascular disease: a multi-state homogeneous semi-Markov model. Acta Diabetol 2018; 55: 253-262.
904. Ebrahimof S, Hosseini-Esfahani F, Mirmiran P, Fallah-Kezabi M, Azizi F. Food Patterns and Framingham Risk Score in Iranian Adults: Tehran Lipid and Glucose Study: 2005-2011. Metab Syndr Relat Disord 2018; 16: 64-71.
905. Nazeri P, Kabir A, Dalili H, Mirmiran P, Azizi F: Breast-Milk Iodine Concentrations and Iodine Levels of Infants According to the Iodine Status of the Country of Residence: A Systematic Review and Meta-Analysis. Thyroid 2018, 28: 124-138.
906. Zameni F, Bakhtiyari M, Mansournia MA, Ramezankhani Z, Azizi F, Hadaegh F: Is incident type 2 diabetes associated with cumulative excess weight and abdominal adiposity? Tehran Lipid and Glucose Study. Diabet Esre Search and Clinical Practice 2018; 136: 134-142.
907. Eslami A, Lotfaliany M, Akbarpour S, Azizi F, Hadaegh F: Trend of cardiovascular risk factors in the older Iranian population: 2002–2014. Geriatr Geromtol Int 2018; 18: 130-137.
908. Teymoori F, Asghari G, Mirmiran P, Azizi F. High dietary intake of aromatic amino acids increases risk of hypertension. J Am Soc Hypertens 2018; 12: 25-33.
909. Minooee S, Ramezani Tehrani F, Rahmati M, Mansournia MA, Azizi F. Prediction of age at menopause in women with polycystic ovary syndrome. Climacteric 2018; 21: 29-34.
910. Nasiri Amiri F, Ramezani Tehrani F, Esmailzadeh S, Tohidi M, Azizi F, Basirat Z. Sexual function in women with polycystic ovary syndrome and their hormonal and clinical correlations. Int J Impot Res Int J Impot Res 2018; 30: 54-61.
911. Kabootari M, Asgari S, Mansournia MA, Khalili D, Valizadeh M, Azizi F, Hadaegh F: Different Weight Histories and Risk of Incident Coronary Heart Disease and Stroke: Tehran Lipid and Glucose Study. J Am Heart Assoc 2018; 7(4). pii: e006924.
912. Abdi H, Gharibzadeh S, Tasdighi E, Amouzegar A, Mehran L, Tohidi M, Azizi F: Associations Between Thyroid and Blood Pressure in Euthyroid Adults: A 9-Year Longitudinal Study. Horm Metab Res 2018; 50: 1–8.
913. Mohammadi M, Azizi F, Hedayati M. Iodine deficiency status in the WHO Eastern Mediterranean Region: a systematic review. Environ Geochem Health. Environ Geochem Health 2018; 40: 87-97.
914. Bahadoran Z, Carlström M, Ghasemi A, Mirmiran P, Azizi F, Hadaegh F. Total antioxidant capacity of the diet modulates the association between habitual nitrate intake and cardiovascular events: A longitudinal follow-up in Tehran Lipid and Glucose Study. Nutr Metab (Lond) 2018; 15: 19.
915. Azizi F, Amouzegar A. Management of thyrotoxicosis in children and adolescents: 35 years' experience in 304 patients. J Pediatr Endocrinol Metab 2018; 31: 159-165.
916. Yuzbashian E, Asghari G, Mirmiran P, Amouzegar-Bahambari P, Azizi F. Adherence to low-sodium Dietary Approaches to Stop Hypertension - style diet may decrease the risk of incident chronic kidney disease among high-risk patients: a secondary prevention in prospective cohort study. Nephrol Dial Transplant 2018; 33: 1159-1168.
917. Rabani S, Sardarinia M, Akbarpour S, Azizi F, Khalili D, Hadaegh F. 12-year trends in cardiovascular risk factors (2002-2005 through 2011-2014) in patients with cardiovascular diseases: Tehran lipid and glucose study. PLoS One 2018; 13: e0195543.
918. Koochakpoor G, Mirmiran P, Daneshpour MS, Hosseini-Esfahani F, Sedaghati-Khayat B, Hosseini SA, Azizi F. Dietary factors influence the association of cyclin D2 polymorphism rs11063069 with the risk of metabolic syndrome. Nutr Res 2018; 52: 48-56.
919. Amiri M, Ramezani Tehrani F, Nahidi F, Kabir A, Azizi F. Comparing the effects of combined oral contraceptives containing progestins with low androgenic and antiandrogenic activities on the hypothalamic-pituitary-gonadal axis in patients with polycystic ovary syndrome: systematic review and meta-analysis. JMIR Res Protoc 2018; 7: e113.
920. Abbasi M, Daneshpour MS, Hedayati M, Mottaghi A, Pourvali K, Azizi F. The relationship between MnSOD Val16Ala gene polymorphism and the level of serum total antioxidant capacity with the risk of chronic kidney disease in type 2 diabetic patients: a nested case-control study in the Tehran lipid glucose study. Nutr Metab (Lond) 2018; 15: 25.
921. Asghari G, Farhadnejad H, Teymoori F, Mirmiran P, Tohidi M, Azizi F. High dietary intake of branched-chain amino acids is associated with an increased risk of insulin resistance in adults. J Diabetes 2018; 10: 357-364.
922. Amouzegar A, Kazemian E, Abdi H, Mansournia MA, Bakhtiyari M, Hosseini MS, Azizi F. Association between thyroid function and development of different obesity phenotypes in euthyroid adults: A nine-year follow-up. Thyroid 2018; 28(4): 458-464.
923. Bahadoran Z, Mirmiran P, Azizi F, Ghasemi A. Nitrate-rich dietary supplementation during pregnancy: The pros and cons.Pregnancy Hypertension 2018; 11: 44-46.
924. Goshtasebi A, Hosseinpour-Niazi S, Mirmiran P, Lamyian M, Moghaddam Banaem L, Azizi F. Pre-pregnancy consumption of starchy vegetables and legumes and risk of gestational diabetes mellitus among Tehranian women. Diabetes Res Clin Pract 2018; 139: 131-138.
925. Nazeri N, Dalili H, Mehrabi Y, Hedayati M, Mirmiran P, Azizi F: Is there any difference between the iodine statuses of breast-fed and formula- fed infants and their mothers in an area with iodine sufficiency? Br J Nutr 2018; 119: 1012-1018.
926. Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M, Minooee S, Rahmati M, Azizi F. Effects of Levothyroxine on pregnant women with subclinical hypothyroidism, negative for thyroid peroxidase antibodies. J Clin Endocrinol Metab 2018; 103: 926-935.
927. Farhadnejad H, Asghari G, Mirmiran P, Azizi F. Dietary approach to stop hypertension diet and cardiovascular risk factors among 10- to 18-year-old individuals. Pediatr Obes 2018; 13: 185-194.
928. Delshad H, Mirmiran P, Abdollahi Z, Salehi F, Azizi F. Continuously sustained elimination of iodine deficiency: a quarter of a century success in the Islamic Republic of Iran. J Endocrinol Invest 2018; 41: 1089-1095.
929. Mirmiran P, Yuzbashian E, Asghari G, Sarverzadeh S, Azizi F. Dietary fibre intake in relation to the risk of incident chronic kidney disease. Br J Nutr 2018; 119: 479-485.
930. Nazarpour S, Ramezani Tehrani F, Simbar M, Minooee S, Rahmati M, Mansournia MA, Azizi F. Establishment of trimester-specific reference range for thyroid hormones during pregnancy. Clin Biochem 2018; 53: 49-54.
931. Azizi F, Mehran L, Hosseinpanah F, Delshad H, Amouzegar A. Secondary and tertiary preventions of thyroid disease. Endocr Res 2018; 43: 124-140.
932. Jalali-Farahani S, Amiri P, Akbar HM, Cheraghi L, Karimi M, Azizi F. Effects of a Healthy Lifestyle Education on the Incidence of Metabolic Syndrome in Children during a 13-Year Follow-up. Int J Behav Med 2018; 25: 131-140.
933. Hooshmand F, Asghari G, Yuzbashian E, Mahdavi M, Mirmiran P, Azizi F. Modified Healthy Eating Index and Incidence of Metabolic Syndrome in Children and Adolescents: Tehran Lipid and Glucose Study. J Pediatr 2018; 197: 134-139.e2.
934. Amiri P, Jalali-Farahani S, Masihay Akbar H, Cheraghi L, Khalili D, Momenan A, Mirmiran P, Ghanbarian A, Hedayati M, Hosseini-Esfahani F, Azizi F. The Effects of a Community-Based Lifestyle Intervention on Metabolic Syndrome and Its Components in Adolescents: Findings of a Decade Follow-Up. Metab Syndr Relat Disord 2018; 16: 215-223.
935. Azizi F: Postpartum thyroid disorders. Ann Thyroid 2018; 3: 13.
936. Zafari N, Lotfaliany M, Mansournia MA, Khalili D, Azizi F, Hadaegh F. Optimal cut-points of different anthropometric indices and their joint effect in prediction of type 2 diabetes: results of a cohort study. 2018; 18: 691.
937. Kabootari M, Raee MR, Akbarpour S, Asgari S, Azizi F, Hadaegh F. Serum alkaline phosphatase and the risk of coronary heart disease, stroke and all-cause mortality: Tehran Lipid and Glucose Study. BMJ Open 2018; 8(11): e023735.
938. Khaloo P, Hasheminia M, Tohidi M, Abdi H, Mansournia MA, Azizi F, Hadaegh F. Impact of 3-year changes in lipid parameters and their ratios on incident type 2 diabetes: Tehran lipid and glucose study. Nutrition & Metabolism 2018; 15: 50.
939. Hashemi A, Nourbakhsh S, Asgari S, Mirbolouk MH, Azizi F, Hadaegh F: Blood pressure components and incident cardiovascular disease and mortality events among Iranian adults with chronic kidney disease during over a decade long follow-up: a prospective cohort study. Transl Med 2018; 16: 230.
940. Asghari G, Dehghan P, Mirmiran P, Yuzbashian E, Mahdavi M, Tohidi M, Neyestani TR, Hosseinpanah F, Azizi F. Insulin metabolism markers are predictors of subclinical atherosclerosis among overweight and obese children and adolescents. BMC Pediatr 2018; 18: 368.
941. Lotfaliany M, Akbarpour S, Zafari N, Mansournia MA, Asgari S, Azizi F, Hadaegh F, Khalili D. World Bank Income Group, Health Expenditure or Cardiometabolic Risk Factors? A Further Explanation of the Wide Gap in Cardiometabolic Mortality Between Worldwide Countries: An Ecological Study. Int J Endocrinol Metab 2018;16: e59946.
942. Mansoori P, Majdzadeh R, Abdi Z, Rudan I, Chan KY; Iranian CHNRI Health Research Priority Setting Group, Aarabi M, Ahmadnezhad E, Ahmadnia S, Akhondzadeh S, Azin A, Azizi F, Dehnavieh R, Eini-Zinab H, Farzadfar F, Farzaei MH, Ghanei M, Haghdoost A, Hantoushzadeh S, Heydari G, Joulaei H, Kalantari N, Kelishadi R, Khosravi A, Larijani B, Mahvi AH, Bavani ARM, Mesdaghinia A, Mokri A, Montazeri A, Mostafavi E, Motevalian SA, Naddafi K, Nikfar S, Nojoumi SA, Noroozian M, Olyaeemanesh A, Omidvar N, Ostadtaghizadeh A, Pourmalek F, Rahimi R, Rahimi-Movaghar A, Rashidian A, Razaghi E, Sadeghi-Bazargani H, Zalani GS, Soori H, Tabrizi JS, Vedadhir A, Yazdizadeh B, Yunesian M, Zare M. Setting research priorities to achieve long-term health targets in Iran. J Glob Health 2018; 8: 020702.
943. Nazarpour S, Ramezani Tehrani F, Rahmati M, Minooee S, Simbar M, Noroozzadeh M, Azizi F. Validation of Billewicz Scoring System for Detection of Overt Hypothyroidism During Pregnancy. Int J Endocrinol Metab 2018; 16: e64249.
944. Asghari G, Farhadnejad H, Hosseinpanah F, Moslehi N, Mirmiran P, Azizi F. Effect of vitamin D supplementation on serum 25-hydroxyvitamin D concentration in children and adolescents: a systematic review and meta-analysis protocol. BMJ Open 2018; 8: e021636.
945. Amiri P, Jalali-Farahani S, Rezaei M, Cheraghi L, Hosseinpanah F, Azizi F. Which obesity phenotypes predict poor health-related quality of life in adult men and women? Tehran Lipid and Glucose Study. PLoS One 2018; 13: e0203028.
946. Taherian R, Jalali-Farahani S, Karimi M, Amiri P, Maghsoudi E, Mirmiran P, Azizi F. Factors Associated with Pre-Hypertension Among Tehranian Adults: A Novel Application of Structural Equation Models. Int J Endocrinol Metab 2018; 16: e59706.
947. Barzin M, Aryannezhad S, Serahati S, Beikyazdi A, Azizi F, Valizadeh M, Ziadlou M, Hosseinpanah F. Incidence of obesity and its predictors in children and adolescents in 10 years of follow up: Tehran lipid and glucose study (TLGS). BMC Pediatr 2018; 18: 245.
948. Salehinia F, Abdi H, Hadaegh F, Serahati S, Valizadeh M, Azizi F, Hosseinpanah F. Abdominal obesity phenotypes and incident diabetes over 12 years of follow-up: The Tehran Lipid and glucose study. Diabetes Res Clin Pract 2018; 144: 17-24.
949. Mirmiran P, Bahadoran Z, Nazeri P, Azizi F. Dietary sodium to potassium ratio and the incidence of hypertension and cardiovascular disease: A population-based longitudinal study. Clinical Experimen Hyper 2018; 40:772-79.
950. Abdi H, Azizi F, Amouzegar A. Insulin Monotherapy Versus Insulin Combined with Other Glucose-Lowering Agents in Type 2 Diabetes: A Narrative Review. Int J Endocrinol Metab 2018; 16: e65600.
951. Fahimfar N, Khalili D, Sepanlou SG, Malekzadeh R, Azizi F, Mansournia MA, Roohafza H, Emamian MH, Hadaegh F, Poustchi H, Mansourian M, Hashemi H, Sharafkhah M, Pourshams A, Farzadfar F, Steyerberg EW, Fotouhi A. Cardiovascular mortality in a Western Asian country: results from the Iran Cohort Consortium. BMJ Open 2018; 8: e020303.
952. Esfandiar Z, Hosseini-Esfahani F, Daneshpour MS, Zand H, Mirmiran P, Azizi F. Cholesteryl ester transfer protein gene variations and macronutrient intakes interaction in relation to metabolic syndrome: Tehran lipid and glucose study. Iran J Basic Med Sci 2018; 21: 586-592.
953. Mirmiran P, Yousefi R, Mottaghi A, Azizi F. Advanced glycation end products and risk of hypertension in Iranian adults: Tehran lipid and glucose study. J Res Med Sci 2018; 23: 43.
954. Farhadnejad H, Teymoori F, Asghari G, Mirmiran P, Azizi F. The Association of Potato Intake with Risk for Incident Type 2 Diabetes in Adults. Can J Diabetes 2018; pii: S1499-2671(17)30947-4.
955. Ghasemi A, Asgari S, Hadaegh F, Kheirandish M, Azimzadeh I, Azizi F, Tohidi M. New modified Friedewald formulae for estimating low-density lipoprotein cholesterol according to triglyceride levels: extraction and validation.  Endocrine 2018; 62: 404-411.
956. Ramezankhani A, Ehteshami-Afshar S, Hasheminia M, Hajebrahimi MA, Azizi F, Hadaegh F. Optimum cutoff values of anthropometric indices of obesity for predicting hypertension: more than one decades of follow-up in an Iranian population. J Hum Hypertens 2018; 32: 838-848.
957. Mirmiran P, Hadavi H, Mottaghi A, Azizi F. Effect of dietary patterns on oxidative stress in Patiants with metabolic syndrome: Tehran Lipid and Glucose Study. Caspian J Intern Med 2018; 9: 376-385.
958. Zarkesh M, Zadeh-Vakili A, Akbarzadeh M, Fanaei SA, Hedayati M, Azizi F. The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer. BMC Cancer 2018; 18: 1199.
959. Behboudi-Gandevani S, Ramezani Tehrani F, Hosseinpanah F, Khalili D, Cheraghi L, Kazemijaliseh H, Azizi F. Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study. Fertil Steril 2018; 110: 1377-1386.
960. Shabani N, Razaviyan J, Paryan M, Tavangar SM, Azizi F, Mohammadi-Yeganeh S, Hedayati M. Evaluation of miRNAs expression in medullary thyroid carcinoma tissue samples: miR-34a and miR-144 as promising overexpressed markers in MTC. Hum Pathol 2018; 79: 212-221.
961. Zarkesh M, Zadeh-Vakili A, Azizi F, Fanaei SA, Foroughi F, Hedayati M. The Association of BRAF V600E Mutation With Tissue Inhibitor of Metalloproteinase-3 Expression and Clinicopathological Features in Papillary Thyroid Cancer. Int J Endocrinol Metab 2018; 16(2): e56120.
962. Mirmiran P, Esfandyari S, Moghadam SK, Bahadoran Z, Azizi F. Fatty acid quality and quantity of diet and risk of type 2 diabetes in adults: Tehran Lipid and Glucose Study. J Diabetes Complications 2018; 32: 655-659
963. Moslehi N, Shab-Bidar S, Ramezani Tehrani F, Mirmiran P, Azizi F. Is ovarian reserve associated with body mass index and obesity in reproductive aged women? Menopause 2018; 25: 1046-1055.
964. Sohrab G, Ebrahimof S, Hosseinpour-Niazi S, Yuzbashian E, Mirmiran P, Azizi F. The Association of Dietary Intakes of Total Polyphenol and Its Subclasses with the Risk of Metabolic Syndrome: Tehran Lipid and Glucose Study. Metab Syndr Relat Disord 2018; 16: 274-281.
965. Nazeri P, Dalili H, Mehrabi Y, Hedayati M, Mirmiran P, Azizi F. Breast Milk Iodine Concentration Rather than Maternal Urinary Iodine Is a Reliable Indicator for Monitoring Iodine Status of Breastfed Neonates. Biol Trace Elem Res 2018; 185(1):71-77.
966. Asghari G, Yuzbashian E, Shahemi S, Gaeini Z, Mirmiran P, Azizi F. Dietary total antioxidant capacity and incidence of chronic kidney disease in subjects with dysglycemia: Tehran Lipid and Glucose Study. Eur J Nutr 2018; 57: 2377-2385.
967. Tohidi M, Baghbani-Oskouei A, Ahanchi NS, Azizi F, Hadaegh F. Fasting plasma glucose is a stronger predictor of diabetes than triglyceride-glucose index, triglycerides/high-density lipoprotein cholesterol, and homeostasis model assessment of insulin resistance: Tehran Lipid and Glucose Study. Acta Diabetol 2018; 55: 1067-1074
968. Nazeri P, Tahmasebinejad Z, Mehrabi Y, Hedayati M, Mirmiran P, Azizi F. Lactating Mothers and Infants Residing in an Area with an Effective Salt Iodization Program Have No Need for Iodine Supplements: Results from a Double-Blind, Placebo-Controlled, Randomized Controlled Trial. Thyroid 2018; 28: 1547-1558.
969. Barzin M, Piri Z, Serahati S, Valizadeh M, Azizi F, Hosseinpanah F. Incidence of abdominal obesity and its risk factors among Tehranian adults. Public Health Nutr 2018; 21: 3111-3117.
970. Asghari G, Khalaj A, Ghadimi M, Mahdavi M, Farhadnejad H, Valizadeh M, Azizi F, Barzin M, Hosseinpanah F. Prevalence of Micronutrient Deficiencies Prior to Bariatric Surgery: Tehran Obesity Treatment Study (TOTS). Obes Surg 2018; 28: 2465-2472.
971. Mirmiran P, Hosseini S, Hosseinpour-Niazi S, Azizi F. Legume consumption increase adiponectin concentrations among type 2 diabetic patients: A randomized crossover clinical trial. Endocrinol Diabetes Nutr 2018: S2530-0164(18)30182-4.
972. Barghchi E, Azizi F: Is subclinical thyroid dysfunction associated with coronary heart disease? J Cardiothorac Med 2018; 6: 338-343.
973. Mirmiran P, Carlström M, Bahadoran Z, Azizi F. Long-term effects of coffee and caffeine intake on the risk of pre-diabetes and type 2 diabetes: Findings from a population with low coffee consumption. Nutr Metab Cardiovasc Dis 2018; 28: 1261-1266.
974. Nozhat Z, Mohammadi-Yeganeh S, Azizi F, Zarkesh M, Hedayati M. Effects of metformin on the PI3K/AKT/FOXO1 pathway in anaplastic thyroid Cancer cell lines. Daru 2018; 26(2):93-103.
975. Depmann M, Eijkemans MJC, Broer SL, Ramezani Tehrani F, Solaymani-Dodaran M, Azizi F, Lambalk CB, Randolph JF, Harlow SD, Freeman EW, Sammel MD, Verschuren WMM, Van der Schouw YT,Mol BW, Broekmans FJM. Does AMH relate to timing of menopause? Results of an individual [atient data meta-analysis. JCEM 2018; 103: 3593-3600.
976. NCD Risk Factor Collaboration (NCD-RisC), Azizi F: Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: a pooled analysis of 1018 population-based measurement studies with 88.6 million participants. Internal J Epidemiol 2018; 47: 872-883i.
977. Barzin M, Kalantar Motamedi MA, Khalaj AR, Serahati S, Khalili D, Morakabati A, Valizadeh M, Azizi F, Hosseinpanah F, Rakhshani N. Nonalcoholic Fatty Liver Disease and Liver Fibrosis in Bariatric Patients: Tehran Obesity Treatment Study (TOTS). Hepatitis Monthly: May 2018, 18 (5); e64380.
978. Khajavi AR, Khalili D, Azizi F, Hadaegh F: Impact of temperature and air pollution on cardiovascular disease and death in Iran: A 15-year follow-up of Tehran Lipid and Glucose Study. Science of the Total Environment 2019; 661: 243–250.
979. Khalili-Moghadam S, Mirmiran P, Bahadoran Z, Azizi F. The Mediterranean diet and risk of type 2 diabetes in Iranian population. Eur J Clin Nutr 2019; 73: 72-78.
980. Amiri M, Tehrani FR, Bidhendi-Yarandi R, Behboudi-Gandevani S, Azizi F, Carmina E. Relationships Between Biochemical Markers of Hyperandrogenism and Metabolic Parameters in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Horm Metab Res 2019; 51: 22-34.
981. Khalili-Moghadam S, Mirmiran P, Bahadoran Z, Azizi F. The Mediterranean diet and risk of type 2 diabetes in Iranian population. Eur J Clin Nutr 2019; 73: 72-78.
982. Mirmiran P, Hosseini S, Hosseinpour-Niazi S, Azizi F. Legume consumption increase adiponectin concentrations among type 2 diabetic patients: A randomized crossover clinical trial. Endocrinol Diabetes Nutr 2019; 66: 49-55.
983. Ahanchi NS, Hadaegh F, Alipour A, Ghanbarian1 A, Azizi F, Khalili D. Application of Latent Class Analysis to Identify Metabolic syndrome Components patterns in adults: tehran Lipid and Glucose study. Scientific RepoRts 2019; 9: 1572.
984. Hosseini-Esfahani F, Esfandiar Z, Mirmiran P, Daneshpour MS, Ghanbarian A, Azizi F: The interaction of cholesteryl ester transfer protein gene variations and diet on changes in serum lipid profiles. Europ J Clin Nutr 2019; Published online.
985. Khalili D, Asgari S, Lotfaliany M, Zafari N, Hadaegh F, Momenan AB, Nowroozpoor A, Hosseini-Esfahani F, Mirmiran P, Amiri  P, Azizi F: Long-Term Effectiveness of a Lifestyle Intervention: A Pragmatic Community Trial to Prevent Metabolic Syndrome. Am J Prev Med 2019; 56: 437−446.